the Final Program Book
Transcription
the Final Program Book
SHEASPRING.ORG | #SHEA2016 SHEA Spring 2016 Conference SCIENCE GUIDING PREVENTION FINAL PROGRAM May 18-21 ATLANTA, GEORGIA Westin Peachtree Hotel Dear Colleagues, On behalf of the Society for Healthcare Epidemiology of America (SHEA), the Planning Committee, and the Board of Trustees, welcome to the SHEA Spring 2016 Conference: Science Guiding Prevention in Atlanta, GA. CONTENTS Accreditation Information, 1-2 Financial Disclosures, 3 Instructions to Acquire Your Certificate(s), 4-5 Networking Events, 6-7 General Information, 7 SHEA Awards, 8-9 Schedule at a Glance, 10-13 Westin Peachtree Hotel Floor Plan, 14-15 We are all excited to welcome you for the next few days to immerse yourself in education and training related to infection prevention, healthcare epi and antibiotic stewardship in many different settings. We are very proud of the sessions and speakers taking part in this conference. We feel strongly that all attendees will leave Atlanta with new ideas and methods to implement at your own institutions. SHEA believes education is the basis for fulfilling our vision statement – safe healthcare for all – and is proud to sponsor educational efforts that so closely align with this mission. We understand you have many choices when it comes to meeting your educational needs for the year and are thankful you selected SHEA as one of those meetings. SHEA Spring 2016 Conference highlights you will not want to miss include: • Focused scientific abstracts related to healthcare epidemiology, surveillance, implementation science and patient safety, and prevention strategies in poster form during breakfast and lunch breaks and a limited number of oral presentations • All the educational sessions in the general conference and specialized tracks but especially the plenaries, which are open to ALL attendees • Expanded networking opportunities during breaks • The Women in Epi Networking Reception on Wednesday, May 18 • Mentorship Networking Breakfast on Thursday, May 19 (by invitation only) • SHEA Education & Research Foundation Dinner on Thursday, May 19 (extra ticket purchase) • International Meet and Greet Breakfast on Friday, May 20 (by invitation only) Wednesday, May 18, 16-20 Thursday, May 19, 21-36 Friday, May 20, 37-54 Saturday, May 21, 53-54 The next few days are jam-packed with education from experts in the field. If you have a spare moment, find us or another member of the planning committee or board and let us know how we are doing, we would love to have your feedback in real time. Please do not forget to submit your evaluations after the meeting as well. Thank you again for joining us. Enjoy the conference! Sincerely, Co-Chairs, Scientific Program Silvia Munoz-Price, MD Institute for Health and Society/Department of Medicine Froedtert and the Medical College of Wisconsin Health Research Center Milwaukee, WI ENDORSING PARTNERS The Society for Post-Acute and Long-Term Care Medicine (AMDA) Pediatric Infectious Disease Society (PIDS) Society of Infectious Diseases Pharmacists (SIDP) Thomas R. Talbot, MD Vanderbilt University Nashville, TN CME, CEU, CPE & EVALUATION INFORMATION The overall goal for SHEA Spring 2016 is for participants to gain valuable knowledge about the latest research and science in healthcare epidemiology, practical skills and strategies to implement this knowledge, and ongoing connections with other professionals in the field of healthcare epidemiology and infection prevention. At the conclusion of the course, learners should be able to: • Review and critique new scientific evidence related to epidemiologic methods and prevention of healthcare-associated infections (HAIs) • Identify evolving public policy developments and their impact on HAI prevention • Compare and contrast differing approaches to controversial aspects of HAI prevention • Translate best methods in healthcare epidemiology, antibiotic stewardship, surveillance, prevention, and research into practice • Apply and evaluate appropriate antibiotic stewardship practices in acute and non-acute healthcare settings • Discuss current best practices in HAI prevention in individual clinical settings including pediatrics and long-term care SHEA/CDC TRAINING CERTIFICATE COURSE IN HEALTHCARE EPIDEMIOLOGY At the conclusion of this activity, participants should be able to: • Describe the process of surveillance for healthcare-associated infections and how to apply surveillance techniques and methods INFORMATION • Define trends in transmission and control of healthcareassociated infections and drug resistant-pathogens, as well as other emerging infections in the healthcare setting • Apply and define outbreak investigation techniques and evidence-based infection prevention strategies • Evaluate the unique approaches to infection prevention among special populations • Describe the role of leadership and clinical education in infection prevention efforts • Gain a working knowledge of the role of the healthcare epidemiologist in antibiotic stewardship, epidemiology research, the microbiology laboratory, and emergency preparedness SHEA ANTIBIOTIC STEWARDSHIP TRAINING COURSE At the conclusion of this activity, participants should be able to: • Identify the rationale for antibiotic stewardship programs in healthcare institutions and communicate this rationale to other healthcare providers • Evaluate components of effective antibiotic stewardship programs and implement interventions in their healthcare setting • Apply strategies for and measuring both process and outcomes measures • Assess available data, including pharmacy and microbiology data, and the informatics strategies needed to support antibiotic stewardship in their institution • Identify concepts from improvement science and change theory to enhance implementation of antibiotic stewardship activities SHEA/CDC/AMDA INFECTION PREVENTION IN POST-ACUTE & LONG-TERM CARE CERTIFICATE COURSE At the conclusion of this activity, participants should be able to: • Describe surveillance definitions and recognize differences in applying them in the post-acute and long-term care settings • Identify opportunities for infection prevention, including those caused by multi-drug resistant organisms, in the post-acute and long-term care settings • Discuss recognition and response to common outbreaks in the post-acute and long-term care settings • Apply principles of occupational health and safety to healthcare workers and staff in the post-acute and long-term care settings • Recognize the need for and opportunities to practice antibiotic stewardship in the post-acute and long-term care settings SCIENCE GUIDING PREVENTION 1 ACCREDITATION INFORMATION ACCREDITATION ACCREDITATION INFORMATION ACCREDITATION TARGET AUDIENCE NURSES This conference is designed for physicians, infection preventionists, pediatricians, healthcare epidemiologists, infectious disease specialists, microbiologists, nurses, pharmacists, and other healthcare professionals interested in healthcare epidemiology, infection prevention, surveillance, research methods, patient safety, and quality improvement. This continuing nursing education activity was approved by the Virginia Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. ACCREDITATION STATEMENT The Society for Healthcare Epidemiology of America is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. PHYSICIANS The Society for Healthcare Epidemiology of America designates this live activity for a maximum of 27.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. INTERNATIONAL PHYSICIANS The American Medical Association has determined that physicians not licensed in the United States who participate in this continuing medical education activity are eligible for AMA PRA Category 1 Credit(s)™. 2 INFORMATION SHEA Spring 2016 Conference Nurses who complete this activity will be awarded a maximum of 27.5 contact hours. PHARMACISTS (Credits only available for the SHEA Antibiotic Stewardship Training Course) The continuing education activities for pharmacists have been developed through a joint providership of ProCE, Inc. and SHEA. ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE). Participants attending the conference CPE activities may earn a maximum of eleven and one half (11.50) contact hours of CPE credit. Note: some of the CPE sessions are being held concurrently. The sessions offering ACPE credit are designated in the Program brochure with a UAN (Universal Activity Number) and hours of CPE credit. The release date for these CPE activities is May 18, 2016. Conference registration fees cover the cost of CPE credit. Statements of completion will be issued at www.ProCE.com upon successful completion of the online CPE activity learning assessment(s) and activity evaluation(s). All learning assessment(s) and activity evaluation(s) must be completed no later than June 24, 2016. No partial credit will be given for any individual session. Conflict of interest disclosures are required of all faculty and shall be provided to all participants at the conference. SUCCESSFUL COMPLETION STATEMENT Participants are expected to claim only those hours spent in the educational activity approved for continuing education credit. Certificates of Attendance are provided to registered attendees based upon completion of the online evaluation. On May 18, attendees will receive a link from Confex to complete the assessment and evaluation online. Once your evaluation is completed, you may print your certificate automatically. Please refer to page 4 for additional information on the evaluation. CONTENT VALIDATION STATEMENT The Society for Healthcare Epidemiology of America accepts the following content validation statements and expects all persons involved in its professional education activities to abide by these statements with regard to any recommendations for clinical care. • All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contradictions in the care of patients; AND/OR • All scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis. DISCLOSURES In accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Standards for Commercial Support for Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months relevant to the content presented. SHEA identifies and manages all conflicts of interest prior to delivering the educational activity to learners. PLANNING COMMITTEE & SPEAKERS Silvia Munoz-Price, MD (Planning Co-Chair) Scientific Advisor: Xenex, Clorox Speaker’s Bureau: Ecolab Thomas R. Talbot, MD (Planning Co-Chair) Research Support: Sanofi Pasteur, Medimmune, Gilead Scientific Advisor: Novartis Deverick J. Anderson, MD Disclosed no relevant financial relationships Laurie Conway, PhD Disclosed no relevant financial relationships Susan Huang, MD Provides Product: Sage, Molnlycke, 3M, Clorox John Jernigan, MD Mary Ellen Nepps, Esq. Michael Calderwood, MD Disclosed no relevant financial relationships Disclosed no relevant financial relationships Marion Kainer, MD Eric Pamer, MD Disclosed no relevant financial relationships Disclosed no relevant financial relationships Michael Klompas, MD Trish Perl, MD Disclosed no relevant financial relationships Scientific Advisor: Merck, Zurec, Clorox Ebbing Lautenbach, MD Peter Pronovost, MD Research Grant: bioMerieux Disclosed no relevant financial relationships Disclosed no relevant financial relationships Curtis Donskey, MD Belinda Ostrowsky, MD Disclosed no relevant financial relationships Eli Perencevich, MD Investigator Grant: Merck Christopher Pfeiffer, MD Disclosed no relevant financial relationships Kari Simonsen, MD Research Funding: The Medicines Company, Merck, Cempra Pharmaceuticals, Astellas Nimalie D. Stone, MD Disclosed no relevant financial relationships Kavita Trivedi, MD (AS Track Co-Chair) Speaker’s Bureau: Premier Jessica Johnson (Staff) Disclosed no relevant financial relationships Kimberly Mace (Staff) Disclosed no relevant financial relationships SPEAKERS Hilary Babcock, MD Disclosed no relevant financial relationships Raymond Chinn, MD Disclosed no relevant financial relationships Louise Dembry, MD Stock Options: ReadyDock (West Hartford, CT) Daniel Diekema, MD Simon Lax, PhD Daniel Raymond, MD Scientific Advisor: 3M, Seres Health Research Grant: 3M, EcoLab, GOJO, Merck, Cepheid Disclosed no relevant financial relationships Disclosed no relevant financial relationships Grace Lee, MD Nasia Safdar, MD Shira Doron, MD Disclosed no relevant financial relationships Disclosed no relevant financial relationships Tammy Lundstrom, MD Thomas Sandora, MD Disclosed no relevant financial relationships Disclosed no relevant financial relationships Conan MacDougall, PharmD Emily Sickbert-Bennett, PhD Consultant: Actavis Pharmaceuticals, Cubist Pharmaceuticals Disclosed no relevant financial relationships Maryn McKenna, MSJ Arjun Srinivasan, MD Disclosed no relevant financial relationships Disclosed no relevant financial relationships Leonard Mermel, DO James Steinberg, MD Consultant: Catheter Connections, EndoVene, CareFusion, Elcam, PuraCath Disclosed no relevant financial relationships Aaron Milstone, MD Research Grant: Sage, MITRE Corporation Research Grant: GSK, Sanofi-Pasteur Honorarium: 3M Travel Support: Johnson and Johnson Lona Mody, MD Ermira Tartari, MSc Disclosed no relevant financial relationships Disclosed no relevant financial relationships Daniel Morgan, MD Robert Weinstein, MD Disclosed no relevant financial relationships Disclosed no relevant financial relationships Stephen Muething, MD Deborah S. Yokoe, MD Disclosed no relevant financial relationships Disclosed no relevant financial relationships Scientific Advisor: Allergan, Durata Speaker’s Bureau: Allergan, Merck Frank Drews, MD Disclosed no relevant financial relationships Erik Dubberke, MD Consultant: Sanofi Pasteur, Merck Scientific Advisor: Sanofi Pasteur, Pfizer, Summit, Merck, Daiichi, Valneva Maggie Dudeck, MPH Disclosed no relevant financial relationships Jonathan Edwards, MStat Disclosed no relevant financial relationships Disclosed no relevant financial relationships Sean Barnes, MD Mohamad Fakih, MD Jeffrey Gerber, MD Alex Kallen, MD Disclosed no relevant financial relationships Disclosed no relevant financial relationships Beth Bell, MD Carolyn Gould, MD Matthew Linam, MD Disclosed no relevant financial relationships Disclosed no relevant financial relationships Disclosed no relevant financial relationships Gonzalo Bearman, MD Disclosed no relevant financial relationships Victoria Nahum Disclosed no relevant financial relationships Armando Nahum Research Funding: Pfizer Sarah L. Krein, PhD Gerald Hickson, MD Disclosed no relevant financial relationships Disclosed no relevant financial relationships Disclosed no relevant financial relationships Disclosed no relevant financial relationships Joost Hopman, MD Disclosed no relevant financial relationships Robin Jump, MD (LTC Co-Track Chair) Jerod Nagel, PharmD Disclosed no relevant financial relationships Grant recipient for SCORE study (administered by The Joint Commission): Pfizer Grants for Learning and Change Kerri Thom, MD Sarah Haessler, MD (SHEA/CDC Healthcare Epidemiology Track Chair) Lauri Hicks, DO Whitney Buckel, PharmD Sara Cosgrove, MD (AS Track Liaison) Scientific Advisor: Hospital Association of NY Faculty: NY State Council of Health Systems Pharmacists Consultant: University of Rochester Disclosed no relevant financial relationships Disclosed no relevant financial relationships (LTC Track Co-Chair) Disclosed no relevant financial relationships Elizabeth Dodds-Ashley, PharmD, MHS David Nace, MD Investigator: Clorox, Sage Reserach: Molnyke Latania Logan, MD Disclosed no relevant financial relationships (AS Track Co-Chair) Disclosed no relevant financial relationships Mary Hayden, MD Disclosed no relevant financial relationships Disclosed no relevant financial relationships Michael Bell, MD Anthony Harris, MD Disclosed no relevant financial relationships Disclosed no relevant financial relationships Paul Tambyah, MD SCIENCE GUIDING PREVENTION 3 FINANCIAL DISCLOSURES FINANCIAL INSTRUCTIONSCONTINUING TO ACQUIRE YOUR CERTIFICATE(S) EDUCATION CREDITS ACQUIRING PHYSICIANS AND NURSES CME, CNE, and Attendance Certificates are provided to all registered attendees based upon the completion of the online evaluation. You will receive an email on Wednesday, May 18 with a link to your evaluation. The email will include your registration number which is needed to access your evaluation. All attendees will be asked if they participated any of the three Single Training Course during the conference: • SHEA/CDC Training Certificate Course in Healthcare Epidemiology • SHEA Antibiotic Stewardship Training Course • SHEA/CDC/AMDA Infection Prevention in Post-Acute & Long-Term Care Certificate Course Once selected, your printed Training Course Certificate of completion will be mailed within the next few weeks. You will be able to print your certificate once you have completed the evaluation. To obtain AMA PRA Category 1 Credit™ or CEU credits, participants must: 1. Evaluate all sessions attended, 2. Complete the Attestation/ Evaluation statement at the end of the evaluation. YOUR CERTIFICATES PHARMACISTS CE ACTIVITY EVALUATION AND CREDIT INSTRUCTIONS ATTENDEE PORTAL SHEA 2016 ‐ Guiding Science Prevention The Conference Attendee Portal includes: May 18 - 21, 2016, Atlanta, Georgia • All Full Conference and Track Session Information and PDF Presentations • Oral Abstract Presentations • Poster Abstract Presentations • Presenter/Speaker Information • A Daily Agenda for you to create your own schedule • Listing of all Special Events during the conference • Floor Plans to locate all sessions and events • General Conference Information • Access and complete your Conference Evaluation to download your CME, CNE, and Attendance Certificates. • Everything you need to know about the meeting, at your fingertips! View the SHEA Spring 2016 Attendee Portal online today at www. sheaspring.org/attendeeportal. 1.To receive CE credit for the activities at this conference, you must complete the activity post-tests and evaluations online no later than Friday, June 24, 2016. 2.Visit www.ProCE.com/evaluation. 3.Click on the Evaluation button, which is listed with the SHEA Spring 2016 Conference - May 18-21, 2016 CE activity. 4.Login to the ProCE CE Center. NOTE: You will need to register as a new user if you have not previously used the ProCE CE Center. 5.Enter the Attendance Codes for all of the CE sessions you attended. NOTE: Each session has a unique attendance code. 6. Follow the online instructions to complete the activity post-tests and evaluations, and to receive CE credit. NOTE: Complete the activity post-tests and evaluations, and claim CE credit only for the sessions you attended. 7.If you need assistance or have questions, please contact ProCE at 630-540-2848 or via email at [email protected]. ACCESS PRESENTATIONS ONLINE As a registrant, you will be able to access all presentations online through the attendee portal at www.sheaspring. org/attendeeportal. Please note: Presentations will be uploaded as they are available. In some cases, this will be after the conference. C R E D I T T R A C K E R SHEA Antibiotic Stewardship Training Course CE Time 4:15 - 4:45 p.m. Thursday, May 19 Antibiotic Stewardship in Skilled Nursing Facilities and Long-Term Care Breakout Session: Beginning Antibiotic Stewardship Breakout Session: Advanced Antibiotic Stewardship What Every Steward Should Know About Pharmacokinetics - Pharmacodynamics Allergies, Interactions and Adverse Events An Update on Duration of Therapy and Therapeutic Monitoring: Our Role as Stewards Antibiotic Stewardship: Navigating the Liability Risks Case Study #1: Using Benchmarking to Enhance Antibiotic Stewardship Friday, May 20 Integration of the Microbiology Lab & Antibiotic Stewardship Rapid Diagnostic Tests and How to Implement their Use: Mini-lecture & Case Study #2 Update on the National Stewardship Activities How to Find Resources at your Institution or Health System Art of Antibiotic Stewardship Informatics and Stewardship Management of Resistant Gram Positive Infections Management of Resistant Gram Negative Infections 4:45 - 5:45 p.m. Case Study #3: Stewardship and C. difficile Infection 11:00 - 12:00 p.m. 1:00 - 2:30 p.m. 2:45 - 3:15 p.m. 3:15 - 3:45 p.m. 3:45 - 4:15 p.m. 4:30 - 5:00 p.m. 5:00 - 5:45 p.m. 8:00 - 8:45 a.m. 8:45 - 9:30 a.m. 10:00 - 10:30 a.m. 10:30 - 11:30 a.m. 11:30 - 12:00 p.m. 2:45 - 3:30 p.m. 3:30 - 4:00 p.m. 4 Title SHEA Spring 2016 Conference CPE/CME/ CNE Credit ACPE UAN 1 0221-9999-16-079-L04-P Attendance Credits Code Earned 0221-9999-16-080-L04-P 0221-9999-16-081-L04-P 0.5 0221-9999-16-082-L01-P 0.5 0221-9999-16-083-L05-P 0.5 0221-9999-16-084-L05-P 0.5 0221-9999-16-085-L03-P 0.75 0221-9999-16-086-L04-P 0.75 0221-9999-16-087-L01-P 0.75 0221-9999-16-088-L04-P 0.5 0221-9999-16-089-L04-P 1 0221-9999-16-090-L04-P 0.5 0221-9999-16-091-L04-P 0.75 0221-9999-16-092-L04-P 0.5 0221-9999-16-093-L01-P 0.5 0221-9999-16-094-L01-P 1 0221-9999-16-095-L05-P 1.5 CREDIT TRACKER SHEA/CDC/AMDA Infection Prevention in Post-Acute & Long-Term Care Certificate Course Full Conference Sessions Time CME /CNE Credit Title CME /CNE Credit Credits Earned Time 10:15 – 11:15 a.m. Joint Session: Introduction to Healthcare Epidemiology Title Wednesday, May 18 Wednesday, May 18 8:00 - 9:30 a.m. Opening Plenary: CDC and Healthcare Associated Infections - Prevention in the Past, Present, and the Future 10:00 - 12:00 p.m. Creating a Level Playing Field with Publically 1.5 11:15 – 12:00 p.m. Joint Session: Transmission of Infectious 2 1 Reprocessing Methods? 11:00 - 12:00 p.m. The Possibilities of Innovation Automated 1 Implementation Academy: Turning Science into Improved Practice 1.5 1:00 -2:15 p.m. Managing Outbreaks 1.25 2:30 – 4:00 p.m. Changing Approaches in Surveillance 1.5 4:15 – 5:30 p.m. Strategies to Prevent Infections and MDROs 1.25 Thursday, May 19 Tools in Hand Hygiene Compliance Measurement 1:00 - 2:30 p.m. 1 0.75 Agents in Healthcare Settings Reported HAI Data 10:00 - 11:00 a.m. Are there Global Standards for Endoscope Credits Earned 8:00 – 8:45 a.m. Occupational Health & Safety 0.75 8:45 – 9:30 a.m. CDI Management 0.75 10:00 – 11:00 a.m. Challenging Situations 1 1 0.75 2:45 - 4:00 p.m. Pediatric Infection Prevention: Focus on Guideline Implementation 1.25 11:00 – 12:00 p.m. Joint Session: Antibiotic Stewardship in 4:15 - 5:45 p.m. Choosing Wisely 1.5 2:45 – 3:30 p.m. 8:00 - 9:30 a.m. Environmental Disinfection 1.5 SHEA/CDC Training Course in Healthcare Epidemiology 8:00 - 9:30 a.m. Selling Your Results: To Suits, Scientists & Society 1.5 Time 2 Thursday, May 19 10:00 - 12:00 p.m. Surgical Site Infection Prevention–Where Do We SCIP & HOP From Here 10:00 - 12:00 p.m. Practical Consideration in HAI Research 2 1:00 - 2:30 p.m. Plenary: Reaching out to New Partners 1.5 2:45 - 4:00 p.m. Pro/Con: To Wash or Rub Off C. difficile & Making the Most of C. difficile PCR 1.25 Updates from the CDC Prevention Epicenters Program: A Public Health/ Academic Research Partnership 1.5 Is there Quality in Quality Metrics? 1.5 4:15 - 5:45 p.m. 4:15 - 5:45 p.m. Skilled Nursing Facilities & Long-Term Care Joint Session: PAC<C: Changing the National Landscape & Infection Prevention CME /CNE Credit Title Credits Earned Wednesday, May 18 10:15 – 11:15 a.m. Joint Session: Introduction to Healthcare 1 11:15 – 12:00 p.m. Joint Session: Transmission of Infectious 0.75 Epidemiology Agents in Healthcare Settings 1:00 – 1:45 p.m. Practical Strategies for Surveillance 0.75 1:45 – 2:30 p.m. The Compendium Strategies for Preventing HAIs 0.75 2:45 – 3:45 p.m. Change Management & the Science of Safety 3:45 – 4:15 p.m. Root Cause Analysis Practical Session 4:30 – 5:30 p.m. Overview of Antibiotic Stewardship Friday, May 20 1 0.5 1 Thursday, May 19 8:00 - 9:30 a.m. Research Methods in Healthcare Epidemiology – Practical Considerations 1.5 8:00 - 9:30 a.m. Novel Engineering Solutions to Environmental Hygiene 1.5 10:00 - 12:00 p.m. Regional Approach to MDRO Prevention 2 10:00 - 12:00 p.m. Challenging Cases and Issues in Infection 2 0.5 1.5 2:45 – 3:30 p.m. Joint Session: PAC<C: Changing the National Landscape & Infection Prevention 0.75 1 3:30 – 4:15 p.m. Environment, Sterilization, & Disinfection 0.75 4:30 – 5:30 p.m. Special Populations: Immunocompromised, ICU, Dialysis & Burn Patients 1 8:00 – 8:45 a.m. Leadership & Communication Skills 0.75 8:45 – 9:30 a.m. The Hospital Epidemiologist as a Clinical Educator 0.75 1 Prevention 1:00 - 2:30 p.m. Plenary: Telling Stories: Using Narrative to Expand Awareness of Infection Prevention 2:45 - 3:45 p.m. Role of One Microbiome in Resistance Against Healthcare Associated Infections 2:45 - 4:00 p.m. Device-Associated Infections: Can Science Bring us to Zero? 1.25 4:15 - 5:45 p.m. A Human Factors & Systems Engineering Approach to Infection Prevention 1.5 8:00 – 8:45 a.m. CDC Problem Sessions: Device Associated Infections 0.75 8:45 – 9:30 a.m. CDC Problem Sessions: Procedure Infections 0.75 10:00 – 10:45 a.m. Unique Aspects of Pediatric Infection Control 0.75 10:45 – 11:30 a.m. Approach to Epidemic/Outbreak Investigation 0.75 11:30 – 12:00 p.m. Problem Session: Outbreak in the OR Friday, May 20 Saturday, May 21 8:00 - 9:30 a.m. Pro/Con: Universal PPE 1.5 8:00 - 9:30 a.m. Crossing the Stewardship Continuum 1.5 10:00 - 12:00 p.m Closing Plenary: Creating a Culture of Accountability & Professionalism to Drive Improvement 2 10:00 – 11:00 a.m. Occupational Health Issues 11:00 – 12:00 p.m. Regulatory & Emergency Preparedness 1 2:45 – 3:30 p.m. How to Read a Study and Perform Research 0.75 3:30 – 4:10 p.m. Business of Infection Prevention: Promoting Growth of a Program 0.75 4:15 – 5:00 p.m. The Role of the Laboratory in Healthcare Epidemiology 0.75 5:00 – 5:45 p.m. Putting it all Together: Leading Your Healthcare Facility through a Massive Exposure Situation 0.75 SCIENCE GUIDING PREVENTION 5 NETWORKING EVENTS NETWORKING LUNCH WITH POSTER VIEWING SHEA MENTORSHIP BREAKFAST 7th Floor: Augusta Ballroom(s) Thursday, May 19, 7:00 – 7:50 a.m. Peachtree Room First Poster Viewing Session Poster Display Hours Wednesday, May 18 Thursday, May 19 7:00 a.m. – 6:00 p.m. 7:00 a.m. – 1:00 p.m. Extended Poster Viewing Hours Wednesday, May 18 6:00 p.m. – 7:00 p.m. Author Presentation Hour Thursday, May 19 SHEA WOMEN IN EPI RECEPTION Wednesday, May 18, 6:00 – 8:00 p.m., Peachtree Ballroom CD Women in the field of Healthcare Epidemiology are encouraged to attend a women’s only reception. Women are increasingly entering the field of hospital epidemiology, but have had few opportunities to meet and discuss the challenges. This reception is designed to facilitate networking and mentoring among women who have succeeded in healthcare hospital epidemiology and those who are still in training or are junior in the field. LONGER BREAK SESSIONS The break sessions throughout the meeting have been extended to allow more time to meet and mingle with other attendees in your field as well as faculty and leadership. Networking Breaks are May 18-21 from 9:30 to 10:00 a.m. in the 7th Floor: Augusta Ballroom(s). 12:00 p.m. – 1:00 p.m. Second Poster Viewing Session Poster Display Hours Thursday, May 19 Friday, May 20 Saturday, May 21 4:30 p.m. – 6:00 p.m. 7:00 a.m. – 6:00 p.m. 7:00 a.m. – 10:00 a.m. Extended Poster Viewing Hours Friday, May 20 6:00 p.m. – 7:00 p.m. Author Presentation Hour Friday, May 20 12:00 p.m. – 1:00 p.m. MEET WITH THE AUTHORS Thursday, May 19, 12:00 – 1:00 p.m. Friday, May 20, 12:00 – 1:00 p.m. 7th Floor: Augusta Ballroom(s) Selected abstract posters will be presented during lunch Thursday and Friday. There will be time during these lunch session to visit and explore the posters and meet with the authors. Posters may also be viewed during lunch on Wednesday, May 18 from 12:00 – 1:00 p.m. but will not have presentations at this time. The top twenty three abstracts will be presented with “SHEA Abstract Award” ribbons. Thursday Poster Topics: VAE, CAUTI, CLABSI, Disinfection/ Sterilization, Environmental Cleaning, Hand Hygiene, Pediatrics, Respiratory Viruses, and SSI Friday Poster Topics: Antibiotic Stewardship, C. difficile, Diagnostic/Microbiology, Implementation Science, Long-Term Care, and MDR GNR 6 SHEA Spring 2016 Conference EVENTS SHEA Mentors and Mentees will gather to discuss the newly implemented SHEA Mentorship Program. This Program is designed to create a strong networking community; providing and enhancing the SHEA membership experience at all levels (e.g. student, fellow, junior faculty and practitioners). The goal is to form relationships that can be carried forward beyond this meeting. The mentoring Program seeks to cultivate supportive and mutually rewarding relationships between the mentee and the mentor. As the mentee seeks advice and support with career development, and goal achievement, the mentor will provide guidance and help the mentee set and attain goals, as well as offer encouragement. Mentors have the satisfaction of sharing their experience & wisdom. As in any teaching relationship, the teacher often benefits from new insights and rejuvenated enthusiasm. This breakfast is open only to SHEA Mentors, SHEA Mentees, and SHEA Leaders. Mentors Aneesa Afroze Mayar Al Mohajer Jaffar Al-Tawfiq Kumar Angamuthu Edward Chapnick Teena Chopra Marci Drees Ozlem Equils Judy Guzman-Cottrill Jesse Jacob Susan Jain Waleed Javaid Marion Kainer Zeina Kanafani Sheetal Kandiah Aaron Milstone Venkat Minnaganti Lona Mody Nathanael Napolitano Michael Oji Belinda Ostrowsky Ravi Pallipamu Chistopher Pfeiffer Aurora Pop-Vicas Michael Rubin Matt Seymour Mark Shelly Arjun Srinvasan Paul Tambyah Kerri Thom David Woodard Sharon Wright Mentees Sujit Suchindran Andre Rossi Mohamed Badawi Sarit Sharma Nagakrishnal Nachimuthu Jerry Jacob Geehan Suleyman Holly Sweet Jonathan Crews Lovisa Olafsdottir Savitha Nagaraj Shambhu Dutta Joshi Ana Carla Silva Caline Matter Priya Nori Matthew Washam Ratna Rao Colleen Roberts Marissa Valentine Oscar Gutierrez-Aguirre Marybeth Sexton Caitlyn Ngam Hajime Kanamori Ana Bardossy Carlos Figueroa Castro Anna Barker Deborah Kupferwasser Elise Martin Norihisa Yamamoto Rishi Parikh Karen Brust Amy Lane GENERAL INFORMATION SPEAKER READY ROOM Chastain A Hours of Operation: Tuesday, May 17, 2:30 – 5:30 p.m. Wednesday, May 18, 6:30 a.m. – 6:00 p.m Friday, May 20, 6:30 a.m. – 6:00 p.m. Saturday, May 21, 6:30 – 10:00 a.m. SHEA INTERNATIONAL BREAKFAST Friday, May 20, 7:00 – 7:50 a.m. Peachtree Room All International attendees & SHEA Leadership are invited to attend this international networking opportunity. This is a time for International members to share and actively participate in conversations on implementing infection prevention best practices and knowledge. This networking event serves as a vehicle for international members to work together to identify the gaps in meeting the needs of infection preventionists and other healthcare professionals outside of the United States. This breakfast is open only to International attendees and SHEA Leaders. FOUNDATION DONATION INFORMATION SHEA is committed to providing members what they need to be leaders in their facilities — now and into the future. Membership dues cover only a small percentage of what SHEA needs to provide these valuable tools and opportunities. We need the help and commitment from all members to continue to recruit and transform SHEA members into SHEA leaders, and to help train the next generation of healthcare epidemiologists. We are asking each SHEA member to ‘Double their Dues’ in 2016. Please visit www.shea-online.org/ Foundation/Donate.aspx to find out how to make an online tax deductible donation or email [email protected] to make your donation. As a thank you, you will receive a “Keep Calm and Let the Epidemiologist Handle It” t-shirt. 2ND ANNUAL SHEA EDUCATION AND RESEARCH FOUNDATION DINNER (Ticketed Event) Thursday, May 19, 6 :00 p.m. Georgia Aquarium, located down the street from the Westin Peachtree hotel. Transportation to the Aquarium will not be provided. The SHEA Education and Research Foundation is hosting its 2nd annual foundation dinner. Speakers this year include David Henderson, MD, and Julie Gerberding, MD, MPH. If you did not purchase a ticket in advance, a limited number of tickets are available for purchase at Registration until 5:00 p.m. Wednesday, May 18. Please note: No transportation will be provided as the Georgia Aquarium is within walking distance to the Westin Peachtree Plaza. SHEA Staff and Atlanta Volunteers will be available as guides for walking groups. Guides will depart from the hotel lobby at 5:30 p.m. to take you to the aquarium. If you are walking on your own, the aquarium’s Oceans Ballroom is located on the first level of the parking deck. If parking at the aquarium, take the elevator to level one and follow the signs to the Oceans Ballroom. Chastain A serves as the speaker ready room for presenters to review and update presentations as well as check for any last-minute issues. Professional audiovisual staff will be available in the speaker ready room to provide assistance. Speakers are required to arrive at the room they are presenting in 15 minutes before their session starts in order to meet with the moderator of the session. REGISTRATION AND MEMBERSHIP BOOTH Peachtree Ballroom Foyer Tuesday, May 17, 2:30 p.m. – 5:30 p.m. Wednesday, May 18 , 6:30 a.m. – 6:00 p.m. Thursday, May 19, 6:30 a.m. – 6:00 p.m. Friday, May 20, 6:30 a.m. – 6:00 p.m. Saturday, May 21, 6:30 – 10:00 a.m. HOTEL INFORMATION SHEA Spring 2016 is being held at the Westin Peachtree in Atlanta, Georgia. A map of the hotel and location of all activities is provided on pages 14-15 of this program. INTERNET CONNECTION Wireless Internet connection will not be provided in meeting rooms. Complimentary WiFi connection will be available in the hotel lobby and guest sleeping rooms. SESSION CHANGES SHEA will display a message board in the registration area (Peachtree Ballroom Foyer), which will display any daily session changes. Julie Gerberding, MD, MPH David Henderson, MD SCIENCE GUIDING PREVENTION 7 SHEA AWARDS SHEA AWARDS JOHNATHAN FREEMAN SCHOLARSHIP AWARDEES BILL RUTALA SCHOLARSHIP GINA PUGLIESE AWARDEES SCHOLARSHIP AWARDEES The Jonathan Freeman Scholarship was established by SHEA to promote the training of outstanding infectious disease fellows who demonstrate interest in the field of healthcare epidemiology. The society established this scholarship in the memory of Jonathan Freeman, MD, MPH, a teacher and researcher in the field of healthcare epidemiology dedicated to improving the delivery of healthcare through the prevention of nosocomial infections. Dr. Freeman was a founding faculty member who for a decade taught the epidemiology and statistics track of the course. The Bill Rutala Scholarship was established by SHEA to promote the training of a non-physician interested in the research of healthcare-associated infections. SHEA established this scholarship in honor of William Rutala, MS, MPH, PhD a prominent SHEA leader the field of healthcare epidemiology research. Dr. Rutala was the SHEA Lectureship awardee in 2012 and has worked tirelessly researching areas such as disinfection, sterilization, cross-infection, healthcare-associated infections, outbreaks, and antibiotic-resistant pathogens. The Gina Pugliese Scholarship was established by SHEA to promote the training of a non-physician infection preventionist (IP) who has shown outstanding interest and leadership in the field or works in a resource limited setting. SHEA established this scholarship in honor of Gina Pugliese, RN, MS, a prominent IP and leader in the field of healthcare epidemiology. Ms. Pugliese was a founding faculty member of the SHEA/CDC Training Course and co-chair for 15 years. Laura Kate Tyner, RN Nebraska Infection Control Assessment and Promotion Program J. Bradford Bertumen, MD Duke University Medical Center Kazuaki Jindai, MD Oregon Health & Science University Rachael Lee, MD University of Alabama at Birmingham Lovisa Bjork Olafsdottir, MD Beth Israel Deaconess Medical Center Nicole Poole, MD Seattle Children’s Hospital Hiroki Saito, MD University of California Irvine Michelle S. Toleman University of Cambridge 8 SHEA Spring 2016 Conference Nicholas M. Moore, MS Rush University Medical Center Rajeshwari Nair, MBBS The University of Iowa INTERNATIONAL AMBASSADORS INTERNATIONAL AMBASSADORS PROGRAM WINNERS In its eighth year, the International Ambassadors Program (IAP) builds collaborative relationships between U.S. and international healthcare professionals with expertise in healthcare epidemiology and infection prevention. Since 2009, SHEA has partnered with 3M to benefit the international community of healthcare professionals dedicated to infection prevention through our International Ambassadors Program. To date SHEA has welcomed 62 Ambassadors representing 35 countries. Wensen Chen, MPH China Jiangsu Province Hospital Elie K. Kabululu, RN Democratic Republic of Congo Centre Medical Evangelique De Nyankunde A Beni Joost Hopman, MD The Netherlands Radboud University Medical Center Aamer Ikram, PhD Pakistan Armed Forces Institute of Pathology Sujan B. Marahatta, PhD Nepal Manmohan Memorial Institute of Health Sciences Nathlee McMorris, MD Jamaica National Public Health Laboratory Vandana K. Eshwara, MD India Kasturba Medical College Corey Forde, DM Barbados Queen Elizabeth Hospital Susan Jain, MN Australia Prince of Wales Hospital Uday Kelkar, MD India Central Government Health Scheme Mbogori M. Murugu, BSN Kenya Infection Prevention Network, Kenya Philip O. Oshun, MPH Nigeria Lagos University Teaching Hospital Jan Gralton, PhD Australia Clinical Excellence Commission Ahmed M. Hakawi, MD Saudi Arabia King Fahad Medical City Thana Khawcharoenporn, MD Thailand Thammasat University Reginaldo A. de Luz, MSc Brazil School of Nursing, University of São Paulo Fu Qiao, MD China West China Hospital, Sichuan University Ratna Rao, MD India Apollo Hopsital, Hyderabad SCIENCE GUIDING PREVENTION 9 SHEA INTERNATIONAL AMASSADORS SHEA SCHEDULE AT A GLANCE SCHEDULE AT A GLANCE WEDNESDAY, MAY 18 l 7:00 – 7:50 a.m. Continental Breakfast 7th Floor: Augusta Ballroom(s) 8:00 - 9:30 a.m. Opening Plenary: CDC and Healthcare Associated Infections —Prevention in Peachtree Ballroom CD the Past, the Present, and the Future 9:30 – 10:00 a.m. l l l 7th Floor: Augusta Ballroom(s) 10:00 – 10:15 a.m. Joint Session: Course Overview Chastain F 10:00 – 12:00 p.m. Creating a Level Playing Field with Publicly Reported HAI Data Savannah Ballroom 10:00 – 11:00 a.m. Are there Global Standards for Endoscope Reprocessing Methods? Chastain Room 10:15 – 11:15 a.m. Joint Session: Introduction to Healthcare Epidemiology Chastain F 11:00 – 12:00 p.m. The Possibilities of Innovation Automated Tools in Hand Hygiene Compliance Chastain Room 11:15 – 12:00 p.m. Joint Session: Transmission of Infectious Agents in Healthcare Settings Chastain F Measurement 12:00 – 1:00 p.m. l l l l l l l l l l l l l l Networking Break Lunch with Poster Viewing 1:00 – 1:45 p.m. Practical Strategies for Surveillance 1:00 -2:15 p.m. Managing Outbreaks 7th Floor: Augusta Ballroom(s) Chastain F Chastain E 1:00 – 2:30 p.m. Implementation Academy: Turning Science into Improved Practice Savannah Ballroom 1:00 – 2:30 p.m. Oral Abstract Session: MDROs Chastain Room 1:45 – 2:30 p.m. The Compendium Strategies for Preventing HAIs Chastain F 2:30 – 4:00 p.m. Changing Approaches in Surveillance Chastain E 2:45 – 3:45 p.m. Change Management & the Science of Safety Chastain F 2:45 – 4:00 p.m. Pediatric Infection Prevention: Focus on Guideline Implementation Savannah Ballroom 2:45 – 3:30 p.m. Oral Abstract Session: Outbreaks Chastain Room 3:45 – 4:15 p.m. Root Cause Analysis Practical Session Chastain F 4:15 – 5:30 p.m. Strategies to Prevent Infections & MDROs Chastain E 4:15 – 5:30 p.m. Oral Abstract Session: Innovation In Infection Prevention Chastain Room 4:15 – 5:45 p.m. Choosing Wisely Savannah Ballroom 4:30 – 5:30 p.m. Overview of Antibiotic Stewardship Chastain F 6:00 – 8:00 p.m. Women in Epi Reception Peachtree Ballroom CD l Plenaries l Oral Abstract Sessions l Full Conference Sessions l SHEA/CDC Training Certificate Course in Healthcare Epidemiology l SHEA/CDC/AMDA Infection Prevention in Post-Acute & Long-Term Care Certificate Course l SHEA Antibiotic Stewardship Training Course Joint Session for Both Tracks 10 SHEA Spring 2016 Conference Joint Session for Both Tracks AT A GLANCE (continued) THURSDAY, MAY 19 l l l l l l 7:00 – 7:50 a.m. Continental Breakfast 7th Floor: Augusta Ballroom(s) 7:00 – 7:50 a.m. Mentorship Breakfast Peachtree Room 8:00 – 8:45 a.m. Occupational Health & Safety Chastain E 8:00 – 8:45 a.m. CDC Problem Session: Device Associated Infections Chastain F 8:00 – 9:30 a.m. Environmental Disinfection Chastain Room 8:00 – 9:30 a.m. Selling Your Results: To Suits, Scientists & Society Savannah Ballroom 8:45 – 9:30 a.m. CDC Problem Session: Procedure Infections Chastain F 8:45 – 9:30 a.m. CDI Management Chastain E 9:30 – 10:00 a.m. l l l l l Networking Break 7th Floor: Augusta Ballroom(s) 10:00 – 10:45 a.m. Unique Aspects of Pediatric Infection Control Chastain F 10:00 – 11:00 a.m. Challenging Situations Chastain E 10:00 – 12:00 p.m. Surgical Site Infection Prevention–Where Do We SCIP & HOP From Here Chastain Room 10:00 – 12:00 p.m. Practical Consideration in HAI Research Savannah Ballroom 10:45 – 11:30 a.m. Approach to Epidemic/Outbreak Investigation Chastain F 11:00 – 12:00 p.m. Joint Session: Antibiotic Stewardship in Skilled Nursing Facilities & Chastain E 11:30 – 12:00 p.m. Problem Session: Outbreak in the OR Chastain F Long-Term Care l 12:00 – 1:00 p.m. l l l l Lunch With Poster Presentations 7th Floor: Augusta Ballroom(s) 1:00 – 2:30 p.m. Breakout: Beginning Antibiotic Stewardship Chastain E 1:00 – 2:30 p.m. Breakout: Advanced Antibiotic Stewardship Chastain F 1:00 – 2:30 p.m. Plenary: Reaching out to New Partners Peachtree Ballroom CD 2:45 – 3:15 p.m. What Every Steward Should Know About Pharmacokinetics Chastain E 2:45 – 3:30 p.m. Joint Session: PAC<C: Changing the National Landscape & Infection Chastain F l l l l l 2:45 – 4:00 p.m. Oral Abstract Session: HAI Surveillance Chastain Room 2:45 – 4:00 p.m. Pro/Con: To Wash or Rub Off C. difficile & Making the Most of C. difficile PCR Savannah Ballroom 3:15 – 3:45 p.m. Allergies, Interactions and Adverse Events Chastain E 3:30 – 4:15 p.m. Environment, Sterilization, & Disinfection Chastain F 3:45 – 4:15 p.m. An Update on Duration of Therapy and Therapeutic Monitoring: Our Role as Chastain E l 4:15 – 5:45 p.m. Updates from the CDC Prevention Epicenters Program: A Public Health/ Chastain Room l l l l 4:15 – 5:45 p.m. Is There Quality in Quality Metrics? Savannah Ballroom 4:30 – 5:00 p.m. Antibiotic Stewardship: Navigating the Liability Risks Chastain E 4:30 – 5:30 p.m. Special Populations: Immunocompromised, ICU, Dialysis & Burn Patients Chastain F 5:00 – 5:45 p.m. Case Study #1: Using Benchmarking to Enhance Antibiotic Stewardship Chastain E 6:00 – 9:00 p.m. 2nd Annual SHEA Education and Research Foundation Dinner Georgia Aquarium – Pharmacodynamics Prevention Stewards Academic Research Partnership (Advance Ticket Purchase Required) SCIENCE GUIDING PREVENTION 11 SCHEDULE AT A GLANCE SCHEDULE SCHEDULE AT A GLANCE SCHEDULE AT A GLANCE FRIDAY, MAY 20 7:00 – 7:50 a.m. Continental Breakfast 7:00 – 7:50 a.m. International Meet and Greet Breakfast 7th Floor: Augusta Ballroom Peachtree Room l l 8:00 – 8:45 a.m. Leadership & Communication Skills Chastain F 8:00 – 8:45 a.m. Integration of the Microbiology Lab & Antibiotic Stewardship: Chastain E l l l l 8:00 – 9:30 a.m. Research Methods in Healthcare Epidemiology – Practical Considerations Savannah Ballroom 8:00 – 9:30 a.m. Novel Engineering Solutions to Environmental Hygiene Chastain Room 8:45 – 9:30 a.m. The Hospital Epidemiologist as a Clinical Educator Chastain F 8:45 – 9:30 a.m. Rapid Diagnostic Tests and How to Implement their Use: Mini-lecture & Chastain E Beginning Concepts Case Study #2 9:30 – 10:00 a.m. l l l l l l l Networking Break 7th Floor: Augusta Ballroom(s) 10:00 – 10:30 a.m. Update on National Stewardship Activities Chastain E 10:00 – 11:00 a.m. Occupational Health Issues Chastain F 10:00 – 12:00 p.m. Regional Approach to MDRO Prevention Savannah Ballroom 10:00 – 12:00 p.m. Challenging Cases and Issues in Infection Prevention Chastain Room 10:30 – 11:30 a.m. How to find Resources at your Institution of Health System Chastain E 11:00 – 12:00 p.m. Regulatory & Emergency Preparedness Chastain F 11:30 – 12:00 p.m. Art of Antibiotic Stewardship Chastain E 12:00 – 1:00 p.m. Lunch With Poster Presentations 7th Floor: Augusta Ballroom(s) l 1:00 – 2:30 p.m. Plenary: Telling Stories: Using Narrative to Expand Awareness of Peachtree Ballroom CD l l l l l l l l l l l l 2:45 – 3:30 p.m. How to Read a Study and Perform Research Chastain F 2:45 – 3:30 p.m. Informatics and Stewardship Chastain E 2:45 – 3:45 p.m. Role of one Microbiome in Resistance Against Healthcare Associated Infections Chastain Room 2:45 – 4:00 p.m. Device-Associated Infections: Can Science Bring us to Zero? Savannah Ballroom 3:30 – 4:00 p.m. Management of Resistant Gram Positive Infections Chastain E 3:30 – 4:10 p.m. Business of Infection Prevention: Promoting Growth of a Program Chastain F 4:15 – 4:45 p.m. Management of Resistant Gram Negative Infections Chastain E 4:15 – 5:00 p.m. The Role of the Laboratory in Healthcare Epidemiology Chastain F 4:15 – 5:45 p.m. A Human Factors & Systems Engineering Approach to Infection Prevention Savannah Ballroom 4:15 – 5:45 p.m. Top Oral Abstract Session Chastain Room 4:45 – 5:45 p.m. Case Study #3: Stewardship and C. difficile Infection Chastain E 5:00 – 5:45 p.m. Putting it all Together: Leading your Healthcare Facility through a Chastain F 12 Infection Prevention Massive Exposure Situation SHEA Spring 2016 Conference A GLANCE (continued) SATURDAY, MAY 21 l l l 7:00 – 7:50 a.m. Continental Breakfast 7th Floor: Augusta Ballroom(s) 8:00 – 9:30 a.m. Pro/Con: Universal PPE Savannah Ballroom 8:00 – 9:30 a.m. Crossing the Stewardship Continuum Chastain F 8:00 – 9:30 a.m. Oral Abstract Session: Antibiotic and Test Stewardship Chastain Room 9:30 – 10:00 a.m. Networking Break l 7th Floor: Augusta Ballroom(s) 10:00 – 12:00 p.m. Closing Plenary: Creating a Culture of Accountability & Professionalism Peachtree Ballroom CD to Drive Improvement l Plenaries l Oral Abstract Sessions l Full Conference Sessions l SHEA/CDC Training Certificate Course in Healthcare Epidemiology l SHEA/CDC/AMDA Infection Prevention in Post-Acute & Long-Term Care Certificate Course l SHEA Antibiotic Stewardship Training Course Joint Session for Both Tracks Joint Session for Both Tracks SCIENCE GUIDING PREVENTION 13 SCHEDULE AT A GLANCE AT WESTIN PEACHTREE HOTEL FLOOR PLAN SCHEDULE WESTIN PEACHTREE HOTEL FLOOR PLAN WESTIN PEACHTREE HOTEL FLOOR PLAN CHASTAIN F POSTER PICKUP CHASTAIN E CHASTAIN A CHASTAIN ROOM 6TH FLOOR Chastain Room: Abstract Presentations, Full Conference Track Sessions Chastain A: Speaker Ready Room AUGUSTA LEVEL, SEVENTH FLOOR Chastain E: SHEA/CDC/AMDA Infection Prevention in Post-Acute & Long-Term Care Certificate Course, SHEA Antibiotic Stewardship Training Course Chastain F: SHEA/CDC Training Certificate Course in Healthcare Epidemiology, Breakout and Joint Sessions ACCESS TO 200 PEACHTREE AUGUSTA ROOM AUGUSTA BALLROOM 7TH FLOOR Augusta Ballroom(s): Breakfast, Networking Breaks, and Lunch with Posters 14 SHEA Spring 2016 Conference PEACHTREE ROOM PEACHTREE BALLROOM 8TH FLOOR Peachtree Ballroom Foyer: Registration, Membership Booth Peachtree Room: Mentorship Breakfast VANNAH LEVEL, TENTH FLOOR International Meet and Greet Breakfast Peachtree Ballroom CD: Plenary Sessions Women in Epi Reception 10TH FLOOR (Escalator access from the 9th Floor) Savannah Ballroom: Full Conference Sessions SAVANNAH BALLROOM SCIENCE GUIDING PREVENTION 15 WESTIN PEACHTREE HOTEL FLOOR PLAN FOYER WEDNESDAY, MAY 18 W E S T I N P E A C H T R E E H O T E L F L O O R P L A N (continued) WEDNESDAY, May 18 SCIENTIFIC PROGRAM CONTINENTAL BREAKFAST 7:00 – 7:50 a.m. 7th Floor: Augusta Ballroom(s) OPENING PLENARY: CDC AND HEALTHCARE ASSOCIATED INFECTIONS: PREVENTION IN THE PAST, THE PRESENT, AND THE FUTURE 8:00 – 9:30 a.m. Peachtree Ballroom CD Moderator: Beth Bell, MD Speakers: Introduction: What is happening at the CDC? Beth Bell, MD Public Health and HAI Prevention: A Changing Paradigm Mike Bell, MD Expanding the Reach: Federal/State Partnership in HAI Prevention - Marion Kainer, MD Exploring the Cutting Edge of HAI Prevention Science: What’s New, What’s Next, What’s on the Horizon John Jernigan, MD Learning Objectives: • Assess the overview of the internal CDC process for dealing with emergent infectious diseases • Discuss the state level perspective on interactions and collaboration with CDC • Describe the long-term vision of CDC and how it affects hospital epidemiologists and infection preventionists NETWORKING BREAK 9:30 – 10:00 a.m. 7th Floor: Augusta Ballroom(s) SCHEDULE ARE THERE GLOBAL STANDARDS FOR ENDOSCOPE REPROCESSING METHODS? 10:00 – 11:00 p.m. Chastain Room Moderators: John Boyce, MD and Carolyn Gould, MD Speakers: MDRO Outbreaks Linked with Endoscopes Alexander Kallen, MD Does One Size Fit All? Global Guidelines for Endoscope Reprocessing - Paul Tambyah, MD Learning Objectives: • Review the implications associated with inadequately decontaminated endoscopes as they relate to several outbreaks across countries. • Evaluate measures for successful decontamination processing of endoscopes. • Identifying produced guidelines and necessary quality controls for endoscope reprocessing practices THE POSSIBILITIES OF INNOVATIVE AUTOMATED TOOLS FOR HAND HYGIENE COMPLIANCE MEASUREMENT 11:00 – 12:00 p.m. Chastain Room Moderators: John Boyce, MD and Susan Huang, MD Speakers: The Evidence behind Unique Methods and Newly Discovered Electronic Tools to Improve Hand Hygiene Joost Hopman, MD Does Real Time Automated Hand Hygiene Compliance Measurement Improve Practice? - Ermira Tartarim, MSc Learning Objectives: FULL CONFERENCE CREATING A LEVEL PLAYING FIELD WITH PUBLICALLY-REPORTED HAI DATA 10:00 – 12:00 p.m. Savannah Ballroom Moderators: Anthony H arris, MD and Daniel Diekema, MD Speakers: The Next Steps for Risk Stratification of HAI Data Anthony Harris, MD Analyzing Reported HAI Data for Variation in Definition Application - Emily Sickbert-Bennett, PhD Moving to Objective Surveillance Outcomes to Level the Playing Field: Hospital - Onset Bacteremia Aaron Milstone, MD Learning Objectives: • Discuss challenges with currently reported HAI metrics • Assess variations in reported HAI data and potential issues with selection and reporting biases • Examine alternative metrics and methods to ensure a more level playing field with regards to reported HAI metrics 16 SHEA Spring 2016 Conference • Identify quantitative and qualitative research evaluation and identifying the challenges in adopting unique electronic methods to measure hand hygiene compliance • Assess the ability of currently available electronic tools in providing adequate hand hygiene actions • Identify the differences in behavioral science linked to the human review process versus automated process in improving hand hygiene compliance PROGRAM JOINT SESSIONS FULL CONFERENCE COURSE OVERVIEW 10:00 - 10:15 a.m. Chastain F Speakers: Sarah Haessler, MD and Nimalie Stone, MD Learning Objectives: • Orientation to course materials • Overview of course structure INTRODUCTION TO HEALTHCARE EPIDEMIOLOGY 10:15 - 11:15 a.m. Chastain F Speaker: Trish Perl, MD Learning Objectives: • Obtain a broad overview of the importance of basic concepts in infection prevention, including hand hygiene and asepsis, isolation precautions, disinfection and sterilization, device reprocessing, and environmental cleaning • Define occupational health-related issues and procedures • Examine immunization of HCW and patients • Review infected HCW assessment • Discuss blood borne pathogen and communicable disease exposure management • Explain environmental infection control, air handling and water • Classify infection control issues related to construction in healthcare facilities • Define the role of healthcare epidemiology across the continuum of care • Define the role of epidemiology beyond infection control • Define the hospital epidemiologist’s role in regulatory compliance TRANSMISSION OF INFECTIOUS AGENTS IN HEALTHCARE SETTINGS 11:15 - 12:00 p.m. Chastain F Speaker: Curtis Donskey, MD Learning Objectives: • Discuss modes of transmission for important healthcare pathogens • Evaluate methods for interruption of transmission of pathogens in healthcare settings • Discuss how to implement effective methods to prevent transmission LUNCH WITH POSTER VIEWING 12:00 – 1:00 p.m. SCHEDULE 7th Floor: Augusta Ballroom(s) Posters may be viewed during this lunch period with no presentations. IMPLEMENTATION ACADEMY: TURNING SCIENCE INTO IMPROVED PRACTICE 1:00 – 2:30 p.m. Savannah Ballroom Moderators: Jennifer Meddings, MD and Sarah Krein, PhD Speakers: Implementation Methods: Understanding the Models and Methods - Sarah Krein, PhD CAUTI Prevention in Post-Acute and Long-Term Care: Applying Principles of Implementation Science Lona Mody, MD Real-Life Case Examples: Discussing Implementation Challenges in the Trenches - Silvia Munoz-Price, MD A couple of case examples will be presented in this session. Learning Objectives: • Identify key models and methods in the field of implementation science • Discuss implementation focused strategies and approaches for preventing MDROs • Describe the application of implementation principles as part of a large-scale collaborative focusing on preventing CAUTI in the long-term care setting ORAL ABSTRACT SESSION: MDROS 1:00 – 2:30 p.m. Chastain Room Moderators: Alex Kallen, MD and Brooke Decker, MD 7967All-Cause Mortality, Among Hospitalized Patients, With Carbapenem-Resistant Enterobacteriaceae (CRE) Sandra N. Bulens, MPH1, Uzma Ansari, MS1, Tatiana Travis, BS1, Kelly McCormick, MSPH2, David Kleinbaum, PhD1, Valerie S. Albrecht, MPH1, Maroya Walters, PhD ScM1, Jesse Jacob, MD3,4, Christopher Bower, MPH4,5,6, Lucy Wilson, MD7, Elisabeth Vaeth, MPH8, Ruth Lynfield, MD9, Kristin Shaw, MPH9, Paula M. Snippes Vagnone, MT9, Wendy Bamberg, MD10, Sarah Janelle10, Ghinwa Dumyati, MD, FSHEA11,12, Cathleen Concannon, MPH11,13, Erin C Phipps, DVM, MPH14, Nicole Kenslow, MPH14, Zintars Beldavs, MS15, P. Maureen Cassidy, MPH15, Marion A. Kainer, MD, MPH16, Jacquelyn Mounsey, BSN, RN17, Maria Karlsson, PhD1 and Alexander J. Kallen, MD, MPH1, (1)Centers for Disease Control and Prevention, Atlanta, GA, (2)Division of Healthcare Quality Promotion, CDC, Atlanta, GA, (3) Emory University School of Medicine, Division of Infectious Diseases, Atlanta, GA, (4)Georgia Emerging Infections Program, Decatur, GA, (5) Atlanta Research and Education Foundation, Atlanta, GA, (6)Atlanta Veterans Affairs Medical Center, Decatur, GA, (7)Department of Health & Mental Hygiene, Baltimore, MD, (8)6Maryland Department of Health and Mental Hygiene, Baltimore, MD, (9)Minnesota Department of Health, Saint Paul, MN, (10)Colorado Department of Public Health & Environment, Denver, CO, (11)New York Emerging Infections Program, Rochester, NY, (12)University of Rochester Medical Center - Center for Community Health, Rochester, NY, (13)University of Rochester Medical Center, Rochester, NY, (14)University of New Mexico, New Mexico Emerging Infections Program, Albuquerque, NM, (15)Oregon Health Authority, Portland, OR, (16)Tennessee Department of Health, Nashville, TN, (17)Tennessee Emerging Infections Program, Vanderbilt University, Nashville, TN (Continued to page 18) SCIENCE GUIDING PREVENTION 17 WEDNESDAY, May 18 SCIENTIFIC WEDNESDAY, May 18 SCIENTIFIC PROGRAM 8110Genomic and Epidemiological Analysis Identifies EMRSA-15 Transmission In the UK Community Michelle S Toleman1, Emmeline R Watkins2, Tom Williams1, Francesc Coll1, Bernadette Nazareth2, Belinda Sadler3, Nick Brown4, Julian Parkhill5 and Sharon J Peacock1,6, (1)University of Cambridge, Cambridge, United Kingdom, (2)Health Protection Team, PHE East of England, Thetford, United Kingdom, (3)Infection Prevention & Control Cambridgeshire & Peterborough CCG, Cambridgeshire, United Kingdom, (4)PHE Clinical Microbiology and Public Health Laboratory, Cambridge, United Kingdom, (5)Wellcome Trust Sanger Institute, Cambridge, United Kingdom, (6)LSHTM, London, United Kingdom 8144 Factors Leading to Transmission Risk of Acinetobacter baumannii Kerri Thom, MD, MS1, Clare Rock, MD, MS2, Sarah S Jackson, MPH1, J. Kristie Johnson, PhD3, Laurence S. Magder, PhD1, Robert A. Bonomo, MD4 and Anthony Harris, MD, MPH1, (1)Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, (2)Department of Medicine, Division of Infectious Diseases, Johns Hopkins University, Baltimore, MD, (3) University of Maryland, Baltimore, MD, (4)Louis Stokes Cleveland VA Medical Center, Cleveland, OH 8125Prevalence of Multi Drug Resistant Organism (MDRO) Contamination in Nursing Homes Michael Bolaris, MD1,2,3, James A McKinnell, MD2, Bryn Launer, BS2, Kyle Ramsay, BS2, Raveena Singh, MS4, Tabitha Dutciuc, MPH4, Marlene Estevez, BA4, Tom Tjoa, MS MPH4, Ellena Peterson, PhD5, Kaye Evans, BS6, Susan S. Huang, MD, MPH4 and Loren Miller, MD, MPH7,8, (1)Department of Pediatrics, Harbor UCLA Medical Center, David Geffen School of Medicine at UCLA, Torrance, CA, (2)Infectious Disease Clinical Outcomes Research Unit (ID-CORE), Division of Infectious Disease, Los Angeles Biomedical Research Institute at Harbor-University of California Los Angeles (UCLA) Medical Center, Torrance, CA, (3)Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, CA, (4)Division of Infectious Diseases and Health Policy Research Institute, University of California, Irvine School of Medicine, Irvine, CA, (5)Department of Pathology and Laboratory Medicine, University of California School of Medicine, Irvine, CA, (6)Department of Pathology and Laboratory Medicine, University of California, Irvine School of Medicine, Irvine, CA, (7)Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, CA, CA, (8)Department of Medicine, Division of Infectious Disease, Harbor-UCLA Medical Center, David Geffen School of Medicine, Torrance, CA 7787SAVE’M STAT: Staph Aureus Vancomycin Evaluation of MIC: A Semi-Automated Tool for Analyzing Trends Robert Clifford, PhD1, Uzo Chukwuma2, Charlotte Neumann2, Paige Waterman, MD3, Emma Milburn2, Jacob Moran-Gilad4, Michael Julius, PMP1, Mary Hinkle, MD1 and Emil Lesho, DO1, (1)Walter Reed Army Institute of Research, Silver Spring, MD, (2)Navy and Marine Corps Public Health Center, Portsmouth, VA, (3)Armed Forces Health Surveillance Center, Silver Spring, MD, (4)Ben-Gurion University of the Negev, Be’er Sheva, Israel 7987Genomic Analysis of Transmission of KPC-Producing Enterobacter and Klebsiella Species Hajime Kanamori, MD, PhD, MPH1,2, Christian M. Parobek3, Jonathan J. Juliano1, David Van Duin1, David J. Weber, MD, MPH1,4 and William A. Rutala, PhD, MPH1,4, (1)Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC, (2) Hospital Epidemiology, University of North Carolina Health Care, Chapel Hill, NC, (3)University of North Carolina School of Medicine, Chapel Hill, NC, (4)Hospital Epidemiology, UNC Medical Center, Chapel Hill, NC 18 SHEA Spring 2016 Conference SCHEDULE PEDIATRIC INFECTION PREVENTION: FOCUS ON GUIDELINE 2:45 – 4:00 p.m. Savannah Ballroom Moderators: Kari Simonsen, MD and Matthew Linam, MD Speakers: Isolation Precautions and Parents and Visitors Matthew Linam, MD Animals, Healthcare and Children - Gonzalo Bearman, MD Implementation of the CF Guidelines - Kari Simonsen, MD Learning Objectives: • Discuss the role parents and visitors play in the transmission of pathogenic organisms Discuss the current evidence supporting the use of isolation precautions and hand hygiene by parents and visitors • Discuss the role of animal-to-human transmission of infections in healthcare settings Develop strategies to minimize the risks associated with animals in healthcare settings • Discuss the potential healthcare sources and modes of transmission of cystic fibrosis pathogens to children with cystic fibrosis • Develop strategies to minimize the risk of transmission and acquisition of cystic fibrosis pathogens in patients with cystic fibrosis ORAL ABSTRACT SESSION: OUTBREAKS 2:45 – 3:30 p.m. Chastain Room Moderators: Marion Kainer, MD and Michael Bell, MD 8164Outbreak of Mycobacterium chimaera Infections in Cardiac Surgery Patients Linked to Heater-Coolers Emily J Cooper, RN, MS, CIC, WellSpan Health, York, PA 8122Screening of Exposed Healthcare Workers During an Outbreak of MERS in Saudi Arabia Dr. Hanan Balkhy, MD1, Aiman El-Saed, MD, PHD2, Henry BaffoeBonnie, MD2, Thamer H Alenazi, MD2, Azzam Mohammed2, Nimfa L. Dagunton, BSN, RN1, Fatimah Abdulkarim, PHN2, Sameera Al Johani, MD3, Waseem Khan, MD2 and Dina Afurong, RN2, (1)King Abdulaziz Medical City, Riyadh, Saudi Arabia, (2)King Abdulaziz Medical City; Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia, (3)Pathology and Laboratory Medicine Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia 8232Rethinking Measles Exposures in Health Care Settings: Missed Opportunities to Prevent Transmission Emmanuel Mendoza, MPH, Dulmini Wilson, MPH, Chhandasi Pamina Bagchi, MPH, Idriss Fassassi, MPH, Jon LaMori, MA, Franklin Pratt, MD and Michelle T. Parra, PhD, Los Angeles County Department of Public Health Immunization Program, Los Angeles, CA PROGRAM ORAL ABSTRACT SESSION: INNOVATION IN INFECTION PREVENTION 4:15 – 5:30 p.m. Chastain Room Moderators: Belinda Ostrowsky, MD and Rebekah Moehring, MD 8146Post-Discharge Central Line Management in the Nursing Home Shruti K. Gohil, MD, MPH1,2, Mohamad Al Sharif, MD3, Raveena Singh, MS4 and Susan S. Huang, MD, MPH4,5, (1)University of California, Irvine School of Medicine, Assistant Professor, Irvine, CA, (2)UC Irvine Medical Center, Associate Medical Director, Epidemiology & Infection Prevention, Irvine, CA, (3)University of California Irvine School of Medicine, Division of Infectious Diseases, Orange, CA, (4) Division of Infectious Diseases and Health Policy Research Institute, University of California, Irvine School of Medicine, Irvine, CA, (5) Epidemiology and Infection Prevention, UC Irvine Health, Orange, CA 7942Sustained Improvement in Hand Hygiene at 3 Sites with Badge-based Monitoring and Individual Feedback Liberty R. Dykehouse, MSN, RN, ACNS-BC, CIC1, Megan E. Read, MPH, MLS, CIC2 and Jessica Buckner, MSN, RN3, (1)Mercy Health Saint Mary’s, Grand Rapids, MI, (2)Dartmouth-Hitchcock Medical Center, Lebanon, NH, (3)Annie Penn Hospital, Reidsville, NC 8235Cost-effectiveness of Infectious Diseases (ID) Consultation for S. aureus Bacteremia in Hemodialysis Thomas C. Rose1, Jesse Jacob, MD2,3 and Chad Robichaux, MPH3,4, (1)Emory University School of Medicine, Atlanta, GA, (2) Emory University School of Medicine, Division of Infectious Diseases, Atlanta, GA, (3)Emory University, Atlanta, GA, (4)Emory Healthcare, Decatur, GA 8018Optimizing Urine Culture Ordering Practices Using the Electronic Medical Record: A Pilot Study Daniel K. Shirley, MD, MS1, Harry Scholtz, DO1, Kurt Osterby, BS2, Barry C. Fox, MD1 and Nasia Safdar, MD, PhD3,4, (1)University of Wisconsin School of Medicine and Public Health, Madison, WI, (2)UW Health, University Hospital, Madison, WI, (3)The William S. Middleton Veterans Affairs Medical Center, Madison, WI, (4)University of Wisconsin School of Medicine & Public Health, Madison, WI 7799Increasing the Uptake of Influenza Vaccination by Family Members of Pediatric Ambulatory Patients Su Jin Joo, MD1,2, Sandra Rojas-Honan, RN, BSN2 and Andi Shane, MD, MPH, MSc2,3, (1)Division of Pediatric Infectious Diseases, Emory University School of Medicine, Atlanta, GA, (2) Children’s Healthcare of Atlanta, Atlanta, GA, (3)Emory University School of Medicine, Atlanta, GA SCHEDULE CHOOSING WISELY Co-Organized by The Society of Infectious Diseases Pharmacists (SIDP) 4:15 – 5:45 p.m. Savannah Ballroom Moderators: Elizabeth Dodds-Ashley, PharmD and Gonzalo Bearman, MD Speakers: Choosing Wisely Campaign - Daniel Morgan, MD Improving the Culture of Culturing: Why the Urine Mohamad Fakih, MD The Role of Up and Coming Antibiotics at the Local Level Conan MacDougall, PharmD Learning Objectives: • Examine approaches to reduce patient harm related to inappropriate utilization of diagnostic tests and treatments. • Review the Choosing Wisely campaign and the new SHEA Choosing Wisely metrics • Describe strategies to improve urine culture utilization and as a result reducing antibiotic use and false positive UTI diagnoses • Describe the role of new and emerging anti-infective agents at the local level • List key factors in assessing whether new anti-infective agents add significantly to the local antibiotic formulary SHEA/CDC TRAINING CERTIFICATE COURSE IN HEALTHCARE EPIDEMIOLOGY Course Moderator: Sarah Haessler, MD PRACTICAL STRATEGIES FOR SURVEILLANCE 1:00 – 1:45 p.m. Chastain F Speaker: Laurie Conway, PhD Learning Objectives: • Identify core components of an HAI surveillance program • Select optimal methods for collection and analysis of surveillance data • Correlate relationship between surveillance and prevention activities • Evaluate surveillance findings and incorporate into effective intervention plans THE COMPENDIUM STRATEGIES FOR PREVENTING HAIs 1:45 – 2:30 p.m. Chastain F Speaker: Deborah S. Yokoe, MD Learning Objectives: • Identify priority recommendations of Compendium of Strategies to prevent healthcare-associated infections in acute-care settings and associated resources • Identify practical methods and tools to meet basic and advanced recommendations SCIENCE GUIDING PREVENTION 19 WEDNESDAY, May 18 SCIENTIFIC WEDNESDAY, May 18 SCIENTIFIC PROGRAM SHEA/CDC TRAINING C E RT I F I C AT E C O U R S E CHANGE MANAGEMENT AND THE SCIENCE OF SAFETY 2:45 – 3:45 p.m. 1:00 – 2:15 p.m. Chastain F Chastain E Speaker: David Nace, MD Learning Objectives: Learning Objectives: • Compare the differences between RCA and FMEA and when to utilize each method in the setting of HAI • Develop the infrastructure and team necessary to perform a RCA or FMEA • Identify the scoring methodology for individual failure modes in a FMEA • Justify the use of RCA and FMEA • Evaluate how the patient safety/infection prevention Program intersects with the institution’s strategic plan • Review basic concepts regarding patient safety, quality science, implementation science, human factor design, and organizational change ROOT CAUSE ANALYSIS PRACTICAL SESSION Chastain F Speaker: Tammy Lundstrom, MD Learning Objectives: • • • • SHEA/CDC/AMDA INFECTION PREVENTION IN PAC & LTC CERTIFICATE COURSE MANAGING OUTBREAKS Speaker: Tammy Lundstrom, MD 3:45 – 4:15 p.m. SCHEDULE Perform an RCA related to HAI in a team setting Evaluate process changes necessary for a thorough RCA Evaluate RCA measures of success Identify how accreditation bodies will evaluate an effective RCA • Describe how the long-term care environment influences outbreak risk and impacts outbreak detection and response • Identify common causes of outbreaks in post-acute and long-term care settings • Discuss strategies to manage outbreaks that occur in the long-term care environment CHANGING APPROACHES IN SURVEILLANCE 2:30 – 4:00 p.m. Chastain E Speaker: Nimalie Stone, MD Learning Objectives: • Review surveillance criteria used to define infections in post-acute and long-term care settings • Compare different methods for surveillance data collection in post-acute and long-term care settings • Identify how to use surveillance data to guide infection prevention and antibiotic stewardship efforts in post-acute and long-term care STRATEGIES TO PREVENT INFECTIONS AND MDROS 4:10 – 5:30 p.m. Chastain E OVERVIEW OF ANTIBIOTIC STEWARDSHIP Speakers: Lona Mody, MD, and Shira Doron, MD 4:30 – 5:30 p.m. Learning Objectives: Chastain F Speaker: Sara Cosgrove, MD Learning Objectives: • Discuss the rationale for antibiotic stewardship • Discuss the elements and activities of a stewardship program • Discuss approaches to help prescribers make good decisions about antibiotics • Translate emerging national initiatives to encourage and enhance antibiotic stewardship • Describe risk factors and interventions to prevent deviceassociated infections among residents in post-acute and long-term care • Review challenges in diagnosis of infection due to C. difficile and MDROs in post-acute and long-term care • Describe strategies for preventing the spread of Multidrug Resistant Organisms in post-acute and long-term care WOMEN IN EPI RECEPTION 6:00 – 8:00 p.m. 20 SHEA Spring 2016 Conference Peachtree Ballroom CD PROGRAM CONTINENTAL BREAKFAST 7:00 – 7:50 a.m. 7th Floor: Augusta Ballroom(s) MENTORSHIP BREAKFAST 7:00 – 7:50 a.m. Peachtree Room This breakfast is open only to SHEA Mentors, SHEA Mentees, and SHEA Leaders. FULL CONFERENCE ENVIRONMENTAL DISINFECTION 8:00 – 9:30 a.m. Chastain Room Moderators: Philip Carling, MD and Emily Sickbert-Bennett, PhD Speakers: UV Light/Peroxide - Deverick Anderson, MD Monitoring - Curtis Donskey, MD Return on Investment and Robots - Trish Perl, MD Learning Objectives: SCHEDULE S H E A / C D C C E R T I F I C AT E C O U R S E I N H O S P I TA L E P I D E M I O L O G Y C O U R S E CDC PROBLEM SESSION: DEVICE-ASSOCIATED INFECTIONS 8:00 – 8:45 a.m. Chastain F Speakers: Jonathan Edwards, MStat and Maggie Dudeck, MPH Learning Objectives: • Summarize decisions on how to prioritize surveillance efforts • Identify analytical methods for assessing temporal changes in infection rates • Indicate the role of risk adjustment when analyzing infection rate data • Identify methods of analysis for assessing intervention effectiveness • Assess, interpret, and summarize data that are imprecise • Using NHSN to understand and benchmark your hospital’s data CDC PROBLEM SESSION: PROCEDURE INFECTIONS • Discuss the current state of hospital cleaning and disinfection • Discuss the pros and cons of alternative or enhanced strategies for room cleaning and disinfection 8:45 – 9:30 a.m. SELLING YOUR RESULTS: TO SUITS, SCIENTISTS, AND SOCIETY Learning Objectives: 8:00 – 9:30 a.m. Savannah Ballroom Moderators: Daniel Diekema, MD and Anthony Harris, MD Speakers: The VP of Quality Perspective - Louise Dembry, MD Social Media - Eli Perencevich, MD Selling into Broader Society - Arjun Srinivasan, MD Chastain F Speakers: Jonathan Edwards, MStat and Maggie Dudeck, MPH • Summarize decisions on how to prioritize surveillance efforts • Identify analytical methods for assessing temporal changes in infection rates • Indicate the role of risk adjustment when analyzing infection rate data • Identify methods of analysis for assessing intervention effectiveness • Assess, interpret, and summarize data that are imprecise • Identifying how NHSN can help you understand and benchmark your hospital’s data Learning Objectives: • Assess key persuasion techniques when dealing with C level administrators • Recognize how to influence your peers using hospital epidemiology data • Identify the fundamental components of how to transform societal perceptions related to infection control SCIENCE GUIDING PREVENTION 21 THURSDAY, MAY 19 SCIENTIFIC SCIENTIFIC PROGRAM SHEA/CDC/AMDA INFECTION PREVENTION I N PA C & LT C C E R T I F I C AT E C O U R S E OCCUPATIONAL HEALTH AND SAFETY 8:00 – 8:45 a.m. Chastain E FULL CONFERENCE SURGICAL SITE INFECTION PREVENTION: WHERE DO WE SCIP AND HOP FROM HERE? Speaker: David Nace, MD 10:00 – 12:00 p.m. Learning Objectives: Moderators: Marci Drees, MD and Deverick Anderson, MD Speakers: Pre-Op Screening and Choice of Prophylaxis Trish Perl, MD Splish Splash I was Taking a Bath: The Case for Antibiotic Surgical Washes and Other Antibiotic Delivery Systems Belinda Ostrowsky, MD A Bundle of Bundles- Extending Bundled Infection Prevention and ASP Approach Across Surgical Procedures Jerod Nagel, PharmD • Review common occupational health issues in the long-term care setting • Identify how to manage common occupation health issues in long-term care settings • Identify regulatory requirements pertaining to occupational health issues in long-term care THURSDAY, MAY 19 SCHEDULE CDI MANAGEMENT 8:45 – 9:30 a.m. Chastain E Speaker: Robin Jump, MD Learning Objectives: Learning Objectives: • Define the management and prevention of CDI in post acute care. NETWORKING BREAK 9:30 – 10:00 a.m. Chastain Room 7th Floor: Augusta Ballroom(s) • Review infection prevention and stewardship processes and interventions in the post SCIP and HOP Era to prevent SSIs • Discuss data and implementation of more proactive screening to guide prophylaxis for surgical procedures (including screening from MRSA or other MDRO pathogens or for specific high risk procedures) • Describe the data (or lack thereof) and practices for a series of washes (chlorhexidine, antibiotic solutions, impregnated beads) that are used in surgical procedures • Describe” bundles” that address both prescribing and infection prevention strategies; these would address a series of surgery types and locations PRACTICAL CONSIDERATIONS IN HAI RESEARCH 10:00 – 12:00 p.m. Savannah Ballroom Moderators: Ann-Christine Nyquist, MD and Shruti Gohil, MD Speakers: Ethics of QI and QI Research: The Blurring of the Lines Susan Huang, MD Engaging Patients and other Stakeholders in your Research - Jeffrey Gerber, MD HAI/AS Research on a Shoestring - Leonard Mermel, DO Is Something Better than Nothing? Gauging the Level of Evidence for Implementation - Eli Perencevich, MD Learning Objectives: • Describe critical elements of ethics and stakeholders in developing HAI research • Discuss how to maximize opportunities to conduct HAI research when funds are limited • Assess the level of evidence for various interventions as a critical step prior to implementation 22 SHEA Spring 2016 Conference PROGRAM S H E A / C D C T R A I N I N G C E R T I F I C AT E C O U R S E I N H E A LT H C A R E E P I D E M I O L O G Y UNIQUE ASPECTS OF PEDIATRIC INFECTION CONTROL 10:00 – 10:45 a.m. SCHEDULE SHEA/CDC/AMDA INFECTION PREVENTION I N PA C & LT C C E R T I F I C AT E C O U R S E CHALLENGING SITUATIONS 10:00 – 11:00 a.m. Chastain F Chastain E Speaker: Thomas Sandora, MD Panelists: David Nace, MD, Robin Jump, MD, Shira Doron, MD, and Silvia Munoz-Price, MD Learning Objectives: Learning Objectives: • Identify risk factors for healthcare-associated infections that are unique to children • Discuss common pediatric infections and how to prevent them • Define unique aspects of infection control in special populations, including neonatal intensive care units • Describe pediatric modifications to typical infection prevention strategies • Discuss challenging infection control situations that might arise in post-acute and long-term care such as outbreaks, healthcare personnel vaccination, and antibiotic overuse APPROACH TO EPIDEMIC/OUTBREAKS INVESTIGATION 10:45 – 11:30 a.m. Chastain F Speaker: Arjun Srinivasan, MD JOINT SESSIONS ANTIBIOTIC STEWARDSHIP IN SKILLED NURSING FACILITIES AND LONG-TERM CARE 11:00 – 12:00 p.m. Chastain E Speaker: Kavita Trivedi, MD Learning Objectives: Learning Objectives: • • • • Identify and define an outbreak Illustrate how to perform an outbreak analysis Analyze how to manage and control an outbreak Indicate methods to find and investigate cases in an outbreak investigation • Recognize when a formal risk factor study is needed and how to select the appropriate study design (e.g., case control vs. cohort) for an outbreak investigation • Recognize when and how to communicate with facility administrators, risk management, public affairs, clinical staff and patients/families about the need for, progress of, and outcome of an outbreak investigation • Review the potential role of molecular typing of microbial isolates in an outbreak investigation • Define the unique challenges for resources, team development and measurement in long-term care settings • Identify starter strategies for implementing effective antibiotic stewardship in long-term care settings • Describe collaborations between acute care and long-term care to create effect antibiotic stewardship programs CPE Number: 0221-9999-16-079-L04-P PROBLEM SESSION: OUTBREAK IN THE OR 11:30 – 12:00 p.m. Chastain F Speaker: Arjun Srinivasan, MD Learning Objectives: • Apply the lessons of outbreak investigation to a real world example • Identify some of the practical issues that arise when doing an outbreak investigation SCIENCE GUIDING PREVENTION 23 THURSDAY, MAY 19 SCIENTIFIC POSTER PRESENTATIONS: THURSDAY, MAY 19 SCIENTIFIC PROGRAM POSTER LUNCH PRESENTATIONS 12:00 – 1:00 p.m. 7th Floor: Augusta Ballroom 501 Adherence to the Ventilator Bundle and Risk of Ventilator-Associated Events Bryan D Harris, MD1, Gale A Thomas2, Michael S Chaikowski2 and Thomas Talbot III, MD, MPH1, (1)Vanderbilt University School of Medicine, Nashville, TN, (2)Vanderbilt University Medical Center, Nashville, TN 502 Preventing CAUTI in the ICUs: Why Culturing Practices Trump the Effect of Device Care Ana C Bardossy, MD1, Takiah Williams, RN2, Karen Jones, RN3, Susan Szpunar, MPH, DrPH3, Yuan Xin, MPH1, Marcus Zervos, MD1, George Alangaden, MD4, Katherine Reyes, MD, MPH1 and Mohamad Fakih, MD, MPH5, (1)Henry Ford Health System, Detroit, MI, (2)St. John Hospital and Medical Center, Grosse Pointe, MI, (3)St John Hospital & Medical Center, Grosse Pointe Woods, MI, (4)Wayne State University, Detroit, MI, (5)Care Excellence, Ascension Health, Grosse Pointe Woods, MI 503 Barriers to Implement Prevention Strategies for Catheter Associated Urinary Tract Infections (CAUTI) Adriana Jimenez, MPH, BSMT.1,2, Dennise De Pascale, BSMT.2, Jose Guillermo Castro, MD.3, Ronda Sinkowitz-Cochran, MPH.4, Carolyn Gould, MD, MSCR4, Katie Coutts, MPH4, Matthew J. Hagan5, Esther I. Diaz, MD5 and Valeria Bagley, MD, MPH5, (1)Florida International University Robert Stempel College of Public Health & Social Work, Miami, FL, (2)Jackson Memorial Hospital - Department of Infection Prevention and Control, Miami, FL, (3)Division of Infectious Diseases University of Miami Miller School of Medicine, Miami, FL, (4) Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA, (5)University of Miami, Miami, FL 504 The Placement of an Indwelling Urinary Catheter: Art or Science? Lovisa B Olafsdottir, MD, Sharon B. Wright, MD, MPH, FIDSA, FSHEA, Michael N. Cocci, MD and Graham M. Snyder, MD, SM, Beth Israel Deaconess Medical Center, Boston, MA 505 Standardizing Urine Culture Practices Reduces Misclassification of Catheter Associated Urinary Tract Lisa Reif, MSN, RN, APRN-CCNS1, Esther Baker, MSN, RN, CIC2, William Asbury, PharmD2, Owen Samuels, MD3, Sujan C. Reddy, MD MS4, Nathan Spell, MD3 and Jay Varkey, MD3, (1)Emory University, Atlanta, GA, (2)Emory Healthcare, Atlanta, GA, (3)Emory University School of Medicine, Atlanta, GA, (4)Emory University School of Medicine, Division of Infectious Diseases, Atlanta, GA 506 Urinary Catheter Awareness, Orders and Indications in ICUs Jennifer Meddings, MD, MSc1, Latoya Kuhn, MPH2 and Heidi Reichert, MA1, (1)University of Michigan, Ann Arbor, MI, (2)VA Ann Arbor Health System, Ann Arbor, MI 507 Catheter Associated Urinary Tract Infections Reduced by 79% through a Bundled Approach Priya Sampathkumar, MD1, Rodney L. Thompson, MD2 and Tamara Buechler, MD2, (1)Mayo Clinic College of Medicine, Rochester, MN, (2) Mayo Clinic, Rochester, MN SCHEDULE 508 Knowledge Survey in Nursing Homes Reveals Actionable Gaps in Knowledge of Infection Control Barbara Trautner, MD, PhD1,2, Todd Greene, PhD3,4, Andrew Rolle, MPH5, Barbara Edson, RN, MBA, MHA5, Sara McNamara, MPH4, Heidi Wald, MD, MPH6, Sarah Krein, PhD, RN3,4, Sanjay Saint, MD, MPH3,4 and Lona Mody, MD, MSc3,4, (1)Baylor College of Medicine, Houston, TX, (2)Center for Innovations in Quality, Effectiveness and Safety, Houston, TX, (3)VA Ann Arbor Healthcare System, Ann Arbor, MI, (4)University of Michigan, Ann Arbor, MI, (5)Health Research & Educational Trust in partnership with the American Hospital Association, Chicago, IL, (6)University of Colorado, School of Medicine, Aurora, CO 509 How Good Are We at Maintaining Our Devices in the ICUs? A View of Two Tertiary Care Teaching Centers Ana C Bardossy, MD1, Takiah Williams, RN2, Karen Jones, RN3, Susan Szpunar, MPH, DrPH3, Yuan Xin, MPH1, Marcus Zervos, MD1,4, George Alangaden, MD1,4, Katherine Reyes, MD, MPH1 and Mohamad Fakih, MD, MPH5, (1)Henry Ford Health System, Detroit, MI, (2)St. John Hospital and Medical Center, Grosse Pointe, MI, (3)St John Hospital & Medical Center, Grosse Pointe Woods, MI, (4)Wayne State University, Detroit, MI, (5)Care Excellence, Ascension Health, Grosse Pointe Woods, MI 510 Reliability Testing of a New Decision Support Tool That Promotes the Appropriate Use of Urinary Cath Jan J Gralton, BSc (Hons), PhD1,2, Alistair Henry, BA (Hons)1,3 and Paul Curtis, MBBS1, (1)Clinical Excellence Commission, Sydney NSW 2000, Australia, (2)University of New South Wales, Sydney NSW 2052, Australia, (3)Macquarie University, Sydney NSW 2109, Australia 511 Developing a User-Friendly Report for ElectronicallyAssisted CAUTI Surveillance Felicia Skelton, MD1,2, Bryan Campbell, PhD1, Deborah Horwitz, PA2, Sanjay Saint, MD, MPH3,4, Sarah Krein, PhD, RN3,4, Anne Sales, PhD, RN3,4 and Barbara Trautner, MD, PhD1,2, (1)Center for Innovations in Quality, Effectiveness and Safety, Houston, TX, (2)Baylor College of Medicine, Houston, TX, (3)University of Michigan, Ann Arbor, MI, (4)VA Ann Arbor Healthcare System, Ann Arbor, MI 512 Implementing Best Practices for CAUTI Reduction Maureen A. Seckel, APRN, Kathy M. Wroten, MS, BSN, RN, CIC, Denise French, MSN, RN, APN, GCNS-BC, Tamekia Thomas, MSN, RN, PCCN, ACNS-BC, Gwen Ebbert, RN, MSN, BA, RN-BC, Craig Martine, MSN, RN, CCRN, Nancy Davis, BSN, RN, CIC, Lorraine Adkins, BSN, RN, CIC, Janice Gibson-Gerrity, MS, BSN, RN, Brian Stephan, BA, Maureen Berry, Patricia Curtin, MD, Linda LaskowskiJones, MS, APRN, ACNS-BC, Emily Penman, MD and Marci Drees, MD, MS, Christiana Care Health System, Newark, DE 513 A Look at the Indications Selected for Urinary Catheter Insertion in the Emergency Department Anthony Baffoe-Bonnie, MD1, Jim Wong, MD2, Fatima Wong, DO3 and Shikha Vasudeva, MD4, (1)Carilion Clinic-VTC-School of Medicine, Roanoke, VA, (2)Carilion Clinic, Roanoke, VA, (3)Carilion Clinic/VTC- School of Medicine, Roanoke, VA, (4)Carilion Clinic-VTCSchool of Medicine, Roanoke, VA 514 Clinical Decision Support Interventions to Reduce CAUTI: Pitfalls of Implementation Zachary N Gordon, MD, Julie Mangino, MD, Daniel S Eiferman, MD, Iahn Gonsenhauser, MD and Susan D Moffatt-Bruce, MD, PhD, The Ohio State University Wexner Medical Center, Columbus, OH 515 A Sustained Process Improvement-Reduction of Catheter-Associated Urinary Track Infections by 71% Maureen Bunch, MSN, RN CIC, Vibra Hospital, Thornton, CO Top Poster Abstract 24 SHEA Spring 2016 Conference PROGRAM 516 Physicians are Unaware of Presence of Peripheral Intravenous Catheters in Medical Inpatients Shimontini Mitra, MD, Elizabeth Targan, MD, Alexandra Rose, MD, Megan Ritter, MD, Mary T. LaSalvia, MD, MPH and Sharon B. Wright, MD, MPH, FIDSA, FSHEA, Beth Israel Deaconess Medical Center, Boston, MA 517 How Can Leadership Line Care Rounds Prevent Central Line Associated Bloodstream Infections? Hana Hakim, MD, MS, Angie Owings, MSN, RN, CIC, Sherry Johnson, MSN, CCRN, CPON, NE-BC, JoBeth McBee, MSN, APN, NE-BC, PPCNP-BC, BMTCN and Mike Gipson, BS, MBA, St. Jude Children’s Research Hospital, Memphis, TN 518 Insertion Site Inflammation, CLABSI, and Readmissions Due to Outpatient Central Lines Hiroki Saito, MD, MPH1, Mohamad Al Sharif, MD1, Bardia Bahadori1, Li Chen, BA1, Tara E. Seery, MD2, Jennifer Yim, RN, BSN, CIC3, Linda Dickey, RN, MPH, CIC3, Susan S. Huang, MD, MPH1,3 and Shruti K. Gohil, MD, MPH1,3, (1)University of California Irvine School of Medicine, Division of Infectious Diseases, Orange, CA, (2)University of California Irvine School of Medicine, Division of Hematology Oncology, Orange, CA, (3)Epidemiology and Infection Prevention, UC Irvine Health, Orange, CA 519 Complications of Central Venous Catheters in the Home Sara Keller, MD1, Deborah Williams, BSN, MPH2, Dawn Hohl, PhD, RN2, Amanda Krosche, BS1, Ayse Gurses, PhD, MS, MPH3, John Adamovich, MHA2, Mitra Gavgani, PharmD2, Mary Myers, RN, MSN2, David Hirsch, RN, MSN, MBA2, Trish Perl, MD, MSc1 and Sara Cosgrove, MD, MS1, (1)Johns Hopkins University School of Medicine, Baltimore, MD, (2)Johns Hopkins Home Care Group and Pharmaquip Infusion Pharmacy, Baltimore, MD, (3)Johns Hopkins University Armstrong Institute for Patient Safety, Baltimore, MD 520 CAUTIon CAUTI: How Changing Your Definition May Create a CLABSI Epidemic Mohamad Fakih, MD, MPH, Clariecia Groves, MS, Angelo Bufalino, PhD, Michelle Heavens, MHA, RN and Ann Hendrich, PhD, RN, Care Excellence, Ascension Health, St. Louis, MO 521 Review of Strategies to Reduce CLABSI and CAUTI in Adult ICUs with Persistently High Infection Rates Payal K Patel, MD, MPH1, Jennifer Meddings, MD, MSc1, Ashwin Gupta, MD1, Valerie Vaughn, MD1 and Jason D. Mann, MSA2, (1) University of Michigan, Ann Arbor, MI, (2)Ann Arbor VA Healthcare System, Ann Arbor, MI 522 Impact of the CMS Healthcare-Acquired Conditions Policy on Billing Rates of Two Targeted Conditions Alison Kawai, ScD1, Michael S. Calderwood, MD, MPH2,3, Robert Jin, MS4 and Grace Lee, MD, MPH4,5, (1)Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, (2)Harvard Medical School and Harvard Pilgrim Health Care Institute, Department of Population Medicine, Boston, MA, (3)Brigham and Women’s Hospital, Boston, MA, (4)Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, (5) Children’s Hospital Boston, Harvard Medical School and Harvard Pilgrim Healthcare Institute, Boston, MA 523 CMS HAC Policy for CLABSI and CAUTI had Minimal Impact on Hospital Reimbursement Michael S. Calderwood, MD, MPH1, Alison Tse Kawai, ScD2, Robert Jin, MS2 and Grace Lee, MD, MPH2, (1)Brigham and Women’s Hospital, Boston, MA, (2)Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA SCHEDULE 524 Knowledge vs Practice: A cross-Sectional Survey on Healthcare Workers Regarding Infection Control Imran Hasanoglu, M.D1, Rahmet Guner, Prof. Dr2, Fatma Yekta Korkmaz, M.D2, Bircan Kayaaslan, M.D2, Gul Ruhsar Yilmaz, Associate Professor1, Zeliha Kocak Tufan, Associate Professor2, Tumer Guven, Associate Professor2, Turan Buzgan, Associate Professor2 and Mehmet A. Tasyaran, Prof.Dr2, (1)Ankara Ataturk Training and Research Hospital, Ankara, Turkey, (2)Yildirim Beyazit University Faculty of Medicine, Ankara, Turkey 525 Psychological Safety and Non-adherence to the Central Line Bundle Interventions in the VHA Heather M. Gilmartin, PhD, NP1, Paula Langner, MS1, Katerine Osatuke, PhD2, Rachael Hasselbeck, MSN, MBA, RN3 and Catherine Battaglia, PhD, RN1, (1)Denver VA Medical Center, Denver, CO, (2) Veterans Health Administration, National Center for Organizational Development, Cincinnati, OH, (3)Veterans Health Administration Inpatient Evaluation Center, Cincinnati, OH 526 Implementation of Multiple Interventions to Decrease Central Line Associated Bloodstream Infections Susan C. Bleasdale, MD, Margaret Newman, MD and Monica K. Sikka, MD, University of Illinois at Chicago, Chicago, IL 527 The Impact on CLABSIs with the Implementation of Chlorhexidine Dressings for Post-Insertion Care Kapil Vyas, D.O.1 and Aneesa Afroze, M.D.2, (1)Internal Medicine Residency at Mercy Medical Center, Des Moines, IA, (2)Chest, Infectious Diseases and Critical Care Associates, P.C., Clive, IA 528 Total House Surveillance of CLABSI in Large Tertiary Care Hospital in Saudi Arabia Joseph Boutros Tannous, BS, MT, CIC1, Aiman El-Saed Ramadan, MD, PHD1, Henry Baffoe Bonnie, MD, PHD1, Bassem Abukhzam, BS1, Nimfa L. Dagunton, BSN, RN1, Bassema Shadfan, BS1, Kassem Zehri1, Marissa Alarcon, BSN, RN2, Khawla Salman, BS1, Ahmad Ibrahim, BS1, Tamer Abu Areshih, BS1, Ohaila Slim, BS1, Hisham Eid, BS1, Azzam Mohammed1, Tereza Portugal1 and Dr. Hanan Balkhy, MD1, (1)King Abdulaziz Medical City, Riyadh, Saudi Arabia, (2)King Abdulaziz Medical City Ministry of National Guard, Riyadh, Saudi Arabia 529 Evaluation of a Far Ultraviolet Light Device for Decontamination of Gloves Myreen E. Tomas, MD1, Jennifer Cadnum, BS1,2, Annette Jencson, BSMT, CIC3 and Curtis J. Donskey, MD1, (1)Geriatric Research Education and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (2)Case Western Reserve University, Cleveland, OH, (3)Cleveland VA Medical Center, Cleveland, OH 530 Adenosine Triphosphate Quantification Correlates Poorly with Microbial Contamination of Duodenoscope Lovisa B Olafsdottir, MD1, Sharon B. Wright, MD, MPH, FIDSA, FSHEA1, Anne Smithey1, Alice Chen1,2, Elizabeth B. Hirsch, PharmD1,2, Benjamin V. Lane, BS1 and Graham M. Snyder, MD, SM1, (1)Beth Israel Deaconess Medical Center, Boston, MA, (2) Northeastern University, Boston, MA 531 Evaluation of a Spray Disinfectant for Decontamination of PPE Prior to Removal Sreelatha Koganti, MD1, Heba Alhmidi, MD1, Myreen E. Tomas, MD2, Jennifer Cadnum, BS2,3, Christopher Sass, BS4, Annette Jencson, BSMT, CIC4 and Curtis J. Donskey, MD2,3, (1)Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (2)Geriatric Research Education and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (3)Case Western Reserve University, Cleveland, OH, (4)Cleveland VA Medical Center, Cleveland, OH SCIENCE GUIDING PREVENTION 25 POSTER PRESENTATIONS: THURSDAY, MAY 19 SCIENTIFIC POSTER PRESENTATIONS: THURSDAY, MAY 19 SCIENTIFIC PROGRAM 532 Comparison of Far-UV and UV-C Light for Inactivation of Bacteriophage MS2 on PPE Annette Jencson, BSMT, CIC1, Myreen E. Tomas, MD2, Jennifer L. Cadnum, BS2,3 and Curtis J. Donskey, MD2,3, (1)Cleveland VA Medical Center, Cleveland, OH, (2)Geriatric Research Education and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (3) Case Western Reserve University, Cleveland, OH 533 Prospective Randomized Trial Comparing Three Duodenoscope High-Level Disinfection and Sterilization Graham M. Snyder, MD, SM , Sharon B. Wright, MD, MPH, FIDSA, FSHEA1, Anne Smithey1, Meir Mizrahi, MD1, Michelle Sheppard, RN, BS1, Elizabeth B. Hirsch, PharmD1,2 and Mandeep Sawhney, MBBS, Ms1, (1)Beth Israel Deaconess Medical Center, Boston, MA, (2) Northeastern University, Boston, MA 1 534 Evaluation of a Novel Alcohol-Based Surface Disinfectant for Disinfection of Hard and Soft Surfaces Heba Alhmidi, MD1, Sreelatha Koganti, MD1, Jennifer Cadnum, BS2,3 and Curtis J. Donskey, MD2,3, (1)Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (2)Geriatric Research Education and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (3) Case Western Reserve University, Cleveland, OH 535 Incorporation of an Ultraviolet Light Room Decontamination Device in a Transplant Unit Abhishek Deshpande, MD PhD , Justin Hartlej, BS , Jennifer L. Cadnum, BS3,4, Thriveen Sankar Chittoor Mana, MS, MBA3,4, Annette Jencson, BSMT, CIC4, Thomas G. Fraser, MD2 and Curtis J. Donskey, MD3,4, (1)Medicine Institute Center for Value Based Care Research, Cleveland Clinic, Cleveland, OH, (2)Department of Infectious Diseases, Cleveland Clinic, Cleveland, OH, (3)Case Western Reserve University, Cleveland, OH, (4)Geriatric Research, Education, and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH 1,2 1 536 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures and Infections Susan C. Bleasdale, MD1,2, Kristen Crawford1 and Monica K. Sikka, MD1,2, (1)University of Illinois at Chicago, Chicago, IL, (2)Jesse Brown Va Medical Center, Chicago, IL 537 RCA for Consistent High Water Cultures in Water from Dialysis and RO Machines Pallavi Yadav, MBBS, MHA, CQPA1, Dawn England, MPH2 and Caprice Vanderkolk, RN, BS, MS, BC-NE2, (1)University Of Minnesota Medical Center, Minneapolis, MN, (2)University of Minnesota Health, Minneapolis, MN 538 Efficacy of a Visible Light Disinfection System Against Healthcare-Associated Pathogens Jennifer Cadnum, BS1,2, Christopher Sass, BS3 and Curtis Donskey, MD4, (1)Geriatric Research Education and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (2)Case Western Reserve University, Cleveland, OH, (3)Cleveland VA Medical Center, Cleveland, OH, (4)Geriatric Research, Education, and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH 539 Effectiveness of an Environmental Cleaning Management Plan Implemented by The Quality Department Derya Mahmutoglu, MD1, Javeria Haque, MD2, Mary Beth Graham, MD2 and L. Silvia Munoz-Price, MD, PhD2, (1)Medical College of Wisconsin, Milwaukee, WI, (2)Division of Infectious Diseases, Medical College of Wisconsin, Milwaukee, WI SCHEDULE 540 A Low-Intensity Ultraviolet-C Device for Decontamination of High-Touch Common Use Objects Sreelatha Koganti, MD1, Heba Alhmidi, MD1, Jennifer L. Cadnum, BS2,3, Aaron Ali Sheikh, MSW2, Annette Jencson, BSMT, CIC4 and Curtis J. Donskey, MD2,3, (1)Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (2)Case Western Reserve University, Cleveland, OH, (3)Geriatric Research Education and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (4) Cleveland VA Medical Center, Cleveland, OH 541 An Ultraviolet Device for Decontamination of Personal Items of Long-Term Care Facility Residents Heba Alhmidi, MD1, Sreelatha Koganti, MD1, Jennifer L. Cadnum, BS2,3 and Curtis J. Donskey, MD2,3, (1)Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (2)Case Western Reserve University, Cleveland, OH, (3)Geriatric Research Education and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH 542 Implementation of Upper Room Germicidal Irradiation in a Closed Dementia Long-Term Care Unit Cathy St. Pierre, Ph.D., APRN1, James J. McDevitt, Ph.D., APRN2, Donald K. Milton, MD, DrPH3 and Richard A. Martinello, MD4, (1) Edith Norse Rogers Memorial VA Medical Center, Bedford, MA, (2)Harvard School of Public Health, Boston, MA, (3)University of Maryland, College Park, MD, (4)Yale University, New Haven, CT 543 Evaluation of an Automated Room Decontamination Device using Aerosolized Peracetic Acid Thriveen Sankar Chittoor Mana, MS, MBA1, Jennifer Cadnum, BS1,2, Annette Jencson, BSMT, CIC2, Brett M. Sitzlar, BS3 and Curtis Donskey, MD3, (1)Case Western Reserve University, Cleveland, OH, (2)Cleveland VA Medical Center, Cleveland, OH, (3)Geriatric Research, Education, and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH 544 Variation in Practices to Clean and Disinfect Surfaces in SHEA Research Network Facilities Sujan C. Reddy, MD MS1, Philip C. Carling, M.D.2, Daniel Morgan, MD, MS3 and Jesse Jacob, MD1, (1)Emory University School of Medicine, Division of Infectious Diseases, Atlanta, GA, (2)Boston University School of Medicine, Boston, MA, (3)University of Maryland School of Medicine, Baltimore, MD 545 Briefly Intervening to Affect Cleaning Outcomes: No Good Deed Goes Unpunished Robert Clifford, PhD1, Eve Hosford, MS1, Ana Ong, BS1, Douglas Richesson1, Susan Fraser2, Yoon I Kwak, MS1, Sonia Miller2, Michael Julius, PMP1, Patrick McGann, PhD1 and Emil Lesho, DO1, (1)Walter Reed Army Institute of Research, Silver Spring, MD, (2)Ft. Belvoir Community Hospital, Ft. Belvoir, VA 546 Evaluation of a Novel Silver Based Laundry Treatment to Reduce Bacterial Contamination of Textiles John J Openshaw, MD1, Bill Morris2, Gregory V Lowry, PhD3 and Aydin Nazmi, PhD4, (1)Stanford University, Stanford, CA, (2)Applied Silver, Hayward, CA, (3)Carnegie Mellon University, Pittsburgh, PA, (4)California Polytechnic State University, San Luis Obispo, San Luis Obispo, CA 547 Can Using Active UV-C Technology to Treat the Air Reduce Surface Pathogens in a Healthcare Setting? Linda Lee, DrPH, MBA, American Green Technology, South Bend, IN, DNV-GL, Milford, OH Top Poster Abstract 26 SHEA Spring 2016 Conference PROGRAM SCHEDULE 548 Portable, Affordable, and Adjustable: Evaluation of a Novel Ultraviolet Light Decontamination Device 556 A Randomized Trial to Determine the Impact of a Patient Hand Hygiene Intervention 549 Effectiveness of an Ultraviolet Light Decontamination Device in Reducing Hospital Room Contamination 557 Use of Targeted Solutions Tool and Electronic Monitoring to Improve Hand Hygiene Performance Jennifer Cadnum, BS1,2, Sreelatha Koganti, MD3, Heba Alhmidi, MD3, Annette Jencson, BSMT, CIC4, J. Itty Mathew, MLS2 and Curtis J. Donskey, MD1,2, (1)Geriatric Research Education and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (2)Case Western Reserve University, Cleveland, OH, (3)Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (4)Cleveland VA Medical Center, Cleveland, OH Abhishek Deshpande, MD PhD1,2, Justin Hartlej, BS2, Jennifer Cadnum, BS3,4, Annette Jencson, BSMT, CIC3, Thriveen Sankar Chittoor Mana, MS, MBA3,4, Thomas G. Fraser, MD1 and Curtis J. Donskey, MD3,4, (1)Department of Infectious Diseases, Cleveland Clinic, Cleveland, OH, (2)Medicine Institute Center for Value Based Care Research, Cleveland Clinic, Cleveland, OH, (3)Geriatric Research, Education, and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (4)Case Western Reserve University, Cleveland, OH 550 UV Light Decontamination of CRE from High Touch Surfaces in Patient Room Clare Rock, MD, MS1, Melanie Curless, RN MPH CIC2, Karen Carroll, MD3, Tracy Howard2, Elaine Nowakowski2, Kathryn A. Carson, Sc.M.4, Polly Trexler, MS, CIC2 and Lisa L. Maragakis, MD MPH1, (1)Department of Medicine, Division of Infectious Diseases, Johns Hopkins University, Baltimore, MD, (2)The Johns Hopkins Hospital, Baltimore, MD, (3)John Hopkins University, Baltimore, MD, (4) Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 551 Hospital Air-Handler Shutdown Increases Airborne Viable Particle Counts Patricia L. Harris, M.S.N., R.N.1, Paul D. Wiser, BSN2, Diana L. Toy, B.S.N., R.N.1, Shelia M. Cloud-Woods, M.S.N., R.N.1, Charles W. Jennings1, Cornelius J. Clancy, M.D.1 and Brooke K. Decker, M.D.1, (1)VA Pittsburgh Healthcare System, Pittsburgh, PA, (2)VA Pittsburgh Healthcare System, Pittsburgh, PA 552 Barriers, Perceptions and Compliance: Hand Hygiene in the Operating Room and Endoscopy Suite Laura Pedersen, BS, Kimberly Elgin, BSN, Barbara Peace, RN, Nadia Masroor, BS, Kakotan Sanogo, MS, Kaila Cooper, MSN, RN, CIC, Michelle Doll, MD, Gene Peterson, MD, PhD, Mike Stevens, MD, MPH and Gonzalo Bearman, MD, MPH, VCU Health, Richmond, VA 553 The Experience of Being a Hand Hygiene Auditor in Australia Susan Jain, Master of Nursing, PhD candidate1, Denise Edgar, RN BN MPH2, Janine Bothe, DN RN MA3, Helen Newman, RN2, Annmaree Wilson, RN RM BSc2, Beth Bint, RN2, Megan Brown, RN BN MSc2, Suzanne Alexander, RN BSc2 and Joanna Harris, RN BSc (Hons)2, (1)Prince of Wales Hospital, Randwick, Australia, (2)Illawarra Shoalhaven Local Health District, Wollongong, Wollongong, Australia, (3)St. George Hospital, Kogarah, Australia 555 Jumanji! Improving Hand Hygiene Compliance by Use of a Code Word on Inpatient Medical Units Ching Zhu, MD, Alok K. Tewari, MD, Erika Runge, MD, Alex Carbo, MD and Sharon B. Wright, MD, MPH, FIDSA, FSHEA, Beth Israel Deaconess Medical Center, Boston, MA Venkata Sunkesula, MD, MS1,2, Sirisha Kundrapu, MD, MS1,2, Jennifer Cadnum, BS1,2, Shanina Knighton, PhD(c), RN3 and Curtis Donskey, MD4, (1)Case Western Reserve University, Cleveland, OH, (2)Cleveland VA Medical Center, Cleveland, OH, (3)Cleveland VA Medical Center, National VA Quality Scholars, Cleveland, OH, (4) Geriatric Research, Education, and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH J. William Kelly, MD1, Dawn Blackhurst, PhD2, Connie Steed, RN, MSN, CIC2, Sue Boeker, BSN, RN, CIC2 and Wendy McAtee, BS2, (1)Greenville Health Systems, Greenville, SC, (2)Greenville Health System, Greenville, SC 558 Knowledge on the Moment of Hand Hygiene among Nurses in the Acute Care Hospitals Young Ji Kang, RN, MSN1, Jae Sim Jeong, RN, MPH, PhD2, Hye Ran Choi, RN, MPH3, Eun Suk Park, RN, PhD4 and Sang-Ho Choi, MD, PhD5, (1)Asan Medical Center, Seoul, Korea, The Republic of, (2)Department of Nursing, University of Ulsan, Seoul, South Korea, (3)University of Ulsan, Seoul, South Korea, (4)Severance Hospital, Seoul, South Korea, (5)Department of Infectious Diseases, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea 559 Glove Use as a Contributing Factor to Non-compliance With Hand Hygiene Anjali Majumdar, MD1, Shana Burrowes, MPH2, Josephine Brumit, DNP, RN1, Michelle H. Williams, RN, MSN, CIC1, Michael Anne Preas, RN, BSN, CIC1 and Surbhi Leekha, MBBS, MPH3, (1)University of Maryland Medical Center, Baltimore, MD, (2)University of Maryland, Baltimore, MD, (3)University of Maryland School of Medicine, Baltimore, MD 560 Does Changing Point-of-Use Reminder Signs More Frequently Improve Hand Hygiene Compliance? Heather Reisinger, PhD1, Mark Vander Weg, PhD2, Cassie Cunningham Goedken, MPH3, Mary Vaughan Sarrazin, PhD2, Carrie Franciscus, MA3 and Eli N Perencevich, MD, MS4,5, (1)CADRE - Iowa City VAHCS and Carver College of Medicine, University of Iowa, Iowa City, IA, (2)CADRE - Iowa City VAHCS; University of Iowa, Iowa City, IA, (3)CADRE - Iowa City VAHCS, Iowa City, IA, (4)Iowa City VA Medical Center, Iowa City, IA, (5)University of Iowa Carver College of Medicine, Iowa City, IA 561 What Hand Hygiene Delivery Method is Preferred by Patients in the Acute and Long-Term Care Settings? Shanina Knighton, PhD(c), RN1,2, Curtis J. Donskey, MD3 and Cherese McDowell, BSN4, (1)Case Western Reserve University Frances Payne Bolton School of Nursing, Cleveland, OH, (2)Cleveland VA Medical Center, National VA Quality Scholars, Cleveland, OH, (3) Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH, (4)Cleveland VA Medical Center, Cleveland, OH 562 Using an Alternative to Real Time Locating System for Electronic Hand Hygiene Monitoring at a VA Hos Christopher Crnich, MD, PhD1, Linda McKinley, RN, MPH, CIC1, Katherine Matteson, RN, MSN, CIC1, Catherine Stampfli, RN, MSN2, Karen Hunt, BSN2, Theresa Landvoght, BSN2, Jane McCarthy, BSN, MSN2, Lakeatia Phillips, BSN2 and Stacie Rhinehart, RN, MSN2, (1) William S. Middleton Memorial VA Hospital, Madison, WI, (2)Wm. S. Middleton Memorial VA Hospital, Madison, WI 563 Foam Soap is not as Effective as Liquid Soap in Eliminating the Hand Flora Nicolette Dixon1, Margie Morgan, PhD2 and Ozlem Equils, MD, FAAP2,3, (1)Bainbridge High School, Bainbridge Island, WA, (2) Cedars-Sinai Medical Center/UCLA School of Medicine, Los Angeles, CA, (3)Pfizer Inc, New York, NY SCIENCE GUIDING PREVENTION 27 POSTER PRESENTATIONS: THURSDAY, MAY 19 SCIENTIFIC POSTER PRESENTATIONS: THURSDAY, MAY 19 SCIENTIFIC PROGRAM 564 Hand Hygiene in the 21st Century: Can We Really Improve? Robert Brandon Hulette, Meharry Medical College, Nashville, TN 565 Real-time Feedback between Job Classes as an Intervention for Hand Hygiene Compliance Emily Sickbert-Bennett, PhD, MS1,2, Lauren M. DiBiase, MS1,2, David J. Weber, MD, MPH1,2, Lisa Teal, BSN1, Elizabeth M. Walters, BSN1, Rebecca H. Brooks, BSN1, Judie Bringhurst, BSN1, Katherine Schultz, BSN, MPH1, Sherie Goldbach1 and William A. Rutala, PhD, MPH1,2, (1)Hospital Epidemiology, UNC Medical Center, Chapel Hill, NC, (2)Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC 566 Improved Visitor Hand Hygiene Reduces Respiratory Viral Infections in a Neonatal Intensive Care Unit Elizabeth M. Marrero, MSN, RN, CNOR(e)1, Audrey Echlin, RN1, Lori Thorpe, BSN, RNC-NIC1, Anna Gaspar, MSN, RN, CCRN1, Jacques de Marche’, MHA1, Michele Honeycutt, RN, BSN, CIC1 and Matthew Linam, MD, MS2, (1)Arkansas Children’s Hospital, Little Rock, AR, (2)University of Arkansas for Medical Sciences, Division of Pediatrics, Infectious Diseases Section, Little Rock, AR 567 Seasonal Variation in Bare Below the Elbow Compliance Nadia Masroor, BS1, Michelle Doll, MD1, Kakotan Sanogo, MS1, Kaila Cooper, MSN, RN, CIC1, Mike Stevens, MD, MPH1, Michael Edmond, MD2 and Gonzalo Bearman, MD, MPH1, (1)VCU Health, Richmond, VA, (2)University of Iowa Hospitals and Clinics, Iowa City, IA 568 Handrub and Soap Consumption as a Monitoring Tool in a Dutch Teaching Hospital Suzanne D. van der Werff, PhD1, Annie Kaiser, MSc1, Martine Caris, MD1,2, Mireille Dekker1, Rosa van Mansfeld, MD, PhD1 and Christina M.J.E. Vandenbroucke-Grauls, MD, PhD1, (1)Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, Netherlands, (2)Department of Internal Medicine, VU University Medical Center, Amsterdam, Netherlands 569 Mortality Associated with Candida Infections Among Neonates: a Meta-Analysis Marin L Schweizer, PhD1, Melissa Ward, MS1, Daniel Fulton, MD1, Eli Perencevich, MD, MS1, Jennifer McDanel, PhD1, Rajeshwari Nair, MBBS, PhD1, Richard E. Nelson, PhD2, Karim Khader, PhD3, Matthew Samore, MD3, Loreen Herwaldt, MD1, Amy Blevins, MALS4 and Daniel Diekema, MD1, (1)University of Iowa Carver College of Medicine, Iowa City, IA, (2)Division of Epidemiology, University of Utah, Salt Lake City, UT, (3)University of Utah School of Medicine, Salt Lake City, UT, (4)University of Iowa, Hardin Library for the Health Sciences, Iowa City, IA 570 Incidence of Rotavirus,Norovirus,Adenovirus & Clostridium difficile (CDI) in Intestinal Transplant Luis F Guzman, MD1, Diana F Florescu, MD2, Andre Kalil, MD3, Fang Qiu, PhD2, Lisa Hill, APRN2 and Heather Chambers, APRN2, (1)UNMC, Omaha, NE, (2)University of Nebraska Medical Center, Omaha, NE, (3)University of Nebraska Med Ctr, Omaha, NE 571 Evaluation of Chlorhexidine Bathing as Part of a Bundled Approach to Reduce NICU CLABSIs Andrea Green Hines, MD1, Donnetta Perkins, RN, BSN2, Brenda Heybrock, RN, CIC2, Lynne Willett, MD2, Mel Hall2, Crista Latimer, APRN-NNP2, Chelsey Phalen, APRN-NNP2 and Kari Simonsen, MD3, (1)Section of Pediatric Infectious Diseases, University of Nebraska Medical Center, Omaha, NE, (2)Children’s Hospital and Medical Center, Omaha, NE, (3)University of Nebraska Medical Center, Omaha, NE SCHEDULE 572 Human Factors Approach to Disseminating an Intervention for Improving Blood Culture Utilization Anping Xie, PhD1, Anne F. King, BSN2, Charlotte Z. Woods-Hill, MD2, Judy Ascenzi, DNP, RN, CCRN2, Ayse P. Gurses, PhD, MPH, MS1, James C. Fackler, MD2 and Aaron M. Milstone, MD MHS2, (1) Armstrong Institute for Patient Safety and Quality, Johns Hopkins University, Baltimore, MD, (2)Johns Hopkins Medical Institutions, Baltimore, MD 573 Epidemiology and Antimicrobial Susceptibility of Pediatric Invasive Acinetobacter Infections Ishminder Kaur, M.D., Jennifer Vodzak, M.D., Alan Evangelista, PhD, Sarah S. Long, M.D. and Jane M. Gould, M.D., St. Christopher’s Hospital for Children/ Drexel University College of Medicine, Philadelphia, PA 574 Risk Factors for MRSA Colonization in the Neonatal Intensive Care Unit: A Meta-Analysis Matthew Washam, MD, MPH, Jon Woltmann, MD, Beth Haberman, MD, David Haslam, MD and Mary Allen Staat, MD, MPH, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 576 Surgical Site Infections in Children Following VEPTR Surgery Jonathan Crews, MD, MS1,2, Marina Mina, BS2, Eric Johnson, BS3, Janette Guillen, RN2, James W. Simmons, MD1,2 and Ajeya Joshi, MD1,2, (1)Baylor College of Medicine, San Antonio, TX, (2) Children’s Hospital of San Antonio, San Antonio, TX, (3)University of Texas Health Sciences Center San Antonio, San Antonio, TX 577 Prolonged Rhinovirus Shedding in a Patient with Hodgkin Disease Andrew T. Dysangco, MD1, Amy Beth Kressel, MD, MS1, W. Allan Nix2, Stephanie Dearth3, Reema Patel, MPH3 and Shawn Richards3, (1)Indiana University School of Medicine, Indianapolis, IN, (2)Centers for Disease Control and Prevention, Atlanta, GA, (3)Indiana State Department of Health, Indianapolis, IN 578 Crude Mortality In Patients Hospitalized For Viral Respiratory Infections Lauren DiBiase, MS, CIC1,2, David Weber, MD, MPH1,2, Mellisa Miller, PhD1,2, Hajime Kanamori, MD, PhD, MPH1,2, Emily Sickbert-Bennett, PhD, MS1,2 and William Rutala, PhD, MPH1,2, (1)University of North Carolina Health Care, Chapel Hill, NC, (2)UNC School of Medicine, Chapel Hill, NC 579 Survival of an Enveloped Virus on Toys Richard L Bearden II, MS, Georgia State University, Atlanta, GA 580 Trend of Flu and Respiratory syncytial virus in Emergency Department discharges in U.S, 2009-2012 Chao Song, MPH, Emelline Liu, MSHS and Michele Schoonmaker, PhD, Cepheid, Sunnyvale, CA 581 Predictors of MERS-CoV infection Sameeh Ghazal, MD1, Saleh Alogael, MD1, Talal Altuwijri, MD1, Sarah Alfaraj, MD1, Marzouka Alanazi, MD1, Fahad Bafaqeeh, MD1, Menwer Almajnoni, MD1, Donna McClish, PHD2, Ahmed Alenezi, MD1, Ziad Memish, MD1, Hamza Ghazal, MS3 and Hamza Hamdan, MD1, (1) Prince Mohammed bin Abdulaziz Hospital, Riyadh, Saudi Arabia, (2)Virginia Commonwealth University, Richmond, VA, (3)Alimam Mohammed bin Saud university, Riyadh, Saudi Arabia 582 Door Openings in the Operating Room Associated with Increased Environmental Contamination Brian L Hollenbeck, MD, Susan Cohen, Riya Joshi, MPH, MBBS, Priscilla Perez, Julia Holloway, Lucy Ehrenfeld and Linda Cunningham, RN, New England Baptist Hospital, Boston, MA Top Poster Abstract 28 SHEA Spring 2016 Conference PROGRAM 583 Mortality Attributable to Periprosthetic Joint Infection following Hip and Knee Arthroplasty Sarah H. Yi, PhD, James Baggs, PhD and John Jernigan, MD, MS, Centers for Disease Control and Prevention, Atlanta, GA 585 Zero SSI Infections After Knee Arthroplasty: One Hospital’s Secret Sauce Lynne Karanfil, RN, MA, CIC1, Shawn Mueller, RN, MSN, CIC2 and Wayne Campbell, MD3, (1)MedStar Health, Columbia, MD, (2)MedStar Union Memorial, Baltimore, MD, (3)Union Mem Hosp/Univ of MD, Baltimore, MD 586 No Significant Correlation Between OR Traffic and Surgical Site Infections in a Multicenter Study Shira Abeles, MD1, Frank Myers, MA2, Robert El-Kareh, MD2, Rebecca Marmor, MD2, Mariya Kovryga Kornick3, Shruti Gohil, MD, MPH4, Stuart Cohen, MD5, Nicole Mahr, RN, MS6, Amy Nichols, RN, MBA7, Susan Garritson, PhD7, Catherine Liu, MD8, Zachary Rubin, MD9, Alisa Trout, RN, BSN10, Paul R Allyn, MD10 and Francesca J Torriani, MD2, (1)University of California San Diego, La Jolla, CA, (2)UC San Diego Health, San Diego, CA, (3)UC Irvine Health, Orange, CA, (4)UC Irvine Medical Center, Irvine, CA, (5) University of California, Davis, Sacramento, CA, (6)UC Davis Health System, Sacramento, CA, (7)UC San Francisco Health, San Francisco, CA, (8)University of California, San Francisco, San Francisco, CA, (9)David Geffen School of Medicine at UCLA, Los Angeles, CA, (10)UCLA Health, Santa Monica, CA 587 Improving Risk Adjustment Above Current CDC Methodology Using Electronically-Available Comorbid Cond Sarah S Jackson, MPH, Surbhi Leekha, MBBS, MPH, Lisa Pineles, MA, Laurence S. Magder, PhD, Kerri Thom, MD, MS, Yuan Wang and Anthony Harris, MD, MPH, Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD 588 Incidence and Risk Factors for Healthcare Associated Infections After Hip Surgery Amanda J Hessels, PhD, MPH, RN, CIC, CPHQ1,2 and Elaine L. Larson, RN, PhD, FAAN, CIC1, (1)Columbia University, New York, NY, (2)Meridian Health, Neptune, NJ 590 What’s the Risk? Differing Risk Adjustment Methods for Colon SSI Between NHSN, CMS and NSQIP Marci Drees, MD, MS, Carol Briody, MT (ASCP), CIC, Craig Martine, MSN, RN, CCRN, Brian Stephan, BA, Dennis Witmer, MD and Gerard Fulda, MD, Christiana Care Health System, Newark, DE 591 Reducing Colon Surgery-Related Surgical Site Infection (SSI) Rates Using a Bundle John M Boyce, MD1,2, Heidi Rillstone, RN1, Nicole Colandrea, MT1, Robert W. Stout, MD1,2, Jeffrey Topal, MD1,2, Alan Ruskis, MD1,2, Richard A. Martinello, MD1,2 and Kimberly A. Davis, MD1,2, (1)YaleNew Haven Hospital, New Haven, CT, (2)Yale University School of Medicine, New Haven, CT 592 Identification of Patients with Increased Risk of Mediastinitis Following Cardiac Surgery Cheri Grigg, DVM, MPH , James Baggs, PhD , Rachel Slayton, PhD, MPH1 and John Jernigan, MD, MS1, (1)Division of Healthcare Quality Promotion, CDC, Atlanta, GA, (2)Epidemic Intelligence Service, CDC, Atlanta, GA 1,2 1 593 Evaluation of Sterile Packaging Systems Using a Dynamic Bioaerol Test Method SCHEDULE 595 Rifampin Treatment and Time to Treatment Failure in Staphylococcus aureus Prosthetic Joint Infection Rajeshwari Nair, MBBS, PhD1,2,3, Eli N Perencevich, MD, MS1,2,3, Daniel Diekema, MD2, Michihiko Goto, MD, MSCI1,2, Daniel J Livorsi, MD, MSc1,2, James C Torner, PhD, MS3,4, Trudy L Burns, PhD, MPH3,5, Joseph Cavanaugh, PhD, MS6, Lan Jiang, MS7, Bruce Alexander, PharmD1, Kelly K Richardson, PhD1, Brice F Beck, MA1, Jennifer S McDanel, PhD1,2,3 and Marin L Schweizer, PhD1,2,3, (1)Iowa City VA Medical Center, Iowa City, IA, (2)University of Iowa Carver College of Medicine, Iowa City, IA, (3)Department of Epidemiology, University of Iowa College of Public Health, Iowa City, IA, (4)Departments of Surgery and Neurosurgery, University of Iowa Carver College of Medicine, Iowa City, IA, (5)Department of Pediatrics, University of Iowa College of Public Health, Iowa City, IA, (6)Department of Biostatistics, University of Iowa College of Public Health, Iowa City, IA, (7)Providence VA Medical Center, Providence, RI 596 Propionibacterium Acnes Infection Complicating Pediatric Spine Fusion Ritika Coelho, MD1, Venkatraman Arakoni1, Ryan Goodwin, MD1 and Charles Bartlett Foster, MD2, (1)Cleveland Clinic, Cleveland, OH, (2) Cleveland Clinic Foundation, Cleveland, OH 597 Examining the Effect of Outpatient Facility Type on the Risk of Surgical Site Infection Rishi V. Parikh, MPH, Centers for Disease Control and Prevention, Atlanta, GA 598 Not All Colon Procedures Are Equal: Implication for Risk Adjustment in Publically Reported SSI Rates Michael S. Calderwood, MD, MPH1, Ken Kleinman, ScD2, Michael V. Murphy, BA3, Richard Platt, MD, MSc3 and Susan S. Huang, MD, MPH4, (1)Brigham and Women’s Hospital, Boston, MA, (2)University of Massachusetts Amherst School of Public Health and Health Sciences, Amherst, MA, (3)Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, (4)Division of Infectious Diseases and Health Policy Research Institute, University of California, Irvine School of Medicine, Irvine, CA 599 A Multicenter Study to Identify Risk Factors for Infections Post-Craniotomy Carlos E. F. Starling, MD1, Braulio R.G.M. Couto, PhD2, Gustavo Palmer Irffi, Medical student3, Gabriel Bandeira Tofani, Medical student3, Cynthia Cellina Mendes Silva4, Felipe Coelho Vieira5, Gilberto Diniz Miranda, Medical student6 and Isabela Lorena Alfenas Silva5, (1)Hospital da Baleia, Belo Horizonte, Brazil, (2)Centro Universitário de Belo Horizonte / UNI-BH, Belo Horizonte, Brazil, (3)Centro Universitário de Belo Horizonte - UniBH, Belo Horizonte, Brazil, (4)Centro Universitário de Belo Horizonte - UniBH, Instituto de Engenharia e Tecnologia – IET., Belo Horizonte -MG, Brazil, (5)Centro Universitário de Belo Horizonte - UniBH, Instituto de Engenharia e Tecnologia – IET., Belo Horizonte, Brazil, (6)Faculdade de Ciências Médicas e da Saúde de Juiz de Fora - SUPREMA., Juiz de Fora, Brazil 600 Utility of an Exposure Receipt Assessment: Evaluate ICU Staff on Safety Interventions to Reduce VAE Kisha Jezel Ali, MS, Nishi Rawat, MD, Ting Yang, PhD, MHS, Kathleen Speck, MPH and Sean Berenholtz, MD, MHS, FCCM, Johns Hopkins Medicine Armstrong Institute for Patient Safety and Quality, Baltimore, MD Brian Heimbuch, MS1, Del Harnish, MS1 and Harry Shaffer, MS2, (1)Applied Research Associates, Panama City, FL, (2)Sterilization Consulting Services LLC, Highlands Ranch, CO SCIENCE GUIDING PREVENTION 29 POSTER PRESENTATIONS: THURSDAY, MAY 19 SCIENTIFIC POSTER PRESENTATIONS: THURSDAY, MAY 19 SCIENTIFIC 12:00 – 1:00 p.m. PROGRAM 7th Floor: Augusta Room 601 Cluster Analysis Reveals Unexpected Patterns in Pneumococcal Polysaccharide Vaccination Coverage Brigid Wilson, PhD1, Richard Banks, AS1, Rebecca Carter, BA2, Robin Jump, MD, PhD1,2 and Federico Perez, MD1,2, (1)Louis Stokes Cleveland Veterans Aff Med Ctr, Cleveland, OH, (2)Case Western Reserve University, Cleveland, OH 602 Prevalence of CT/NG and Trichomonas Vaginalis Infection in U.S. Emergency Departments, 2009-2012 Chao Song, MPH, Emelline Liu, MSHS and Michele Schoonmaker, PhD, Cepheid, Sunnyvale, CA 603 Cobweb Chart for Infection Rates Braulio R.G.M. Couto, PhD1, Carlos E. F. Starling, MD2 and Joaquim José Cunha Junior, MSc3, (1)Centro Universitário de Belo Horizonte / UNI-BH, Belo Horizonte, Brazil, (2)Hospital da Baleia, Belo Horizonte, Brazil, (3)Centro Universitário de Belo Horizonte – UniBH, Belo Horizonte, Brazil 604 A Prospective Cohort Study: Intensive Care UnitAcquired Infections and Their Impact on Mortality Bircan Kayaaslan, M.D1, Gul Ruhsar Yilmaz, Associate Professor2, Imran Hasanoglu, M.D2, Fatma Yekta Korkmaz, M.D1, Rahmet Guner, Prof. Dr1, Zeliha Kocak Tufan, Associate Professor1, Tumer Guven, Associate Professor1, Seval Izdes, Proffesor3, Turan Buzgan, Associate Professor1 and Mehmet Akin Tasyaran, Professor4, (1) Yildirim Beyazit University Faculty of Medicine, Ankara, Turkey, (2) Ankara Ataturk Training and Research Hospital, Ankara, Turkey, (3)Yildirim Beyazit University Faculty of Medicine, Department of Anesthesiology and Reanimation, Ankara, Turkey, (4)Yildirim Beyazit University Faculty of Medicine, Department of Infectious Disease and Clinical Microbiology, Ankara, Turkey 605 Outbreaks of Nosocomial Influenza Like Illness in France, 2001-2015 Elodie Munier-Marion1, Thomas Bénet1,2, Sophan Soing-Altrach3, Sylvie Maugat3, Sophie Vaux3 and Philippe Vanhems, MD, PhD2,4, (1) Infection Control and Epidemiology Unit, Lyon, France, (2)Emerging Pathogens Laboratory - Fondation Mérieux, Centre International de Recherche en Infectiologie (CIRI) Inserm U1111, CNRS UMR5308, Lyon, France, (3)French Institute of Public Health Surveillance, SaintMaurice, France, (4)Infection Control and Epidemiology Unit, Lyon, France 606 Change in Epidemiological Characteristics of HealthCare Associated Infections in Five-Year Period Hurrem Bodur, Fatmanur Pepe, Esragul Akıncı, Dilek Kanyilmaz, Ahmet Sertcelik, Meltem Arzu Yetkin, Aliye Bastug, Ayse But, Halide Arslaner, Adalet Aypak and Pinar Onguru, Ankara Numune Education and Research Hospital, Ankara, Turkey 607 The Physician’s Role in Ebola Preparedness Planning Costi D. Sifri, MD1, Kyle Enfield, MD, MS2, Trish Perl, MD, MSc3 and Jessica D. Lewis, MD2, (1)University of Virginia, Charlottesville, VA, (2)University of Virginia Health System, Charlottesville, VA, (3)Johns Hopkins Medical Institutions and University, Baltimore, MD SCHEDULE 608 Carbapenem-Resistant Klebsiella Pneumoniae Isolated in Belo Horizonte, Brazil: a Multi-Centre Study Braulio R.G.M. Couto, PhD1, Carlos E. F. Starling, MD2,3,4, Gustavo Palmer Irffi, Medical student5, Gabriel Bandeira Tofani, Medical student5, Gilberto Diniz Miranda, Medical student6, Daniela Santiago Dias Araújo7, Lucas Felipe Silva8, Sandy Luiza Martins Oliveira9, Mariana C Melo10 and Maria Izabella V Rocha11, (1)Centro Universitário de Belo Horizonte / UNI-BH, Belo Horizonte, Brazil, (2)Hospital da Baleia, Belo Horizonte, Brazil, (3)Hospital Vera Cruz, Belo Horizonte, Brazil, (4) Vera Cruz Hospital, Belo Horizonte, MG, Brazil, (5)Centro Universitário de Belo Horizonte - UniBH, Belo Horizonte, Brazil, (6)Faculdade de Ciências Médicas e da Saúde de Juiz de Fora - SUPREMA., Juiz de Fora, Brazil, (7)Centro Universitário de Belo Horizonte - UniBH, Instituto de Engenharia e Tecnologia – IET., Belo Horioznte, Brazil, (8)Centro Universitário de Belo Horizonte - UniBH, Instituto de Engenharia e Tecnologia – IET., Belo Horizonte, Brazil, (9)Centro Universitário de Belo Horizonte - UniBH, Instituto de Engenharia e Tecnologia – IET., Belo Horizonte -MG, Brazil, (10)Hospital Luxemburgo, Belo Horizonte, BRAZIL, (11)Hospital da Baleia, Belo Horizont, Brazil 609 Improving Understanding of Publicly Reported Healthcare-Associated Infection (HAI) Data Max Masnick, PhD1, Daniel Morgan, MD, MS2,3, Mark D Macek, DDS, DrPH4, John D. Sorkin, MD, PhD3,5, Jessica P. Brown, PhD1, Penny Rheingans, PhD6 and Anthony Harris, MD, MPH1, (1)Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, (2)VA Maryland Healthcare System, Baltimore, MD, (3)University of Maryland School of Medicine, Baltimore, MD, (4)University of Maryland School of Dentistry, Baltimore, MD, (5)Veterans Affairs Maryland Healthcare System Geriatrics Research, Education, and Clinical Center, Baltimore, MD, (6)Department of Computer Science and Electrical Engineering, University of Maryland Baltimore County, Baltimore, MD 610 Ability of Healthcare-Associated Infection (HAI) Data to Differentiate Hospitals Nationwide Max Masnick, PhD1, Daniel Morgan, MD, MS2,3, John D. Sorkin, MD, PhD4, Mark D Macek, DDS, DrPH5, Jessica P. Brown, PhD1, Penny Rheingans, PhD6 and Anthony Harris, MD, MPH1, (1)Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, (2)VA Maryland Healthcare System, Baltimore, MD, (3)University of Maryland School of Medicine, Baltimore, MD, (4)Veterans Affairs Maryland Healthcare System Geriatrics Research, Education, and Clinical Center, Baltimore, MD, (5)University of Maryland School of Dentistry, Baltimore, MD, (6) Department of Computer Science and Electrical Engineering, University of Maryland Baltimore County, Baltimore, MD 611 Challenges for Epidemiological Nurses in Polish Hospitals – After 20 Years of Modern IC in Poland Jadwiga Wojkowska-Mach, dr1, Malgorzata Bulanda, Prof.1 and Anna Rozanska, PhD2, (1)Jagiellonian University Medical School, Kraków, Poland, (2)Chair of Microbiology Jagiellonian University Medical College, Kraków, Poland 612 Development of Multidrug-Resistant Tuberculosis in a Non-Adherent HIV-Infected Patient Mohammad Hudeeb, M.D. and Mayar Al Mohajer, MD FACP, University of Arizona, Tucson, AZ Top Poster Abstract 30 SHEA Spring 2016 Conference PROGRAM 613 The Impact of a Course on Healthcare Epidemiology as Shown through a Before and After Analysis Amanda Krosche, BS1, Victoria J. Fraser, MD2, Anthony Harris, MD, MPH3, Jenna Los, MA1, Leonard Mermel, DO, ScM4, Jonathan Teter, MS1, David Pegues, MD5, Trish Perl, MD, MSc6 and Kerri Thom, MD, MS3, (1)Johns Hopkins University School of Medicine, Baltimore, MD, (2)Washington University School of Medicine, St. Louis, MO, (3) Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, (4)Brown University, Providence, RI, (5)University of Pennsylvania, Philadelphia, PA, (6) Johns Hopkins Medical Institutions and University, Baltimore, MD 614 Repeated Prevalence Surveys of HealthcareAssociated Infections Maija-Liisa Rummukainen, MD, PhD1, Maire Matsinen, RN1, Tiina Tiitinen, RN1, Maija-Liisa Lauritsalo, RN1 and Hannu Kautiainen, MSc2, (1)Central Finland Health Care District, Jyväskylä, Finland, (2)Medcare Oy, Äänekoski, Finland 615 Teaching Healthcare Epidemiology including IP, and ASP: Impact of a Face to Face Training Course Amanda Krosche, BS1, Jonathan Teter, MS1, Trish M Perl, MD, MSc1, David Pegues, MD2, Leonard Mermel, DO, ScM3, Jenna Los, MA1, Anthony Harris, MD, MPH4, Victoria Fraser, MD5 and Kerri Thom, MD, MS4, (1)Johns Hopkins University School of Medicine, Baltimore, MD, (2)University of Pennsylvania, Philadelphia, PA, (3) Brown University, Providence, RI, (4)Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, (5)Washington Univ School of Med, Saint Louis, MO 616 Consideration of Seasonality in Antimicrobial Use (AU) Raphaelle H. Beard, MPH1, Jessica Vakili2, Ashley Fell, MPH1 and Marion A. Kainer, MD, MPH1, (1)Tennessee Department of Health, Nashville, TN, (2)Tennessee Dept of Health, Nashville, TN 617 A Web-Based Method for Tracking Calling Effort for a Clostridium difficile Case-Control Study Corinne M. Davis, MPH, MS and Marion A. Kainer, MD, MPH, Tennessee Department of Health, Nashville, TN 618 Knowledge, Attitude and Practice of Medical Staff in Collecting Blood Cultures: A Multi-Center Study Archana Nair, MD1, Sean Elliott, MD2 and Mayar Al Mohajer, MD FACP3, (1)University of Arizona Medical Center at South Campus, Tucson, AZ, (2)Univ of Arizona Hlth Sci Ctr, Tucson, AZ, (3)University of Arizona - Section of Infectious Disease, Tucson, AZ 619 Surveillance for ERCP Associated Infections Nathan A. Pinsky1,2 and Mary Anderson, BS1, (1)Edward Hospital, Naperville, IL, (2)University of Illinois, Urbana/Champaign, Urbana, IL 620 Delayed Processing of Simulated Duodenoscope and Patient Cultures Yields Viable Bacteria Alice Chen1,2, Benjamin V. Lane, BS2, Sharon B. Wright, MD, MPH, FIDSA, FSHEA2, David S. Yassa, MD, MPH2, Graham M. Snyder, MD, SM2 and Elizabeth B. Hirsch, PharmD1,2, (1) Northeastern University, Boston, MA, (2)Beth Israel Deaconess Medical Center, Boston, MA 621 2500 Genomes: A Cautionary Tale of Implementing Genomic Epidemiology Across Healthcare Enterprises Emil Lesho, DO1, Robert Clifford, PhD1, Fatma Onmus-Leone, MS1, Lakshmi Appalla1, Erik C. Snesrud, MS1, Yoon I Kwak, MS1, Ana Ong, BS1, Rosslyn Maybank1, Paige Waterman, MD2, Patricia Rohrbeck2, Michael Julius, PMP1, Amanda Roth1, Joshua Martinez1, Lindsey Nielsen, PhD3, Eric Steele3, Patrick McGann, PhD1 and Mary Hinkle, MD1, (1)Walter Reed Army Institute of Research, Silver Spring, MD, (2)Armed Forces Health Surveillance Center, Silver Spring, MD, (3)San Antonio Military Medical Center, San Antonio, TX SCHEDULE 622 Infection Prevention Needs Assessment of Nebraska Acute, Long-Term, and Ambulatory Care Facilities L. Kate Tyner, BSN1, Peg Gilbert, MS2, Margaret Drake, MT3, Benjamin Scott, MS1, Mark Rupp4 and Shelly Schwedhelm, MSN1, (1)Nebraska Medicine, Nebraska Infection Control Assessment & Promotion Program (ICAP), Omaha, NE, (2)CIMRO of Nebraska, Nebraska Medicine, Nebraska Infection Control Assessment & Promotion Program (ICAP), Lincoln, NE, (3)Nebraska Medicine, Nebraska Infection Control Assessment & Promotion Program (ICAP), Nebraska DPH Epidemiology Unit, Omaha, NE, (4)University of Nebraska Medical Center, Department of Internal Medicine, Omaha, NE 623 Prevalence and Predictors of Multi Drug Resistance (MDRO) Colonization in Nursing Homes James A McKinnell, MD1,2, Loren Miller, MD, MPH2, Raveena Singh, MS3, Ken Kleinman, ScD4, Ellena Peterson, PhD5, Kaye Evans, BS5, Adrijana Gombosev, MS3, Lauren Heim, MPH3, Tabitha Dutciuc, MPH3, Marlene Estevez, BA3, Bryn Launer, BS2, Tom Tjoa, MS MPH3, Steven Tam, MD3, Michael Bolaris, MD2 and Susan S. Huang, MD, MPH3, (1)Providence Little Company of Mary Hospital, Torrance, CA, (2)Infectious Disease Clinical Outcomes Research Unit (ID-CORE), Division of Infectious Disease, Los Angeles Biomedical Research Institute at Harbor-University of California Los Angeles (UCLA) Medical Center, Torrance, CA, (3)Division of Infectious Diseases and Health Policy Research Institute, University of California, Irvine School of Medicine, Irvine, CA, (4)Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, (5)Department of Pathology and Laboratory Medicine, University of California, Irvine School of Medicine, Irvine, CA 624 The Risk Factors for Acinetobacter Baumannii Infections in Intensive Care Unit: A Prospective Study Bircan Kayaaslan, M.D1, Gul Ruhsar Yilmaz, Associate Professor2, Fatma Yekta Korkmaz, M.D1, Rahmet Guner, Prof. Dr1, Tumer Guven, Associate Professor1, Zeliha Kocak Tufan, Associate Professor1, Seval Izdes, Proffesor3, Imran Hasanoglu, M.D2, Turan Buzgan, Associate Professor1 and Mehmet Akin Tasyaran, Professor4, (1)Yildirim Beyazit University Faculty of Medicine, Ankara, Turkey, (2)Ankara Ataturk Training and Research Hospital, Ankara, Turkey, (3)Yildirim Beyazit University Faculty of Medicine, Deparment of Anesthesiology and Reanimation, Ankara, Turkey, (4)Yildirim Beyazit University Faculty of Medicine, Department of Infectious Disease and Clinical Microbiology, Ankara, Turkey 625 Big Data Guiding Prevention: Improved Surveillance with Large Scale Analytics Uzo Chukwuma1, Trinka Coster2, Michelle LaCour2, Kathryn McAuliffe1, Rosenie Thelus2, Charlotte Neumann1, Mary Hinkle, MD3, Robert Clifford, PhD3, Michael Julius, PMP3, Paige Waterman, MD4 and Emil Lesho, DO3, (1)Navy and Marine Corps Public Health Center, Portsmouth, VA, (2)U.S. Army Pharmacovigelance Center, Falls Church, VA, (3)Walter Reed Army Institute of Research, Silver Spring, MD, (4)Armed Forces Health Surveillance Center, Silver Spring, MD 626 Burden of CRE in Veterans with Spinal Cord Injury (SCI) and Impact of Varying Federal Definitions Katie J. Suda, PharmD, MS1,2, Margaret Fitzpatrick, MD, MS1,3, Martin E. Evans, MD4, Linda Poggensee, MS1, Swetha Ramanathan, MPH1, Stephen Burns, MD5, Charlesnika T. Evans, PhD, MPH1,6 and Makoto Jones, MD, MS7,8, (1)VA Center of Innovation for Complex Chronic Healthcare, Hines, IL, (2)University of Illinois at Chicago, Chicago, IL, (3)Loyola University, Maywood, IL, (4)VHA National Infectious Diseases Service, Lexington, KY, (5)VA Puget Sound Health Care System, Seattle, WA, (6)Northwestern University, Chicago, IL, (7) Salt Lake City VA Medical Center, Salt Lake City, UT, (8)University of Utah, Salt Lake City, UT SCIENCE GUIDING PREVENTION 31 POSTER PRESENTATIONS: THURSDAY, MAY 19 SCIENTIFIC POSTER PRESENTATIONS: THURSDAY, MAY 19 SCIENTIFIC PROGRAM 627 Up or Across? Vertical vs Horizontal Surveillance – Five Year Acinetobacter Screening Peter Harvey1, Juliet G Ferrelli, MS, MT(ASCP), CIC1 and Mohamed H Yassin, MD, PhD2, (1)UPMC Mercy, Pittsburgh, PA, (2)Univ of Pittsburgh, Pittsburgh, PA 628 Regional Variations in Fluoroquinolone NonSusceptibility Among E.coli Bloodstream Isolates in VHA Daniel J Livorsi, MD, MSc1,2, Michihiko Goto, MD, MSCI1,2, Margaret Carrel, PhD1, Makoto Jones, MD, MS3,4, Jennifer S McDanel, PhD1,5, Rajeshwari Nair, MBBS, PhD1,5, Bruce Alexander, PharmD1, Kelly K Richardson, PhD1, Brice F Beck, MA1 and Eli N Perencevich, MD, MS1,2, (1)Iowa City VA Medical Center, Iowa City, IA, (2)University of Iowa Carver College of Medicine, Iowa City, IA, (3)Salt Lake City VA Medical Center, Salt Lake City, UT, (4)University of Utah, Salt Lake City, UT, (5)Department of Epidemiology, University of Iowa College of Public Health, Iowa City, IA 629 Clinical Significance of Positive Admission Surveillance Culture for CRE in Non-Outbreak Setting Chawat Tongma, MD, Kamaljit Singh, MD and Michael Y. Lin, MD, MPH, Rush University Medical Center, Chicago, IL 630 Secondary Bloodstream Infections; Pathogens and Site of Primary Infection, 2010-2015 Onyekachukwu Nwankwo, MD1, David Weber, MD, MPH2, Lauren M. DiBiase, MS3, Emily Vavalle, PhD, MS1 and William Rutala, PhD, MPH4, (1)University of North Carolina at Chapel Hill, Chapel Hill, NC, (2)University of North Carolina at Chapel Hill, Chapel Hill, NC, (3) Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC, (4)UNC School of Medicine, Chapel Hill, NC 631 Legionella Environmental Culture Positivity Is Associated With Free Chlorine Concentration SCHEDULE 632 CRE Producing Carbapenemases Other Than KPC, Reported to CDC, 2009-2015 Debra Taylor, MPH1, Maroya Walters, PhD ScM1, David Lonsway, MMSC2, Meghan Lyman, MD1, David Kuhar, MD1, James K. Rasheed, PhD1, Brandi Limbago, PhD1 and Alexander J. Kallen, MD, MPH1,3, (1)Centers for Disease Control and Prevention, Atlanta, GA, (2)Centers For Disease Control and Prevention, Atlanta, GA, (3) Division of Healthcare Quality Promotion, CDC, Atlanta, GA 633 Definition of Healthcare-Associated Influenza: Criteria Considered by SRN Participants Elodie Munier-Marion1, Thomas Bénet1,2 and Philippe Vanhems, MD, PhD2,3, (1)Infection Control and Epidemiology Unit, Lyon, France, (2)Emerging Pathogens Laboratory - Foundation Mérieux, Centre International de Recherche en Infectiologie (CIRI) Inserm U1111, CNRS UMR5308, Lyon, France, (3)Infection Control and Epidemiology Unit, Lyon, FRANCE 634 What is an Appropriate Antibiotic Choice for Prophylaxis in Redo –Neurosurgeries? Bhagyashri Navalkele, MD1, Oryan Henig, MD2, Kabir Mendiratta, MD1, Elaine Flanagan, MSA1, Paula Robinson, BSN, CIC3, Karolina Kaser, BSN2, Keith Kaye, MD, MPH2 and Teena Chopra, MD, MPH2, (1)Detroit Medical Center, Detroit, MI, (2)Detroit Medical Center, Wayne State University, Detroit, MI, (3)Henry Ford Hospital Health Systems, Detroit, MI 636 Electronic Clostridium difficile Infection Bundle Reduces Time to Initiation of Contact Precautions Courtney M. Dewart, MPH, RN1, Natalia Blanco, MPH1, Betsy Foxman, PhD1 and Anurag N. Malani, MD2, (1)University of Michigan School of Public Health, Ann Arbor, MI, (2)St. Joseph Mercy Health System, Ann Arbor, MI Brooke K. Decker, M.D.1, Patricia L. Harris, M.S.N., R.N.1, Diana L. Toy, B.S.N., R.N.1, Bonnie M. Mihalchik, BS, RN, MT, CIC1, Paul D. Wiser, BSN2, Shelia M. Cloud-Woods, M.S.N., R.N.1, Ali F. Sonel, M.D.1 and Cornelius J. Clancy, M.D.1, (1)VA Pittsburgh Healthcare System, Pittsburgh, PA, (2)VA Pittsburgh Healthcare Sytem, Pittsburgh, PA Top Poster Abstract 32 SHEA Spring 2016 Conference PROGRAM PLENARY: REACHING OUT TO NEW PARTNERS 1:00 – 2:30 p.m. Peachtree Ballroom CD Moderators: Matthew Linam, MD and Thomas Talbot, MD Speakers: Partners in Safety - Peter Pronovost, MD Partners of Peers: Using Collaborations to Drive Improvement - Stephen Muething, MD • Discuss importance of collaboration with partners to achieve lasting HAI reductions • Describe examples of patient safety and collaborative partners involved with HAI reduction programs • Discuss the benefits of collaboration as a way to catalyze efforts to reduce healthcare associated infections SHEA ANTIBIOTIC STEWARDSHIP TRAINING COURSE BREAKOUT SESSION: BEGINNING ANTIBIOTIC STEWARDSHIP Chastain E Speakers: Tailoring to Your Reality: Effective Strategies for Designing a Stewardship Program - Michael Calderwood, MD Measurement in Antibiotic Stewardship Elizabeth Dodds-Ashley, PharmD Learning Objectives: • Explain how to conduct a needs assessment for your institution • Discuss specific stewardship strategies and methods, merits, and drawbacks based on resource availability • Identify best first steps to initiate an antibiotic stewardship program in your institution, with emphasis on both adult and pediatric settings • Explain how to employ pharmacy related metrics – Days of Therapy (DOTs) or Defined Daily Doses (DDDs) for measuring antibiotic use • Discuss relevant process and outcomes measures to sustain the business case for antibiotic stewardship interventions • Discuss methods for measuring and reporting the impact of an antibiotic stewardship program including the National Healthcare Safety Network’s Antibiotic Utilization Module CPE Number: 0221-9999-16-080-L04-P SHEA ANTIBIOTIC STEWARDSHIP TRAINING COURSE BREAKOUT SESSION: ADVANCED ANTIBIOTIC STEWARDSHIP 1:00 – 2:30 p.m. Learning Objectives: 1:00 – 2:30 p.m. SCHEDULE Chastain F Speakers: Advanced Strategies for Implementation: Building Capacity in a Health System - Whitney Buckel, PharmD Advanced Ideas for Measurement in Antimicrobial Stewardship - Conan MacDougall, PharmD Learning Objectives: • Describe unique challenges and strategies for implementing antibiotic stewardship across multiple sites or within a health system • Review approaches to implementing antibiotic stewardship where resources are limited • Discuss scalability - how and where to expand your program • Describe options for antibiotic utilization measurements and merits of each • Examine how to use time-series analyses and other study designs to evaluate stewardship programs • Explain how to assess and respond to antimicrobial shortages in an institution CPE Number: 0221-9999-16-081-L04-P FULL CONFERENCE PRO/CON: TO WASH OR RUB OFF – C. DIFFICILE AND MAKING THE MOST OF C. DIFFICILE PCR 2:45 – 4:00 p.m. Savannah Ballroom Moderators: Daniel Morgan, MD and Abhishek Deshpande, MD Speakers: PRO: Soap and Water Should be Used - Carolyn Gould, MD CON: Alcohol Hand Rub is Fine - Erik Dubberke, MD PRO: PCR - Mary Hayden, MD CON: PCR - Curtis Donskey, MD Learning Objectives: • Assess the pros and cons of using soap and water vs. alcoholbased hand sanitizer for patients infected with C. difficile. • Recognize various approaches to C. difficile testing and their implications for both patient care and infection prevention and control • Learn about the pros and cons of primary PCR-based testing for C. difficile infection SCIENCE GUIDING PREVENTION 33 THURSDAY, MAY 19 SCIENTIFIC SCIENTIFIC PROGRAM FULL CONFERENCE ORAL ABSTRACT SESSION: HAI SURVELLIANCE Moderator: Barbara Trautner, MD and Rebekah Moehring, MD 2:45 – 4:00 p.m. Chastain Room THURSDAY, MAY 19 Carlos E. Figueroa Castro, MD1, Mary Williams, RN, BSN, CIC2, Carrie Johnson, RN, BSN, CIC3, Mary Beth Graham, MD4 and L. Silvia Munoz-Price, MD, PhD5, (1)Medical College of Wisconsin, Milwaukee, WI, (2)Froedtert & The Medical College of Wisconsin, West Bend, WI, (3)Froedtert & The Medical College of Wisconsin, Menomonee Falls, WI, (4)Division of Infectious Diseases, Medical College of Wisconsin, Milwaukee, WI, (5)Institute for Health and Society/Department of Medicine Froedtert and the Medical College of Wisconsin Health Research Center, Milwaukee, WI 8105HAI Antibiotic Resistance Patient Safety Atlas: a New Tool for Geospatial Analysis of NHSN HAI data Raymund B Dantes, MD, MPH1,2, Alfred Junior3, Catherine Capers, MA3, Lindsey Weiner, MPH3, Jonathan R Edwards, MStat4 and Scott Fridkin, MD5, (1)Division of Healthcare Quality Promotion, CDC, Atlanta, GA, (2)Emory University Hospital, Atlanta, GA, (3) Centers for Disease Control and Prevention, ATLANTA, GA, (4) Centers for Disease Control and Prevention, Division of Healthcare Quality Promotion, Atlanta, GA, (5)Centers for Disease Control and Prevention, Atlanta, GA 7686National burden of MRSA, MSSA and CDI among Emergency Department discharges in U.S, 2009-2012 Chao Song, MPH, Emelline Liu, MSHS and Michele Schoonmaker, PhD, Cepheid, Sunnyvale, CA 7976Incidence of Long-Term Care Facility Onset Clostridium difficile Infection in 10 US Sites, 2011-2014 Alice Y. Guh, MD, MPH1, James Baggs, PhD1, Yi Mu, PhD2, Wendy Bamberg, MD3, Zintars Beldavs, MS4, Corinne M. Davis, MPH, MS5, Monica M. Farley, MD6, Stacy M Holzbauer, DVM, MPH1,7, Carol Lyons, MS, MPH8, Rebecca Perlmutter, MPH9, Erin C Phipps, DVM, MPH10, Lisa Winston, MD11, Maria Karlsson, PhD12, Dale N. Gerding, MD13 and Ghinwa Dumyati, MD, FSHEA14, (1)CDC, Atlanta, GA, (2)Division of Healthcare Quality Promotion, CDC, Atlanta, GA, (3) Colorado Department of Public Health & Environment, Denver, CO, (4) Oregon Health Authority, Portland, OR, (5)Tennessee Department of Health, Nashville, TN, (6)Emory University, Atlanta, GA, (7)Minnesota Dept of Health, St. Paul, MN, (8)Yale School of Public Health, Connecticut Emerging Infections Program, New Haven, CT, (9) Maryland Department of Health and Mental Hygiene, Baltimore, MD, (10)University of New Mexico, New Mexico Emerging Infections Program, Albuquerque, NM, (11)University of California, San Francisco, San Francisco, CA, (12)Centers for Disease Control and Prevention, Atlanta, GA, (13)Hines VA Hospital and Loyola University Medical Center, Hines, IL, (14)University of Rochester Medical Center, Rochester, NY 8003National Trends of Severe Sepsis and Septic Shock Using Administrative Claims Data, 2008-2015 Kelly McCormick, MSPH, James Baggs, PhD, Raymund B Dantes, MD, MPH, Anthony E Fiore, MD, MPH, John Jernigan, MD, MS, Shelley Magill, MD, PhD and Lauren Epstein, MD, Division of Healthcare Quality Promotion, CDC, Atlanta, GA SHEA Spring 2016 Conference UPDATES FROM THE CDC PREVENTION EPICENTERS PROGRAM: A PUBLIC HEALTH/ACADEMIC RESEARCH PARTNERSHIP 4:15 – 5:45 p.m. 8087Google Fusion Tables and Data Visualization of Regional C.difficile epidemiology 34 SCHEDULE Chastain Room Moderator: John Jernigan, MD Speakers: What makes the CDC Prevention Epicenter Program Different? - John Jernigan, MD Chlorhexidine Bathing, Antibiotic Resistance, and Control Mary Hayden, MD Environmental Decontamination to Prevent Transmission Deverick Anderson, MD Improving Surveillance and Prevention for Ventilated Patients - Michael Klompas, MD Protection of Healthcare Workers: Vaccines, PPE and Aerosols - Hilary Babcock, MD Strategies to Improve Antimicrobial Stewardship Ebbing Lautenbach, MD Learning Objectives: • List unique features of the CDC Prevention Epicenter Program • List ongoing lines of research being conducted by the investigators in the Program • List high priority research topics for the field IS THERE QUALITY IN QUALITY METRICS? 4:15 – 5:45 p.m. Savannah Ballroom Moderators: Neil Fishman, MD and Marci Drees, MD Speakers: Limitations in SSI Quality Metrics Michael Calderwood, MD Dissonant Metrics - You Win Some, You Lose Some Raymond Chinn, MD Penalizing Quality Hospitals for Hospital-Acquired Conditions - Grace Lee, MD Learning Objectives: • Discuss current hospital quality metrics for healthcare-associated infections • Compare the advantages and disadvantages of different quality metrics for the same healthcare-associated infection • Recognize the limitations of current metrics and their link to quality of care provide PROGRAM JOINT SESSIONS PAC & LTC: CHANGING THE NATIONAL LANDSCAPE & INFECTION PREVENTION 2:45 – 3:30 p.m. Chastain F Speaker: Nimalie Stone, MD • Describe the differences in infrastructure for clinical care and infection prevention in post-acute and long-term care settings compared with acute care hospitals • Describe the gaps and challenges in implementing infection prevention and antibiotic stewardship programs in post-acute and long-term care settings • Highlight the national initiatives which are driving surveillance and prevention activities in this setting S H E A / C D C T R A I N I N G C E R T I F I C AT E C O U R S E I N H O S P I TA L E P I D E M I O L O G Y ENVIRONMENT, STERILIZATION & DISINFECTION WHAT EVERY STEWARD SHOULD KNOW ABOUT PHARMACOKINETICS – PHARMACODYNAMICS Chastain E Speaker: Elizabeth Dodds-Ashley, PharmD Learning Objectives: • Review PK and PD properties of different antibiotic agents and their application to selection of appropriate dosing based on patient, pathogen, and syndrome characteristics • Discuss approaches to therapeutic monitoring of antibiotics such as vancomycin and aminoglycosides • Review approaches for IV to PO conversion CPE Number: 0221-9999-16-082-L01-P ALLERGIES, INTERACTIONS AND ADVERSE EVENTS 3:15 – 3:45 p.m. Chastain F Speaker: Kerri Thom, MD Chastain E Speaker: Jeffrey Gerber, MD Learning Objectives: Learning Objectives: • Identify the Spaulding scheme for selection and use of disinfectants • Identify two control measures that can be employed to prevent fungal transmission during construction/renovation • Indicate when microbiologic sampling of the environment should be done • Perform an overview of sterilization and disinfection SPECIAL POPULATIONS IMMUNOCOMPROMISED, ICU, DIALYSIS AND BURN PATIENTS 4:30 – 5:30 p.m. SHEA ANTIBIOTIC STEWARDSHIP TRAINING COURSE 2:45 – 3:15 p.m. Learning Objectives: 3:30 – 4:15 p.m. SCHEDULE Chastain F Speaker: Deborah Yokoe, MD Learning Objectives: • Recognize how to apply and modify healthcare epidemiology, antibiotic stewardship, and infection prevention approaches for immunocompromised populations • Review the special issues associated with these populations including increased use of invasive devices, increased use of broad-spectrum empiric antibiotics and how intense exposure to the healthcare system increases risks of MDRO acquisition • List different types of allergic reactions to antibiotics and how they may be prevented or minimized • List common drug-drug interactions and explain strategies to avoid them • Discuss common adverse events associated with various antimicrobials CPE Number: 0221-9999-16-083-L05-P AN UPDATE ON DURATION OF THERAPY AND THERAPEUTIC MONITORING: OUR ROLE AS STEWARDS 3:45 – 4:15 p.m. Chastain E Speaker: Kavita Trivedi, MD Learning Objectives: • Explain the science behind duration of antibiotic therapy • Review the uses of inflammatory biomarkers in antibiotic stewardship programs CPE Number: 0221-9999-16-084-L05-P ANTIBIOTIC STEWARDSHIP: NAVIGATING THE LIABILITY RISKS 4:30 – 5:00 p.m. Chastain E Speaker: Mary Ellen Nepps, Esq. Learning Objectives: • Identify legal concepts that are applicable to the practice of antibiotic stewardship • Define the nature and extent of medical-legal risk in the practice of antibiotic stewardship • Discuss approaches for management of risk in the practice of antibiotic stewardship CPE Number: 0221-9999-16-085-L03-P SCIENCE GUIDING PREVENTION 35 THURSDAY, MAY 19 SCIENTIFIC SCIENTIFIC PROGRAM SCHEDULE CASE STUDY #1: USING BENCHMARKING TO ENHANCE ANTIBIOTIC STEWARDSHIP SHEA EDUCATION AND RESEARCH FOUNDATION DINNER 5:00 – 5:45 p.m. 6:00 – 9:00 p.m. Chastain E Speaker: Whitney Buckel, PharmD Learning Objectives: • Describe the utility of benchmarking in antibiotic stewardship • Discuss goals of the NHSN AUR Module • Describe how to use data from the NHSN AUR Module to refine stewardship interventions, highlighting the role of the pharmacist THURSDAY, MAY 19 CPE Number: 0221-9999-16-086-L04-P 36 SHEA Spring 2016 Conference Georgia Aquarium Please note: No transportation will be provided as the Georgia Aquarium is within walking distance to the Westin Peachtree Plaza. SHEA Staff and Atlanta Volunteers will be available as guides for walking groups. Guides will depart from the hotel lobby at 5:30 p.m. to take you to the aquarium. If you are walking on your own, the aquarium’s Oceans Ballroom is located on the first level of the parking deck. If parking at the aquarium, take the elevator to level one and follow the signs to the Oceans Ballroom. SCIENTIFIC PROGRAM CONTINENTAL BREAKFAST 7:00 – 7:50 a.m. 7th Floor: Augusta Ballroom(s) INTERNATIONAL ATTENDEE BREAKFAST 7:00 – 7:50 a.m. Peachtree Room This breakfast is open only to international attendees and SHEA Leaders. SCHEDULE S H E A / C D C T R A I N I N G C E R T I F I C AT E C O U R S E I N H O S P I TA L E P I D E M I O L O G Y LEADERSHIP AND COMMUNICATION SKILLS 8:00 – 8:45 a.m. Chastain F Speaker: Robert Weinstein, MD Learning Objectives: RESEARCH METHODS IN HEALTHCARE EPIDEMIOLOGY – PRACTICAL CONSIDERATIONS 8:00 – 9:30 a.m. Savannah Ballroom Moderators: Nasia Safdar, MD and Graham Snyder, MD Speakers: Pearls and Pitfalls - Obs/Retro - Daniel Morgan, MD Pearls and Pitfalls - Quasi-experimental Design Aaron Milstone, MD Pearls and Pitfalls - Trials - Deverick Anderson, MD Learning Objectives: • Review good methods in healthcare epidemiology research • Learn pros and cons of using common healthcare epidemiology research methods NOVEL ENGINEERING SOLUTIONS TO ENVIRONMENTAL HYGIENE 8:00 – 9:30 a.m. Chastain Room Moderators: Leonard Mermel, DO and Arjun Srinivasan, MD Speakers: The Microbiome of the Built Hospital Environment Simon Lax, PhD Architectural Solutions to Infection Prevention James Steinberg, MD Engineering Healthcare Workers: How Staffing Models Effect Transmission - Sean Barnes, MS Learning Objectives: • Discuss effective facilitation strategies to manage multidisciplinary teams and meetings including the following key strategies: • Agenda development, Inclusiveness, Action and follow up, Clear responsibility and task management, and Feedback mechanisms • Identify the importance of collaboration with other hospital groups/teams and stakeholders • Recognize the basics of effective communication • Indicate basic skills for effective negotiation • Demonstrate how to speak to the financial impacts and cost-effectiveness of proposed interventions THE HOSPITAL EPIDEMIOLOGIST AS A CLINICIAN EDUCATOR 8:45 – 9:30 a.m. Chastain F Speaker: Robert Weinstein, MD Learning Objectives: • Distinguish principles of adult learning necessary to effectively teach and to design educational interventions • Identify varying forums and tools for effective delivery of education including didactic lectures, small-group case-based discussions, and one-on-one instruction • Classify the target audience and be able to vary teaching modalities & methods based on audience, level of training and knowledge base • Identify mechanisms for delivering education including unit-level training, hands-on skills demonstration, computer-based modules, and simulation • Assess the stage of the learner, ensure topic is meaningful and relevant to learner’s work, articulate goals, encourage active learner involvement, and provide feedback • Recognize presentation tools effectively and appropriately, develop effective written educational materials, and educate individual HCP and other stakeholders • Use varying teaching methods targeted at specific audience needs and goals • Discuss the environmental microbiome and how it can affect disease transmission • Propose architectural design solutions for infection prevention and discuss how these solutions can lead to a decrease in disease transmission • Discuss how manipulation of healthcare worker staffing ratios can affect transmission of disease using mathematical modeling SCIENCE GUIDING PREVENTION 37 FRIDAY, MAY 20 FULL CONFERENCE SCIENTIFIC PROGRAM SHEA ANTIBIOTIC STEWARDSHIP TRAINING COURSE INTEGRATION OF THE MICROBIOLOGY LAB & ANTIBIOTIC STEWARDSHIP: BEGINNING CONCEPTS 8:00 – 8:45 a.m. Chastain E Speaker: Daniel Diekema, MD Learning Objectives: • Describe appropriate ways to obtain a culture specimen and other samples for microbiology testing • Review approaches to detecting and reporting antibiotic susceptibilities, including selective reporting • Identify strengths and weaknesses of the antibioGram to assist with decisions on recommendations for empirical therapy RAPID DIAGNOSTIC TESTS AND HOW TO IMPLEMENT THEIR USE: MINI-LECTURE & CASE STUDY #2 Chastain E Learning Objectives: • Describe strengths and weaknesses of common rapid diagnostic tests and used in the microbiology lab • Discuss how the microbiology lab and the antibiotic stewardship program can collaborate to maximize use of rapid diagnostic tests to improve antibiotic use FRIDAY, MAY 20 REGIONAL APPROACH TO MDRO PREVENTION 10:00 – 12:00 p.m. Savannah Ballroom Moderators: Maroya Walters, PhD and Kurt Stevenson, MD Speakers: Modeling the Best Approaches to Regional MDRO Prevention - Susan Huang, MD Challenges to Implementing Regional Programs Christopher Pfeiffer, MD Public Health Coordination of Regional Programs Marion Kainer, MD • Identify rationale supporting a regional approach to MDRO control • Describe challenges to implementing coordinated control efforts from the state and facility perspective • Describe potential effect of regional control efforts based on modeling CHALLENGING CASES AND ISSUES IN INFECTION PREVENTION Speaker: Shira Doron, MD CPE Number: 0221-9999-16-088-L04-P NETWORKING BREAK 9:30 – 10:00 a.m. FULL CONFERENCE Learning Objectives: CPE Number: 0221-9999-16-087-L01-P 8:45 – 9:30 a.m. SCHEDULE 7th Floor: Augusta Ballroom(s) 10:00 – 12:00 p.m. Chastain Room Moderators: Latania Logan, MD and Robert Weinstein, MD Speakers: Case Presenter 1 - Latania Logan, MD Case Presenter 2 - Robert Weinstein, MD Panelist: Peds Perspective - Matthew Linam, MD Panelist: University Medical Center - Laurie Conway, PhD Panelist:Community Hospital - Raymond Chinn, MD Panelist: Post-Acute Care - Deborah Yokoe, MD Learning Objectives: • Discuss real-world challenges in infection prevention in various healthcare settings • Compare strengths and weaknesses of solutions to challenging problems • Formulate management strategies and discuss resources to assist in the implementation of the solutions discussed • Compare knowledge with other peers and assess clinical acumen in infection prevention 38 SHEA Spring 2016 Conference PROGRAM S H E A / C D C T R A I N I N G C E R T I F I C AT E C O U R S E I N H O S P I TA L E P I D E M I O L O G Y OCCUPATIONAL HEALTH ISSUES 10:00 – 11:00 a.m. Chastain F SHEA ANTIBIOTIC STEWARDSHIP TRAINING COURSE UPDATE ON THE NATIONAL STEWARDSHIP ACTIVITIES 10:00 – 10:30 a.m. Speaker: Thomas Talbot, MD Chastain E Speaker: Arjun Srinivasan, MD Learning Objectives: • Illustrate the role of healthcare personnel (HCP) in the transmission of healthcare-associated infections • Identify the recommended strategies, including immunization and use of screening tests, designed to prevent HCP-associated transmission of pathogens • Identify the approach to HCP infected with a bloodborne virus • Summarize the management of contagious disease exposures among HCP, including the use of post-exposure prophylaxis REGULATORY & EMERGENCY PREPAREDNESS 11:00 a.m. – 12:00 p.m. SCHEDULE Learning Objectives: • Describe the national landscape and activities in antibiotic stewardship • Discuss available resources to assist with stewardship implementation CPE Number: 0221-9999-16-089-L04-P HOW TO FIND RESOURCES AT YOUR INSTITUTION OR HEALTH SYSTEM 10:30 – 11:30 a.m. Chastain F Speaker: Louise Dembry, MD Learning Objectives: • State the role and functions of public health entities at local, state, and national levels • Review core emergency preparedness concepts, including emergency response planning, incident command functions, and facility response to emergent events • Assist in policy and response plan development and evaluation for infection-related events, such as bioterrorism or pandemic respiratory pathogens • Recite an overview of the system of state, federal, and accrediting organization oversight and requirements for healthcare facilities prepare for and survive a visit from CMS, TJC, and State DPH Chastain E Speaker: Mohamad Fakih, MD Learning Objectives: • Review how your antibiotic stewardship program intersects with the institution’s strategic plan • Describe how to engage non-traditional stewards such as students, quality improvement teams, and nurses • Explain how to develop and present a business case to institutional leadership for maintenance of a program CPE Number: 0221-9999-16-090-L04-P ART OF ANTIBIOTIC STEWARDSHIP 11:30 – 12:00 p.m. Chastain E Speaker: Sara Cosgrove, MD Learning Objectives: • Distinguish basic theories regarding patient safety, quality science, implementation science and organizational change to implement antibiotic stewardship interventions and to change prescribing habits • Review the complex interpersonal and interprofessional needs to best develop and sustain an antibiotic stewardship program CPE Number: 0221-9999-16-091-L04-P SCIENCE GUIDING PREVENTION 39 FRIDAY, MAY 20 SCIENTIFIC POSTER PRESENTATIONS: FRIDAY, MAY 20 SCIENTIFIC PROGRAM LUNCH WITH POSTER PRESENTATIONS 12:00 – 1:00 p.m. 7th Floor: Augusta Ballroom 501 Deploying a Novel Metric to Contextualize Carbapenem Use at an Academic Tertiary Care Hospital J Daniel Markley, DO1, Anahita Molayi, MSPH2, Shaina Bernard, Pharm D, BCPS1, Kimberly Lee, PharmD1, Kakotan Sanogo3, Gonzalo Bearman, MD, MPH4, Amy Pakyz, Pharm D, MS, PhD3, Michael Stevens, MD1 and Perry Taylor5, (1)Virginia Commonwealth University Medical Center, Richmond, VA, (2)Virginia Commonwealth University School of Medicine, Richmond, VA, (3)Virginia Commonwealth University, Richmond, VA, (4)Medical College of Virginia, Richmond, VA, (5)Virginia Commonwealth University Health System, Richmond, VA 502 A Survey to Optimize the Design of an Antimicrobial Smartphone App at an Academic Medical Center J Daniel Markley, DO1, Gonzalo Bearman, MD, MPH2, Michael Stevens, MD3, Amy Pakyz, Pharm D, MS, PhD4, Shaina Bernard, Pharm D, BCPS1, Kimberly Lee, PharmD1 and Nital Appelbaum5, (1) Virginia Commonwealth University Medical Center, Richmond, VA, (2) Medical College of Virginia, Richmond, VA, (3)VCUHS, Richmond, VA, (4)Virginia Commonwealth University, Richmond, VA, (5)Virginia Commonwealth University Health System, Richmond, VA 503 Safety and Efficacy of Outpatient Parenteral Antibiotic Therapy (OPAT) in an Infectious Disease Clinic Geehan Suleyman, MD1, Rachel Kenney, Pharm D1, Marcus Zervos, MD1,2 and Allison Weinmann, MD1, (1)Henry Ford Health System, Detroit, MI, (2)Wayne State University, Detroit, MI 504 Diagnosis and Treatment of Urinary Tract Infections in Patients Seen in the Emergency Department Ioana Chirca, MD1, Penny Shute2, Meyer Schwartz, MD2 and Heather J Schwartz, NP3, (1)University Hospital Augusta, Augusta, GA, (2)University Hospital, Augusta, GA, (3)Joseph M Still Burn Center, Augusta, GA 505 Pharmacist Managed Penicillin Skin Testing in Hospitalized Patients Jeff Brock, Pharm.D., MBA1, Nathan Peterson, Pharm.D.1 and Aneesa Afroze, M.D.2, (1)Mercy Medical Center, Des Moines, IA, (2) Chest, Infectious Diseases and Critical Care Associates, P.C., Clive, IA 506 Projecting the Impact of Reduction in Antibiotic Usage on the Transmission of MDROs Sean L. Barnes, PhD1, Anthony Harris, MD, MPH2, Clare Rock, MD, MS3, Sara Cosgrove, MD, MS4, Daniel Morgan, MD, MS5 and Kerri Thom, MD, MS2, (1)University of Maryland, College Park, MD, (2) Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, (3)Department of Medicine, Division of Infectious Diseases, Johns Hopkins University, Baltimore, MD, (4)Johns Hopkins University School of Medicine, Baltimore, MD, (5)University of Maryland School of Medicine, Baltimore, MD 507 The Significance of bacteriuria in Patients with ESRD on Hemodialysis Ibrahim Taweel, MD1, Alexsis Duarte1, Norman Beatty, MD1, David Nix, PharmD2 and Mayar Al Mohajer, MD FACP3, (1)University of Arizona - College of medicine, Tucson, AZ, (2)University of ArizonaCollege of Pharmacy, Tucson, AZ, (3)University of Arizona, Tucson, AZ 508 Impact of Empiric Antibiotic Likelihood of Infection Coverage on Inpatients with UTI and ABI Jessica P Ridgway, MD, MS1, Ari Robicsek, MD1,2, Becky Smith, MD2, Jeffery Semel, MD2, Nirav Shah, MD, MPH1 and Lance Peterson, MD1,2, (1)University of Chicago, Chicago, IL, (2)NorthShore University HealthSystem, Evanston, IL SCHEDULE 509 Impact of Antimicrobial Stewardship Program (ASP) in a Rural Community Hospital William L Tillett, PharmD, MPH, Mayo Clinic Health System, Waycross, GA 510 Antimicrobial Stewardship in Critical Access Hospitals: Fighting the Same Battle? Gayle Allenback, MSOT, MPH, GStat1,2, Patricia Cruz, PhD3 and David Woodard, MSc, FSHEA2, (1)University of Nevada School of Medicine, Las Vegas, NV, (2)University of Nevada Las Vegas, Las Vegas, NV, (3)University of Nevada, Las Vegas, Las Vegas, NV 511 Trends in Restricted and Unrestricted Gram-Positive Antimicrobial Consumption at a Virginia Hospital Anahita Molayi, MSPH, Virginia Commonwealth University School of Medicine, Richmond, VA 512 The Role of Infectious Disease Consultation in Patients with Enterococcus Bacteremia Pryce Gaynor, MD MPH, David Nix, PharmD, Kathryn Matthias, PharmD, Tsz Tsui, PharmD and Mayar Al Mohajer, MD FACP, University of Arizona, Tucson, AZ 513 Patterns of Antimicrobial Prescribing in Emergency Departments at Detroit Medical Center (DMC) Oryan Henig, MD, Ryan P. Mynatt, PharmD, Jason Pogue, PharmD, Leah Molloy, PharmD, Jing J. Zhao, PharmD, Kyle Murray, PharmD, Teena Chopra, MD, MPH, Sorabh Dhar, MD, Bhagyashri Navalkele, MD and Keith Kaye, MD, MPH, Detroit Medical Center, Wayne State University, Detroit, MI 514 Perceptions of Use of Twitter to Promote Antibiotic Timeouts and Education: A Pilot Study Jordan R. Wong, PharmD1, Sheetal Kandiah, MD2, Roshan Patel, MD3 and Mina Tadrous4,5, (1)Grady Health System, Atlanta, Georgia, USA, Atlanta, GA, (2)Emory University, Decatur, GA, (3) University of California San Francisco, San Francisco, CA, (4)St. Michael’s Hospital, Toronto, ON, Canada, (5)Leslie Dan Faculty of Pharmacy, Toronto, ON, Canada 515 Provider Prescribing Activities in the Post-Prescription Period: Opportunities for Intervention Kerri Thom, MD, MS1, Pranita Tamma2, Lisa Pineles, MA1, Kate Dzintars, PharmD3, Anthony Harris, MD, MPH1, Daniel Morgan, MD, MS4,5, Edina Avdic, Pharm, D, MBA6 and Sara Cosgrove, MD, MS2, (1)Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, (2)Johns Hopkins University School of Medicine, Baltimore, MD, (3)Johns Hopkins University School of Medicine Department of Medicine, Baltimore, MD, (4)VA Maryland Healthcare System, Baltimore, MD, (5)University of Maryland School of Medicine, Baltimore, MD, (6)The Johns Hopkins Hospital, Baltimore, MD 516 Impact of Antimicrobial Stewardship Interventions on Utilization and Resistance To Fluoroquinolones Michelle T. Hecker, MD1,2, Andrea Son, PharmD2, Nina NaegerMurphy, PharmD2 and Curtis J. Donskey, MD1,3, (1)Case Western Reserve University, Cleveland, OH, (2)MetroHealth Medical Center, Cleveland, OH, (3)Geriatric Research Education and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH 517 City-Wide Evaluation of Urinary Tract Infection Treatment Patterns in the Emergency Department Christopher David Evans, PharmD1, Mary Lourdes Brundige, PharmD2, Mary Staicu, PharmD2, Tina Khadem, PharmD3, Tuong Diep, PharmD4, Christina B Felsen, MPH5, Maryrose LaguioVila, MD2 and Ghinwa Dumyati, MD, FSHEA5, (1)University of Rochester Medical Center, Rochester, NY, (2)Rochester General Hospital, Rochester, NY, (3)Highland Hospital, Rochester, NY, (4) Unity Hospital, Rochester, NY, (5)New York Emerging Infections Program, Rochester, NY Top Poster Abstract 40 SHEA Spring 2016 Conference PROGRAM 518 A Comparison of Antimicrobial Use Summary Measures Using Data Reported From ICUs to NHSN, 2015 Erin N. O’Leary, MPH, Jonathan R Edwards, MStat, Katharina L. van Santen, MSPH, Arjun Srinivasan, MD, Scott Fridkin, MD and Daniel A. Pollock, MD, Centers for Disease Control and Prevention, Division of Healthcare Quality Promotion, Atlanta, GA 519 Expert Consensus on Relevant and Feasible Metrics to Demonstrate Impact of Antimicrobial Stewardship Rebekah W. Moehring, MD, MPH1,2,3, Deverick Anderson, MD, MPH1,4 and Elizabeth Dodds Ashley, PharmD, MHS1,5, (1)Duke Antimicrobial Stewardship Outreach Network, Durham, NC, (2)Duke University Medical System, Durham, NC, (3)Durham Veterans Affairs Medical Center, Durham, NC, (4)Duke University Medical Center, Durham, NC, (5)Duke University, Durham, NC 520 Incorporation of Antimicrobial Stewardship Into a Hospital Committee Structure J Ryan Bariola, MD, Katherine T Lusardi, PharmD and Robert W Bradsher Jr, MD, University of Arkansas for Medical Sciences, Little Rock, AR 521 Barriers and Facilitators to Implementing Antimicrobial Stewardship in Philadelphia-Area Hospitals Julia E. Szymczak, PhD1, Jeffrey S. Gerber, MD, PhD2 and Keith Hamilton, MD3, (1)The Children’s Hospital of Philadelphia, Philadelphia, PA, (2)Division of Infectious Diseases, The Children’s Hospital of Philadelphia, Philadelphia, PA, (3)Hospital of the University of Pennsylvania, Philadelphia, PA 522 Educational Initiative to Decrease Screening for Asymptomatic Bacteriuria at a Community Hospital Montgomery Ford Williams, PharmD1,2, Michael E Wright, PharmD2, Maggie Montgomery, PharmD3, Emily P Doss, PharmD4 and Julie Reznicek, DO5, (1)Belmont University, Nashville, TN, (2)Williamson Medical Center, Franklin, TN, (3)Veterans Affairs New York Harbor Healthcare System, Brooklyn, NY, (4)VA Tennessee Valley Healthcare System, Nashville, TN, (5)VCU Health System, Richmond, VA 523 Fear of Failure: Engaging Patients to Reduce Inappropriate Antibiotic Use after Fecal Transplants Michelle T. Hecker, MD1,2, Edith Ho, MD1,3 and Curtis J. Donskey, MD1,4, (1)Case Western Reserve University, Cleveland, OH, (2)MetroHealth Medical Center, Cleveland, OH, (3)Cleveland VA Medical Center, Cleveland, OH, (4)Geriatric Research Education and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH 524 Vertical Antimicrobial Stewardship to Reduce C. difficile Colitis in Colonized Patients Sara L Revolinski, PharmD1, Njeri Wainaina, MD2, Mary Beth Graham, MD2 and L. Silvia Munoz-Price, MD, PhD3, (1)Froedtert Hospital, Medical College of Wisconsin, Milwaukee, WI, (2)Division of Infectious Diseases, Medical College of Wisconsin, Milwaukee, WI, (3)Institute for Health and Society/Department of Medicine Froedtert and the Medical College of Wisconsin Health Research Center, Milwaukee, WI 525 Urinary Tract Infections: Pilot Study to Improve Guideline Adherence Maroun M. Sfeir, MD, MPH1,2, Alexandra Beranger, MD3 and Thomas Hooton, MD2,3, (1)New York Presbyterian Weill Cornell Medical Center, New York, NY, (2)University of Miami Miller School of Medicine/ Jackson Memorial Hospital, Miami, FL, (3)Miami Veteran Affairs Medical Center, Miami, FL SCHEDULE 526 An Antimicrobial Stewardship Intervention for Asymptomatic Bacteriuria Addressed Cognitive Biases Larissa Grigoryan, MD, PhD1, Aanand D. Naik, MD1,2, Deborah Horwitz, PA1, Jose A. Cadena-Zuluaga, MD3, Jan Patterson, MD4, Roger Zoorob, MD, MPH1 and Barbara Trautner, MD, PhD1,5, (1) Baylor College of Medicine, Houston, TX, (2)Health Services Research and Development Center of Excellence, Michael E. DeBakey VA Medical Center, Baylor College of Medicine, Houston, TX, (3) South Texas Veterans Health Care System, Audie Murphy Division, Pipe Creek, TX, (4)University of Texas Health Science Center at San Antonio, San Antonio, TX, (5)Center for Innovations in Quality, Effectiveness and Safety, Houston, TX 527 Impact of Procalcitonin (PCT) on Antimicrobial Use in an Intensive Care Unit at a Community Hospital Taeyong Sim, MD, Kara Brockhaus, PharmD, Curtis D Collins, PharmD, MS, Anupam Suneja, MD and Anurag Malani, MD, St. Joseph Mercy Health System, Ann Arbor, MI 529 Can a Patient Safety Initiative Change Outpatient Antibiotic Prescription Practice? Kazuaki Jindai, MD1,2, Jackson Musuuza, MD, MPH, MS3, Graeme Forrest, MBBS1,4, Kimberly MacKay, PharmD1, Nasia Safdar, MD, PhD5,6 and Christopher Pfeiffer, MD, MHS1,4, (1)VA Portland Health Care System, Portland, OR, (2)School of Public Health, Oregon Health & Science University, Portland, OR, (3)Institute for Clinical and Translational Research, University of Wisconsin, Madison, WI, (4) Division of Infectious Disease, Oregon Health & Science University, Portland, OR, (5)The William S. Middleton Veterans Affairs Medical Center, Madison, WI, (6)University of Wisconsin School of Medicine & Public Health, Madison, WI 530 Defining Baseline Antimicrobial Utilization and Outcomes Prior to a Stewardship Protocol for Short-C Ethan A. Smith, PharmD, Howard S. Gold, MD, Graham M. Snyder, MD, SM, Monica Mahoney, PharmD and Christopher McCoy, PharmD, Beth Israel Deaconess Medical Center, Boston, MA 531 Implementing Antimicrobial Stewardship Through a Hospital-Nursing Home Partnership Christina B Felsen, MPH1, Gail Quinlan, RN, MS, CIC1, Elizabeth Dodds Ashley, PharmD, MHS2 and Ghinwa Dumyati, MD, FSHEA1, (1)University of Rochester Medical Center - Center for Community Health, Rochester, NY, (2)Duke University, Durham, NC 532 Practical Considerations When Creating a Weighted Incidence Syndromic Combination Antibiogram (WISCA) Courtney Hebert, MD1, Protiva Rahman1, Erinn Hade, PhD1, Karri Bauer2, Mark Lustberg, MD, PhD2, Preeti Pancholi, PhD2, Albert Lai, PhD1, Arka Pattanayak1, Po-Yin Yen, RN, PhD1 and Kurt Stevenson, MD2, (1)The Ohio State University, Columbus, OH, (2)The Ohio State University Wexner Medical Center, Columbus, OH 534 Clinical Guideline Adherence for Asymptomatic Bacteriuria in Spinal Cord Injury Felicia Skelton, MD1,2, Larissa Grigoryan, MD, PhD2, Jun Ying, MS1, Sally Ann Holmes, MD2,3 and Barbara Trautner, MD, PhD1,2, (1)Center for Innovations in Quality, Effectiveness and Safety, Houston, TX, (2) Baylor College of Medicine, Houston, TX, (3)Michael E. DeBakey VA Medical Center, Houston, TX SCIENCE GUIDING PREVENTION 41 POSTER PRESENTATIONS: FRIDAY, MAY 20 SCIENTIFIC POSTER PRESENTATIONS: FRIDAY, MAY 20 SCIENTIFIC PROGRAM 535 What Drives Inappropriate Antibiotic Dispensing? Pharmacist Perspectives in Haryana, India Anna Barker, BA1, Kelli Verhoeven, MPH1, Md Muneeb Ahsan, MSc, B Pharm2, Sazid Alam, MSc, DMLT2, Sharmila Sengupta, MBBS, MD2 and Nasia Safdar, MD, PhD3, (1)Department of Population Health Sciences, School of Medicine and Public Health, University of Wisconsin, Madison, WI, (2)Medanta the Medicity Hospital, Gurgaon, India, (3)University of Wisconsin School of Medicine & Public Health, Madison, WI 536 A Retrospective Case-Control Study to Identify Risk Factors Associated With Clostridium difficile in a Teaching Hospital in Saudi Arabia Nabeela Al-Abdullah, PhD, King Abdulaziz University, Jeddah, Saudi Arabia 537 Gastric Acid Altering Medications as a Risk for Clostridium difficile Infection Kerrie VerLee, MPH, CIC, Chau Nguyen, MS and Donald J Scott, BS, PharmD, Spectrum Health, Grand Rapids, MI SCHEDULE 544 Oral Beta-Lactamase Therapy to Prevent AntibioticInduced Disruption of the Gut Microbiome Klaus Gotlieb, MD, Amy Sloan, John Andrew Bristol, PhD, Steven Hubert, Olivia Coughlin, John Kokai-Kun, PhD, Heidi Whalen, Tracey Roberts, Michael Schlosser, PhD, Sheila Connelly, PhD, Michael Kaleko, MD, PhD and Joseph Sliman, MD, Synthetic Biologics, Inc., Rockville, MD 545 Effect of EMR-Based Intervention on Clostridium difficile Standardized Infection Ratio Raagini Jawa, MD MPH1, Deb Gregson, MSM2, Robert Burke, RN, MA, CIC3, Pooja Phull, MD1, Matthew Bradley4, Kelly Fleming4, Katherine Scanlon, RN5, Nancy Miller, MD6 and Cassandra Pierre, MD, MSc3,7, (1)Internal Medicine, Boston Medical Center, Boston, MA, (2)Quality & Patient Safety, Boston Medical Center, Boston, MA, (3)Epidemiology, Boston Medical Center, Boston, MA, (4)Information Technology Services, Boston Medical Center, Boston, MA, (5)Nursing, Boston Medical Center, Boston, MA, (6)Laboratory Medicine, Boston Medical Center, Boston, MA, (7)Infectious Diseases, Boston University School of Medicine, Boston, MA 538 Reducing Inappropriate C. difficile Testing Using an Electronic Laxative Alert 547 Benefits of Clostridium difficile Polymerase Chain Reaction Screening Followed by Toxin Confirmation 539 Correlation between RT-PCR Cycle Threshold and Clostridium difficile Infection (CDI) Outcomes 548 Time to Specimen Receipt Not Associated with Increased Likelihood of Detecting Clostridium difficile Stephen C Eppes, MD1, Sharon Kleban, MA2 and Marci Drees, MD, MS1, (1)Christiana Care Health System, Newark, DE, (2)Christiana Care Health System, New Castle, DE Byungwoo Choi, MD1, Ken Koon Wong, MD1, Abhishek Deshpande, MD PhD1,2, Thomas G. Fraser, MD3, Gary W. Procop, MD4, Sandra S. Richter, MD4 and Carlos M. Isada, MD1, (1) Department of Infectious Diseases, Medicine Institute, Cleveland Clinic, Cleveland, OH, (2)Medicine Institute Center for Value Based Care Research, Cleveland Clinic, Cleveland, OH, (3)Department of Infectious Diseases, Cleveland Clinic, Cleveland, OH, (4)Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH 540 Fecal Microbiota Transplantation by Freeze-Dried Oral Capsules for Recurrent CDI Michelle T. Hecker, MD1,2, Mark Obrenovich, PhD3, Jennifer Cadnum, BS1,4, Annette Jencson, BSMT, CIC3, Alok K. Jain, MD1,2, Edith Ho, MD1,3 and Curtis J. Donskey, MD1,4, (1)Case Western Reserve University, Cleveland, OH, (2)MetroHealth Medical Center, Cleveland, OH, (3)Cleveland VA Medical Center, Cleveland, OH, (4) Geriatric Research Education and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH 541 Risk of Clostridium difficile Infection in Patients Colonized With Toxigenic C. difficile Cara M Cannon, University of Wisconsin Hospital, Madison, WI University of Wisconsin School of Medicine, Madison, WI 542 Identifying Barriers and Facilitators to CDI Prevention: Nursing and Patient-Related Factors Caitlyn Ngam, MPH1, Nasia Safdar, MD, PhD2,3, Ann Hundt, PhD4, Pascale Carayon, PhD4 and Nicholas Haun, MD1, (1)University of Wisconsin School of Medicine and Public Health, Madison, WI, (2)The William S. Middleton Veterans Affairs Medical Center, Madison, WI, (3) University of Wisconsin School of Medicine & Public Health, Madison, WI, (4)University of Wisconsin-Madison College of Engineering Center for Quality & Productivity Improvement, Madison, WI 543 Cost-effectiveness Analysis of Treatment Strategies for C. difficile infection: a Systematic Review Phuc Le, MPH, PhD1, Van T Nghiem, MSPH2, Michael B Rothberg, MPH, MD1 and Abhishek Deshpande, MD PhD1,3, (1)Medicine Institute Center for Value Based Care Research, Cleveland Clinic, Cleveland, OH, (2)Center for Health Promotion and Prevention Research, The University of Texas School of Public Health, Houston, TX, (3)Department of Infectious Diseases, Cleveland Clinic, Cleveland, OH Philip A. Robinson, MD, Barbara Goss-Bottorff, MPH, MSN, William Griffith, CLS, MT(ASCP) and Sherry Etoch, CLS, MT(ASCP), Hoag Memorial Hospital Presbyterian, Newport Beach, CA Andrew J Barros, MD, Kyle Enfield, MD, MS and Costi Sifri, MD, University of Virginia Health System, Charlottesville, VA 549 A Cross-Sectional Survey of Clostridium difficile Diagnostic Testing and Management in India Anubhav Kanwar, MBBS1 and Curtis J. Donskey, MD2,3, (1)University Hospitals Case Medical Center, Cleveland, OH, (2)Case Western Reserve University, Cleveland, OH, (3)Geriatric Research Education and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH 550 Rotating Mini-Cohorts of Hospitalized Patients with Clostridium difficile Infection Lisa Saidel-Odes, MD1, Gal Ifergane, MD1, Ronit Nativ, RN, MPH2, Seada Eskira, RN, MPH2, Batya Shterer, RN, MA2, Alex Goshansky, RN, MA2, Lea Cohen, BSN, MHA2 and Abraham Borer, MD1, (1) Soroka University Medical Center and Ben-Gurion University of the Negev, Beer-Sheva, Israel, (2)Soroka University Medical Center, Beer-Sheva, Israel 551 Efficacy of Two Hand Hygiene Methods for Clostridium difficile Spore Removal Caroline Zellmer1, Megan Duster, MT2, Marc Oliver Wright, MT, MS3 and Nasia Safdar, MD, PhD4,5, (1)William S. Middleton Veterans Hospital, and Section of Infectious Diseases, Department of Medicine and Department of Infection Control, University of Wisconsin, Madison, WI, Madison, WI, (2)School of Medicine and Public Health, University of Wisconsin, Madison, WI, (3)University of Wisconsin Hospital and Clinics, Infection Control, Madison, WI, (4)The William S. Middleton Veterans Affairs Medical Center, Madison, WI, (5)University of Wisconsin School of Medicine & Public Health, Madison, WI 552 Successful Implementation of Rectal Route Fecal Microbiota Transplantation (FMT) in High Risk Patient Suganya Chandramohan, MD1, Pranatharthi Chandrasekar, MD2, Bicky Thapa, MD2, Babbaljeet Kaur2 and Teena Chopra, MD, MPH2, (1)Wayne State University,Department of Infectious disease, Detroit, MI, (2)Detroit Medical Center, Wayne State University, Detroit, MI Top Poster Abstract 42 SHEA Spring 2016 Conference PROGRAM 553 Persistence of Clostridium difficile Colonization in Long-Term Care Facility Residents Venkata Sunkesula, MD, MS1,2, Sirisha Kundrapu, MD, MS1,2 and Curtis Donskey, MD3, (1)Case Western Reserve University, Cleveland, OH, (2)Cleveland VA Medical Center, Cleveland, OH, (3) Geriatric Research, Education, and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH 554 Investigating the Relationship between Hospital and Nursing Home C. difficile Infection Rates Ghinwa Dumyati, MD, FSHEA1, Rebecca Tsay, MPH2, Deborah Nelson, MSN RN2, Anita Gellert, RN2, Gail Quinlan, RN, MS, CIC1 and Dwight Hardy, PhD3, (1)University of Rochester Medical Center - Center for Community Health, Rochester, NY, (2)University of Rochester, Rochester, NY, (3)University of Rochester Medical Center, Microbiology & Immunology, Rochester, NY 556 Hospital-Onset Clostridium difficile Clusters: Are Index Cases Hospital Onset or Community Onset? J Bradford Bertumen, MD1,2 and Christopher W. Woods, MD1,2, (1) Durham VA Medical Center, Durham, NC, (2)Duke University Medical Center, Durham, NC 557 Results of a Pilot Screening Program for Clostridium difficile among Inpatients Jessica P Ridgway, MD, MS, Cynthia Murillo, M(ASCP), CIC, Sylvia Garcia-Houchins, RN, MBA CIC, Rachel Marrs, MSN, RN CIC, Kathleen G Beavis, MD, Angella Charnot-Katsikas, MD, Vera Tesic, MD, Allison Bartlett, MD, MS and Emily Landon, MD, University of Chicago, Chicago, IL 558 Time for a Patient-Centered Approach to Clostridium difficile Infections Megan E. Meller, MS1,2, Daniel M. Bolt, PhD1, Bruce P. Barrett, MD, Phd1,2, Ajay K. Sethi, Phd, MHS1 and Nasia Safdar, MD, PhD3,4, (1) University of Wisconsin-Madison, Madison, WI, (2)University of Wisconsin Hospitals and Clinics, Madison, WI, (3)The William S. Middleton Veterans Affairs Medical Center, Madison, WI, (4)University of Wisconsin School of Medicine & Public Health, Madison, WI 559 Colonization and Atb Exposure as Time Dependent Factors in Development of C.difficile Colitis Javeria Haque, MD1, Rossana Rosa, MD2, Nathan A Ledeboer, PhD3, Laura Michaelis, MD4, Mary Beth Graham, MD1, Parameswaran Hari, MD, MRCP, MS4, Tami-Lea Mackey3, Kelly Acker5, Ricka Long5, Njeri Wainaina, MD1, Sara L Revolinski, PharmD5, Bronwen Shaw, MD, PhD4, Mary Horowitz, MD, MS4 and L. Silvia MunozPrice, MD, PhD1, (1)Division of Infectious Diseases, Medical College of Wisconsin, Milwaukee, WI, (2)Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, FL, (3) Department of Pathology, Medical College of Wisconsin, Milwaukee, WI, (4)Department of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, (5)Froedtert Hospital, Medical College of Wisconsin, Milwaukee, WI 560 Discordance in CLSI Standards Amongst the Carbapenem Producing Enterobacteriaceae David R. Woodard, MSc1, Fidelis Uzoma Enyinnaya, MPH1,2, Mark P. Buttner, PhD1, Patricia Cruz, PhD1 and Chad Cross, PhD3, (1)University of Nevada, Las Vegas, Las Vegas, NV, (2)Le Moyne College, Syracuse, NY, (3)PaLS-Mathemetics, Nevada State College, Henderson, NV 561 How Well Does Transfer Of Bacterial Pathogens by Culture Swabs Correlate With Transfer by Hands? Anubhav Kanwar, MBBS1, Jennifer Cadnum, BS2,3, Heba Alhmidi, MD4, Sreelatha Koganti, MD4 and Curtis J. Donskey, MD2,3, (1)University Hospitals Case Medical Center, Cleveland, OH, (2) Geriatric Research Education and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (3)Case Western Reserve University, Cleveland, OH, (4)Louis Stokes Cleveland VA Medical Center, Cleveland, OH SCHEDULE 562 Current Epidemiology, Risk Factors and Outcomes of Non-albicans Candidemia at a Tertiary-care Center Woo Jeong Choi, MD1, Odaliz Abreu-Lanfranco, MD1, Linoj Samuel, PhD1, Robert Tibbetts, PhD1, Norman Markowitz, MD1, Marcus Zervos, MD1,2 and George Alangaden, MD1,2, (1)Henry Ford Health System, Detroit, MI, (2)Wayne State University, Detroit, MI 563 Impact of a Testing Algorithm in the Evaluation of Diarrhea in Hospitalized Patients Chad Tewell, M.D.1, James Chappell, M.D., Ph.D.1, Bryan D Harris, MD1, Whitney Jones, PharmD1, George E Nelson, MD1, Thomas Talbot III, MD, MPH2 and Patty W Wright, MD1, (1)Vanderbilt University School of Medicine, Nashville, TN, (2)Vanderbilt University Medical Center, Nashville, TN 564 Survival of Healthcare-Associated Pathogens on Dry Versus Moist Surfaces Jennifer L. Cadnum, BS1,2 and Curtis J. Donskey, MD1,2, (1)Case Western Reserve University, Cleveland, OH, (2)Geriatric Research Education and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH 565 Blogging in Infectious Diseases and Clinical Microbiology: Assessment of the ‘Blogosphere’ Content Rachael E Troughton, MSc, Gabriel Birgand, PharmD, PhD, Luke SP Moore, MBChB, MRCP, FRCPath, MSc, MPH, DTM&H, Enrique Castro-Sanchez, PhD, MPH, RGN, DipTropNurs, PgDip, DLSHTM, Esmita Charani, MSc, Timothy M Rawson, MBBS, BSc, PgD MedEd and Alison Holmes, MA, MD, MPH, FRCP, Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, United Kingdom 566 A Low-Cost Method for Diagnosis of Clostridium difficile Infection in the Developing World Jennifer L. Cadnum, BS1,2, Annette Jencson, BSMT, CIC3, Michelle Nerandzic, BS3, Anubhav Kanwar, MBBS4 and Curtis J. Donskey, MD1,2, (1)Case Western Reserve University, Cleveland, OH, (2)Geriatric Research Education and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (3)Cleveland VA Medical Center, Cleveland, OH, (4)University Hospitals Case Medical Center, Cleveland, OH 567 Comparing ESwab™ and RODAC™ Plates for Detection of Multidrug-Resistant Organisms (MDRO) on Surfaces Koh Okamoto, MD1, Yoona Rhee, MD, ScM1, Michael Schoeny, PhD1, Karen Lolans, BS1, Jennifer Cheng, MD1, Shivani Reddy, MD1, Efrain Salzar1, Melanie Carr1, Patricia Mangan1, Grace McIlroy1, Robert A Weinstein, MD1,2, Mary K. Hayden, MD1 and Kyle J Popovich, MD MS1,2, (1)Rush University Medical Center, Chicago, IL, (2)Cook County Health and Hospitals System, Chicago, IL 568 A “Virtual Clinic” Improves Pneumococcal Vaccinations Among Patients With HIV at a VA Medical Center Richard Banks, AS1, Brigid Wilson, PhD1, Rebecca Carter, BA2, Michelle Montpetite, MBA1, Federico Perez, MD1,2 and Robin Jump, MD, PhD1,2, (1)Louis Stokes Cleveland Veterans Aff Med Ctr, Cleveland, OH, (2)Case Western Reserve University, Cleveland, OH 569 Comparison of 2% Chlorhexidine Gluconate (CHG)Impregnated Cloth vs. 4% Liquid Cleansing Yoona Rhee, MD, ScM1, Koh Okamoto, MD1, Sarah K. Kemble, MD1,2, Karen Lolans, BS1, Michael Lin, MD, MPH1, Louis Fogg, PhD1, Robert A. Weinstein, MD1,3 and Mary K. Hayden, MD1, (1) Rush University Medical Center, Chicago, IL, (2)Chicago Department of Public Health, Chicago, IL, (3)Cook County Health and Hospitals System, Chicago, IL SCIENCE GUIDING PREVENTION 43 POSTER PRESENTATIONS: FRIDAY, MAY 20 SCIENTIFIC PROGRAM 570 The Role of Ethnography in Preventing HealthcareAssociated Infections: A Narrative Review Nasia Safdar, MD, PhD1,2, Kevin Thomas3 and Mary Jo Knobloch, MPH4,5, (1)The William S. Middleton Veterans Affairs Medical Center, Madison, WI, (2)University of Wisconsin School of Medicine & Public Health, Madison, WI, (3)Washington University, St. Louis, MO, (4) University of Wisconsin, Madison, WI, (5)William S. Middleton Memorial Veterans Hospital, Madison, WI 571 Using National Healthcare Safety Network Data to Select Hospitals for Infection Control Assessments Gwendolyn D. Holman, MPH, Ashley Fell, MPH, Katherine Buechel, BSN CIC, Karen Toungett, RN BSN and Marion A. Kainer, MD, MPH, Tennessee Department of Health, Nashville, TN 573 Exploring Implementation in Infection Prevention: the Novel Use of Normalisation Process Theory Lisa Hall, PhD1, Brett G. Mitchell, RN, PhD2, Sally M. Havers, RN, MPH1, Monika Pogorzelska-Maziarz, MPH, PhD3, Anne Gardner, RN, PhD4 and Patricia W. Stone, RN, PhD5, (1)Queensland University of Technology, Brisbane, Qld, Australia, (2)Avondale College of Higher Education, Sydney, NSW, Australia, (3)Thomas Jefferson University, Philadelphia, PA, (4)Australian Catholic University, ACT, Australia, (5) Columbia University, New York, NY 574 Sustainability of Daily Chlorhexidine Bathing in the Intensive Care Unit of a Veterans Hospital Jackson Musuuza, MD, MPH, MS1, Nasia Safdar, MD, PhD2,3 and Tonya Roberts, PhD, RN4, (1)Institute for Clinical and Translational Research, University of Wisconsin, Madison, WI, (2)The William S. Middleton Veterans Affairs Medical Center, Madison, WI, (3)University of Wisconsin School of Medicine & Public Health, Madison, WI, (4) School of Nursing, University of Wisconsin-Madison, Madison, WI 575 Use of an Interferon-gamma Release Assay for Tuberculosis Screening in a Children’s Hospital System Amelia B. Thompson, MD, MPH1, Nikki Mattick, RN2, Trisha E. Hardy, MPH, RD2, Nancy E. Lloyd, MS, RN2 and Andi Shane, MD, MPH, MSc1,2, (1)Emory University School of Medicine, Atlanta, GA, (2) Children’s Healthcare of Atlanta, Atlanta, GA 576 Acceptability and Necessity of Training for Optimal Personal Protective Equipment (PPE) Use Michelle Doll, MD1, Moshe Feldman, PhD2, Sarah Hartigan, MD1,2, Kakotan Sanogo, MS1, Mike Stevens, MD, MPH1,2, Myriah McReynolds, BS1, Nadia Masroor, BS1, Kaila Cooper, MSN, RN, CIC1 and Gonzalo Bearman, MD, MPH1,2, (1)VCU Health, Richmond, VA, (2)Virginia Commonwealth University School of Medicine, Richmond, VA 578 Impact of Cross-Coverage on Antibiotic Prescribing in Nursing Homes Miranda McElligott, MS, BSN1, Christopher Crnich, MD, PhD2,3, Ajay K. Sethi4, Mari Palta, PhD1 and Mozhdeh Bahrainian, MS2, (1) University of Wisconsin - Madison, Madison, WI, (2)University of Wisconsin School of Medicine & Public Health, Madison, WI, (3) William S. Middleton Memorial VA Hospital, Madison, WI, (4)University of Wisconsin-Madison, Madison, WI 580 An Outbreak of Pseudomonas aeruginosa from the tracheal aspirates in the NICU of a tertiary hospital Nimfa L. Dagunton, BSN, RN1, Dr. Saif Al Saif, MD1, Noura Shami, Diploma in Nursing2, Marissa Alarcon, BSN, RN1, Joseph Tannous, BSMT1 and Dr. Hanan Balkhy, MD1, (1)King Abdulaziz Medical City Ministry of National Guard, Riyadh, Saudi Arabia, (2)King Abdulaziz Medical City Ministry of National Guard, Riyadh, Saudi Arabia 581 Risk Factors for Carbapenem Resistance in Klebsiella pneumoniae Bloodstream Infection Gregory Weston, MD1 and Belinda Ostrowsky, MD, MPH2, (1)Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, (2)Montefiore Medical Center, Bronx, NY 44 SHEA Spring 2016 Conference SCHEDULE 582 The Influence of Hospital-Onset Escherichia coli Bacteremia and Multidrug-Resistant Phenotype on Mor POSTER PRESENTATIONS: FRIDAY, MAY 20 POSTER PRESENTATIONS: FRIDAY, MAY 20 SCIENTIFIC Michihiko Goto, MD, MSCI1,2, Daniel Livorsi, MD, MSc3,4, Makoto Jones, MD, MS5,6, Jennifer McDanel, PhD1,2, Rajeshwari Nair, MBBS, PhD1,2, Bruce Alexander, PharmD1, Brice F Beck, MA1, Kelly K Richardson, PhD1 and Eli Perencevich, MD, MS1,2, (1)Iowa City VA Medical Center, Iowa City, IA, (2)University of Iowa Carver College of Medicine, Iowa City, IA, (3)University of Iowa Hospitals & Clinics, Iowa City, IA, (4)Iowa City VAMC, Iowa City, IA, (5)Salt Lake City VA Medical Center, Salt Lake City, UT, (6)University of Utah, Salt Lake City, UT 583 Phenotypic Confirmatory of extended-spectrum β-lactamases (ESBLs) production in Enterobacteriacea Sujan Babu Marahatta, Ph.D1, PR Khanal, M.Sc2 and P Maharjan, B.Sc3, (1)Manmohan Memorial Medical College and Teaching Hospital, Kathmandu, Nepal, (2)Manmohan Memorial Institute of health Sciences, Kathmandu, Nepal, (3)Manmohan Memorial Institute of Health Sciences, Kathmandu, Nepal 584 Severe Infections Caused by Multidrug-Resistant NonFermentative Bacilli in Southern Poland Jadwiga Wojkowska-Mach, dr1, Agnieszka Chmielarczyk2, Monika Pobiega2, Grzegorz Ziolkowski3, Monika Pomorska-Wesolowska4 and Dorota Romaniszyn2, (1)Jagiellonian University Medical School, Krakow, POLAND, (2)Chair of Microbiology Jagiellonian University Medical College, Kraków, Poland, (3)Higher School of Medicine in Sosnowie, Sosnowiec, Poland, (4)Department of Microbiology, Analytical and Microbiological Laboratory of Ruda Slaska, KORLAB NZOZ, Ruda Slaska, Poland 585 Effectiveness of Daily Chlorhexidine Bathing for Reducing Gram-negative Infections: a Meta-analysis Abhishek Deshpande, MD PhD1,2, Aditi Patel, MD1, Parth Parikh, MD1, Jon Otter, PhD3, Priyaleela Thota, MD4, Curtis J. Donskey, MD5,6 and Thomas G. Fraser, MD2, (1)Medicine Institute Center for Value Based Care Research, Cleveland Clinic, Cleveland, OH, (2)Department of Infectious Diseases, Cleveland Clinic, Cleveland, OH, (3)Imperial College Healthcare NHS Trust, London, United Kingdom, (4)Vancive Medical Technologies, Avery Dennison Business, Mentor, OH, (5)Geriatric Research, Education, and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (6) Case Western Reserve University, Cleveland, OH 586 Hypervirulent Hypermucoviscous CarbapenemResistant K. pneumoniae: An Infection Prevention Challenge Melanie S Curless, RN MPH CIC1, Patricia J Simner, PhD, D(ABMM)2, Jennifer Andonian, MPH1, Donna Fellerman, RN, BA, CIC1, Karen C Carroll, MD2, Lisa L K Maragakis, MD, MPH3 and Clare Rock, MD, MS3, (1)The Johns Hopkins Hospital, Baltimore, MD, (2)School of Medicine, Division of Medical Microbiology, Johns Hopkins University, Baltimore, MD, (3)Department of Medicine, Division of Infectious Diseases, Johns Hopkins University, Baltimore, MD 587 Increasing Resistance Among Gram-Negative Bacteria in Veterans with Spinal Cord Injury Margaret Fitzpatrick, MD, MS1,2, Katie J. Suda, PharmD, MS1,3, Stephen Burns, MD4, Makoto Jones, MD, MS5,6, Linda Poggensee, MS1, Swetha Ramanathan, MPH1 and Charlesnika T. Evans, PhD, MPH1,7, (1)VA Center of Innovation for Complex Chronic Healthcare, Hines, IL, (2)Loyola University, Maywood, IL, (3)University of Illinois at Chicago, Chicago, IL, (4)VA Puget Sound Health Care System, Seattle, WA, (5)Salt Lake City VA Medical Center, Salt Lake City, UT, (6)University of Utah, Salt Lake City, UT, (7)Northwestern University, Chicago, IL 589 Control of a Novel Extended-spectrum β-lactamase (ESBL) Salmonella Isangi Outbreak Geehan Suleyman, MD1, Eman Chami, BS, MHA1, Patricia Starr, RN, MPH, CIC1, Jennifer Pietsch, RN, MSN1, Katherine Reyes, MD, MPH1, Marcus Zervos, MD1,2 and George Alangaden, MD1,2, (1)Henry Ford Health System, Detroit, MI, (2)Wayne State University, Detroit, MI PROGRAM 590 Nosocomial Outbreak of a Novel Extended-spectrum β-lactamase-producing Salmonella Isangi Geehan Suleyman, MD1, Robert Tibbetts, PhD1, Mary Perri, BS1, Dora Vager, MLT1, Linoj Samuel, PhD1, Yuan Xin, MPH1, Eman Chami, BS, MHA1, Patricia Starr, RN, MPH, CIC1, Jennifer Pietsch, RN, MSN1, Katherine Reyes, MD, MPH1, Marcus Zervos, MD1,2 and George Alangaden, MD1,2, (1)Henry Ford Health System, Detroit, MI, (2)Wayne State University, Detroit, MI 591 Characterization of Salmonella Isangi Possessing CTX-M15 ESBL Associated with an Outbreak in a US Hospital Geehan Suleyman, MD1, Mary Perri, BS1, Dora Vager, MLT1, Linoj Samuel, PhD1, Marcus Zervos, MD1,2, George Alangaden, MD1,2 and Robert Tibbetts, PhD1, (1)Henry Ford Health System, Detroit, MI, (2) Wayne State University, Detroit, MI 592 Citrobacter freundii blaKPC Producer Outbreak at a Tertiary Acute Care Facility in Miami, FL Adriana Jimenez, MPH, BSMT.1,2, Jose Guillermo Castro, MD.3, Yohei Doi, MD, PhD.4, Luis Shimose, MD.5, Dennise De Pascale, BSMT.1 and Caressa Spychala, BS.4, (1)Jackson Memorial Hospital Department of Infection Prevention and Control, Miami, FL, (2)Florida International University Robert Stempel College of Public Health & Social Work, Miami, FL, (3)Division of Infectious Diseases University of Miami Miller School of Medicine, Miami, FL, (4)University of Pittsburgh, Pittsburgh, PA, (5)University of Miami Miller School of Medicine, Miami, FL 593 Use of Antibiotics with Activity Against CarbapenemResistant Enterobacteriaceae in Pediatrics Kathleen Chiotos, MD1,2, Rachael K. Ross, MPH2, Jeffrey S. Gerber, MD, PhD1,2,3, Matthew Miller, BS2 and Jennifer Han, MD, MSCE3,4, (1)Division of Infectious Diseases, The Children’s Hospital of Philadelphia, Philadelphia, PA, (2)Center for Pediatric Clinical Effectiveness, The Children’s Hospital of Philadelphia, Philadelphia, PA, (3)Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, (4) Division of Infectious Diseases, Department of Medicine, Perelman University School of Medicine, Philadelphia, PA 594 Surveillance and Inter-Facility Communication for Carbapenem-Resistant Enterobacteriaceae (CRE) Julie Kim, BS, John Segreti, MD, Alexander Tomich, DNP, RN, CIC, Chawat Tongma, MD, Mary K. Hayden, MD and Michael Y. Lin, MD, MPH, Rush University Medical Center, Chicago, IL 595 A Contaminated Ice Machine as a Potential Source for Transmission of Carbapenem-Resistant Acenitobac Anubhav Kanwar, MBBS1, T Nicholas Domitrovic, BA2,3, Sreelatha Koganti, MD4, Peter Fuldauer, BSMT3, Jennifer Cadnum, BS5, Robert A. Bonomo, MD6 and Curtis Donskey, MD6, (1)University Hospitals Case Medical Center, Cleveland, OH, (2)Case Western Reserve University, Cleveland, OH, (3)Cleveland VA Medical Center, Cleveland, OH, (4)Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (5)Geriatric Research Education and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (6)Geriatric Research, Education, and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH 596 Emergence of Community-Onset Multi-Resistant E.coli ST131 Bloodstream Infections in Singapore Yin Mo, MBBS1, Patrick N A Harris, MBBS, FRACP2, Roland Jureen, PhD1, Paul Tambyah, MBBS, MD1, David Lye, MBBS, FRACP3 and David L. Paterson, MD, PhD2, (1)National University Hospital, Singapore, Singapore, (2)University of Queensland Centre for Clinical Research, Brisbane, Australia, (3)Tan Tock Seng Hospital, Singapore, Singapore SCHEDULE 597 Surveillance for CRE Colonization Yields Detection of Unexpected Resistance Patterns Rebecca Linfield, Medical Student1, Shelley Miller, PhD1, Patil Injean, Medical Student1, Aric Gregson, MD1, Fady Kaldas, MD1, Zachary Rubin, MD1, Tae Kim, MS, MPH1, Samantha J Eells, PhD1, Romney Humphries, PhD1 and James A McKinnell, MD2, (1)David Geffen School of Medicine at UCLA, Los Angeles, CA, (2)Infectious Disease Clinical Outcomes Research Unit (ID-CORE), Division of Infectious Disease, Los Angeles Biomedical Research Institute at Harbor-University of California Los Angeles (UCLA) Medical Center, Torrance, CA 598 Risk Factors for Invasive Infection with CarbapenemResistant Enterobacteriaceae (CRE) Mary Elizabeth Sexton, MD1,2, Christopher Bower, MPH2,3,4 and Jesse Jacob, MD1,2, (1)Emory University School of Medicine, Division of Infectious Diseases, Atlanta, GA, (2)Georgia Emerging Infections Program, Decatur, GA, (3)Atlanta Veterans Affairs Medical Center, Decatur, GA, (4)Atlanta Research and Education Foundation, Atlanta, GA 599 Risk Factors of Acquiring Carbapenem-Resistant Acinetobacter Baumannii (CRAb): A Prospective Study Norihisa Yamamoto, MD1, Shigeto Hamaguchi, MD, PhD1, Yukihiro Akeda, PhD1, Pitak Santanirand, PhD2, Kumthorn Malathum, MD2 and Kazunori Tomono, MD, PhD1, (1)Osaka University Graduate School of Medicine, Suita, Japan, (2)Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand 600 Alarming Rates of Co-Colonization With MDROS Among Patients With CRE Carriage Kamaljit Singh, MD1, Kody Wyant1, Kathy A Mangold, PhD2, Donna Schora, MT2 and Lance Peterson, MD2, (1)Rush University Medical Center, Chicago, IL, (2)NorthShore University HealthSystem, Evanston, IL 12:00 – 1:00 p.m. 7th Floor: Augusta Room 601 Treatment Duration for Uncomplicated MethicillinResistant Staphylococcus aureus Bacteremia Khulood Rizvi, MD1, Ana C Bardossy, MD2, Daniela Moreno, BS3, Pamela Hartman, BS3, Mary Perri, BS2, Mahan Meredith, MS1 and Marcus Zervos, MD2, (1)Henry Ford hospital, Detroit, MI, (2)Henry Ford Health System, Detroit, MI, (3)Henry Ford Hospital, Detroit, MI 602 Longevity and Hospitalization as a Risk Factor of MRSA Infections in Southern Poland Jadwiga Wojkowska-Mach, dr1, Joanna Natkaniec2, Monika Pobiega2, Monika Pomorska-Wesolowska3, Barbara Gryglewska, PhD4, Anna Rozanska, PhD2, Dorota Romaniszyn2 and Agnieszka Chmielarczyk2, (1)Jagiellonian University Medical School, Krakow, POLAND, (2)Chair of Microbiology Jagiellonian University Medical College, Kraków, Poland, (3)Department of Microbiology, Analytical and Microbiological Laboratory of Ruda Slaska, KORLAB NZOZ, Ruda Slaska, Poland, (4)Jagiellonian University Medical School, Kraków, Poland 603 Risk Factors Associated with VRE and MRSA Colonization Helina M Misikir, MPH1, Ana C Bardossy, MD1, Pamela Hartman, BS1, Daniela Moreno, BS1, Geehan Suleyman, MD2, Mary Perri, BS2, Katherine Reyes, MD, MPH1 and Marcus Zervos, MD1,3, (1)Henry Ford Hospital, Detroit, MI, (2)Henry Ford Health System, Detroit, MI, (3) Wayne State University, Detroit, MI Top Poster Abstract SCIENCE GUIDING PREVENTION 45 POSTER PRESENTATIONS: FRIDAY, MAY 20 SCIENTIFIC POSTER PRESENTATIONS: FRIDAY, MAY 20 SCIENTIFIC PROGRAM 604 Incidence and Outcomes Associated with Methicillinresistant Staphylococcus aureus Infections Rajeshwari Nair, MBBS, PhD1,2, Eli N Perencevich, MD, MS1,2,3, Hsiu-Yin Chiang, PhD, MS2, Stacey M Hockett Sherlock, MAA1,2, Erin C Balkenende, MPH1,2, Jennifer S McDanel, PhD1,2,3, Richard E Nelson, PhD4,5, Matthew H Samore, MD4,5, Karim Khader, PhD5, Amy E Blevins, MALS6, Melissa A Ward, MS2 and Marin L Schweizer, PhD1,2,3, (1)Iowa City VA Medical Center, Iowa City, IA, (2)University of Iowa Carver College of Medicine, Iowa City, IA, (3)Department of Epidemiology, University of Iowa College of Public Health, Iowa City, IA, (4)VA Salt Lake City Health Care System IDEAS Center, Salt Lake City, UT, (5)University of Utah School of Medicine, Salt Lake City, UT, (6)Ruth Lilly Medical Library, Indiana University School of Medicine, Indianapolis, IN 605 Impact of Active MRSA Surveillance on Vancomycin Use Among Inpatients Carlos Acuna-Villaorduna, MD1,2, Judith Strymish, MD2,3 and Kalpana Gupta, MD, MPH4, (1)Boston Medical Center, Boston, MA, (2)VA Boston HCS, West Roxbury, MA, (3)Harvard Medical School, Boston, MA, (4)VA Boston and Boston University School of Medicine, West Roxbury, MA 606 Beliefs and Emotional Response of Patients Colonised With MRSA Toney Poovelikunnel Thomas, PG DipIC. MBA.1, Georgina Gethin, Dr2, Mary Codd, Dr3 and Hilary Humphreys, MD4, (1)Royal College of Surgeons Ireland, Dublin, Ireland, (2)National University of Ireland, Galway, Galway, Ireland, (3)UCD-CSTAR, School of Public Health, Physiotherapy & Sports Science, UCD, Dublin, Ireland, (4) Royal College of Surgeons of Ireland and Beaumont Hospital, Dublin, IRELAND 607 Comparison of Contact Precautions Based on MDRO Status vs. Transmission Risk in a Community Hospital Emily J Cooper, RN, MS, CIC, WellSpan Health, York, PA 608 Perceptions and Use of Gowns and Gloves in Nursing Homes Jennifer S Albrecht, PhD, Lindsay D. Croft, MS, PhD, Daniel Morgan, MD, MS and Mary-Claire Roghmann, MD, MS, University of Maryland School of Medicine, Baltimore, MD 609 Universal Screening and Decolonization for Control of MRSA in Nursing Homes: Follow-up to a RCT Delphine Héquet, MD1, Valentin Rousson, PhD1, Dominique S. Blanc, PhD1, Christophe Büla, MD1, Laetitia Qalla-Widmer1, Eric Masserey, MD2, Giorgio Zanetti, MD, MS1 and Christiane Petignat, MD1, (1)University Hospital, Lausanne, Switzerland, (2)Public Health Canton Vaud, Lausanne, Switzerland SCHEDULE 611 Effect of Mupirocin Prophylaxis on Mupirocin Susceptibility in MRSA Isolates in a NICU Elizabeth Ristagno, MD1, Kristina Bryant, MD1, Lynette Boland, RNC, BSN, CIC2, Gordon Stout, BS1, Alan Junkins, PhD3, Charles Woods, MD, MS1 and Claudia Espinosa, MD, MSc1, (1)University of Louisville, Louisville, KY, (2)Kosair Children’s Hospital, Louisville, KY, (3) Norton Healthcare, Louisville, KY 612 Molecular Characterization of Staphylococcus aureus Strains Isolated From Surgical Site Jadwiga Wojkowska-Mach, dr1, Monika Pomorska-Wesolowska2, Katarzyna Małyszek3, Dorota Romaniszyn4, Monika Pobiega4, Anna Szczypta5, Agnieszka Chmielarczyk4 and Anna Rozanska, PhD4, (1)Jagiellonian University Medical School, Krakow, POLAND, (2) Department of Microbiology, Analytical and Microbiological Laboratory of Ruda Slaska, KORLAB NZOZ, Ruda Slaska, Poland, (3)Arcana Institute Ltd, Krakow, Poland, (4)Chair of Microbiology Jagiellonian University Medical College, Kraków, Poland, (5)Faculty of Health and Medical Science, Andrzej Frycz Modrzewski University, Kraków, Poland 613 Invasive USA100 vs USA300 Methicillin-Resistant Staphylococcus Aureus Infections in 5 states—2013 Isaac See1, Valerie Albrecht, MPH1, Joelle Nadle2, Wendy Bamberg, MD3, Susan Ray, MD4, Mackenzie Koeck, MPH5, Ruth Lynfield, MD5, Ghinwa Dumyati, MD6, William Schaffner, MD7 and Alexander J. Kallen, MD, MPH1, (1)Centers for Disease Control and Prevention, Atlanta, GA, (2)California Emerging Infections Program, Oakland, CA, (3)Colorado Department of Public Health & Enviroment, Denver, CO, (4)Emory University School of Medicine, Atlanta, GA, (5)Minnesota Department of Health, Saint Paul, MN, (6)University of Rochester, Department of Health, Rochester, NY, (7)Vanderbilt University School of Medicine, Nashville, TN 614 Using a Regional Approach to Combat the Spread of Antibiotic-Resistant Organisms Rebecca A. Meyer, MPH1, Shannon M. Harney, MPH2, Raphaelle H. Beard, MPH2 and Marion A. Kainer, MD, MPH2, (1)Tennessee Dept. of Health, Nashville, TN, (2)Tennessee Department of Health, Nashville, TN 615 Improved VRE Surveillance Detects Patients at Risk for Subsequent VRE Infection Rebecca Linfield, Medical Student1, Patil Injean, Medical Student1, Shelley Miller, PhD1, Fady Kaldas, MD1, Zachary Rubin, MD1, Tae Kim, MS, MPH1, Samantha J Eells, PhD1, Aric Gregson, MD1, Romney Humphries, PhD1 and James A McKinnell, MD2, (1)David Geffen School of Medicine at UCLA, Los Angeles, CA, (2)Infectious Disease Clinical Outcomes Research Unit (ID-CORE), Division of Infectious Disease, Los Angeles Biomedical Research Institute at Harbor-University of California Los Angeles (UCLA) Medical Center, Torrance, CA 616 The Impact of Discontinuing Routine Contact Precautions for Endemic MRSA and VRE on Adverse Events Elise M Martin, MD1, Brandy Bryant, MPH2, Dana Russell2, David Elashoff, PhD3, Romney Humphries, PhD1 and Daniel Uslan, MD1, (1)David Geffen School of Medicine at UCLA, Los Angeles, CA, (2) UCLA, Los Angeles, CA, (3)Department of Medicine Statistics Core, David Geffen School of Medicine at UCLA, Los Angeles, CA 617 Daptomycin and Linezolid Non Susceptible Vancomycin Resistant Enterococcus (DLVRE) Matthew H Greene, MD, Bryan D Harris, MD, Whitney Jones, PharmD, Marley A Linder, PharmD, Patty W Wright, MD, Thomas Talbot III, MD, MPH and George E Nelson, MD, Vanderbilt University School of Medicine, Nashville, TN Top Poster Abstract 46 SHEA Spring 2016 Conference PROGRAM 618 Methicillin Resistant Staphylococcus Aureus Nasal Carriage in Homeless Persons, Boston, MA Jessica H Leibler, DrPH1, Casey Leon2, Lena Cardoso2 and Jessie M. Gaeta, MD2,3, (1)Boston University School of Public Health, Boston, MA, (2)Boston Health Care for the Homeless Program, Boston, MA, (3)Boston University School of Medicine, Boston, MA 619 Beginning to See the Light: Simulation Effectively Identifies Safety Gaps in Ebola PPE Training Judith Guzman-Cottrill, DO, Molly Hale, MPH, CIC, Lauren Ogden, MPH and Jeffrey Gold, MD, Oregon Health and Science University, Portland, OR 620 Comparison of Two Interferon-Gamma Release Assays for Screening of Japanese Healthcare Workers Masaki Tanabe, MD, PhD, Akiko Nakamura, Akie Arai, RN, Daisuke Yamasaki, Pharm. D, Kyoko Hirano, Tetsu Kobayashi, MD, PhD, Osamu Taguchi, MD, PhD and Toshihiro Kaneko, MD, PhD, Mie University Hospital, Tsu, Japan 622 Effectiveness of Isolation Gowns in Reducing Clothing Contamination and Pathogen Transmission Heba Alhmidi, MD1, Sreelatha Koganti, MD1, Myreen E. Tomas, MD2, Jennifer Cadnum, BS2,3, Thriveen Sankar Chittoor Mana, MS, MBA3, Annette Jencson, BSMT, CIC4 and Curtis J. Donskey, MD2, (1)Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (2)Geriatric Research Education and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (3)Case Western Reserve University, Cleveland, OH, (4)Cleveland VA Medical Center, Cleveland, OH 623 Don’t forget the mask! Skin and Facemask Contamination due to Incorrect PPE Technique Sreelatha Koganti, MD1, Heba Alhmidi, MD1, Myreen E. Tomas, MD2, Jennifer Cadnum, BS2,3, Thriveen Sankar Chittoor Mana, MS, MBA3, Annette Jencson, BSMT, CIC4 and Curtis J. Donskey, MD2, (1)Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (2)Geriatric Research Education and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (3)Case Western Reserve University, Cleveland, OH, (4)Cleveland VA Medical Center, Cleveland, OH 624 Use of Fluorescent Lotion in Patient Care Simulations to Illustrate Pathogen Dissemination Heba Alhmidi, MD1, Sreelatha Koganti, MD1, Myreen E. Tomas, MD2, Jennifer Cadnum, BS2,3, Annette Jencson, BSMT, CIC4, Thriveen Sankar Chittoor Mana, MS, MBA3 and Curtis J. Donskey, MD2,3, (1)Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (2) Geriatric Research Education and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (3)Case Western Reserve University, Cleveland, OH, (4)Cleveland VA Medical Center, Cleveland, OH 625 Predictors of Healthcare Personnel SelfContamination During Removal of PPE Myreen E. Tomas, MD1, Sirisha Kundrapu, MD, MS2,3, Priyaleela Thota, MD3, Venkata Sunkesula, MD, MS2,3, Jennifer Cadnum, BS1,2, Thriveen Sankar Chittoor Mana, MS, MBA2, Annette Jencson, BSMT, CIC3, Michelle T. Hecker, MD2,4, Amy Ray, MD2,5, Brigid Wilson, PhD1 and Curtis J. Donskey, MD1,2, (1)Geriatric Research Education and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (2)Case Western Reserve University, Cleveland, OH, (3) Cleveland VA Medical Center, Cleveland, OH, (4)MetroHealth Medical Center, Cleveland, OH, (5)University Hospitals Case Medical Center, Cleveland, OH 626 Nurses’ Adherence and Related Factors of Wearing Gloves in Peripheral Intravenous Catheter Insertion SCHEDULE 627 Do Medical Students Receive Training in Correct Use of Personal Protective Equipment? Amrita Rebecca John, MBBS1, Myreen E. Tomas, MD2, Thriveen Sankar Chittoor Mana, MS, MBA3, Adithya Hari, MBBS3 and Curtis J. Donskey, MD2,3, (1)University Hospitals Case Medical Center, Cleveland, OH, (2)Geriatric Research Education and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (3)Case Western Reserve University, Cleveland, OH 628 Simulations Using Surrogate Viruses to Evaluate SelfContamination During Doffing of Ebola PPE Lisa M. Casanova, Ph.D.1, Lisa Teal, BSN2, Emily Sickbert-Bennett, PhD, MS2, William Rutala, PhD, MPH3 and David Weber, MD, MPH4, (1)Georgia State University, Atlanta, GA, (2)Hospital Epidemiology, UNC Medical Center, Chapel Hill, NC, (3)UNC School of Medicine, Chapel Hill, NC, (4)University of North Carolina at Chapel Hill School of Medicine, UNC Health Care, Chapel Hill, NC 629 Survival and Disinfection of Bacteriophage Φ6 on Tyvek Suits Travis W. Brown, MPH, Weiyu Chen, MPH and Lisa M. Casanova, Ph.D., Georgia State University, Atlanta, GA 630 Aerosol Generation During Patient Care Activities Jiayu Li, BS1, Anna Leavey, PhD1, Yang Wang, BS1, Matthew Hink2, Caroline O’Neil, MPH2, Meghan Wallace, BS1, Carey-Ann D. Burnham, PhD3, Pratim Biswas, PhD1 and Hilary Babcock, MD, MPH4, (1)Washington University, Saint Louis, MO, (2)Washington University School of Medicine, St Louis, MO, (3)Washington University School of Medicine, St. Louis, MO, (4)Washington University School of Medicine, Saint Louis, MO 632 U.S. Health Care Personnel Working While Having Influenza-Like Illness, 2014-15 Influenza Season Sophia K. Chiu, MD, MPH1,2, Carla L. Black, PhD3, Xin Yue, MPS, MS3, Marie A. de Perio, MD1, A. Scott Laney, PhD4 and Stacie M. Greby, DVM, MPH3, (1)National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, OH, (2)Epidemic Intelligence Service, Centers for Disease Control and Prevention, Cincinnati, OH, (3)Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, (4)Respiratory Health Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV 633 Varicella Exposure Investigation Takes an Unexpected Turn Oryan Henig, MD, Samyah F Mogalli, MHSA MT(ASCP)CM, Karolina Kaser, BSN, Bhagyashri Navalkele, MD, Elaine Flanagan, MSA, Sorabh Dhar, MD, Marilynn R. Fairfax, MD, PhD, Mark Upfal, MD, MPH, Jim Russell, RN, Keith Kaye, MD, MPH and Teena Chopra, MD, MPH, Detroit Medical Center, Wayne State University, Detroit, MI 634 Double Whammy: Mixed Genotype Norovirus Outbreak in an Adult Psychiatric Unit Michelle T Flood, MSN, RN, CIC1 and Mamta Sharma, MD2, (1) St John Hospital and Medical Center, Grosse Point Woods, MI, (2)St John Hospital & Medical Center, Grosse Pointe Woods, MI 635 An Outbreak of Clostridium difficile Infection Associated with Use of a Defective Commercial Surface Jennifer Cadnum, BS1,2, Michelle Nerandzic, BS3, Annette Jencson, BSMT, CIC3 and Curtis Donskey, MD2, (1)Case Western Reserve University, Cleveland, OH, (2)Geriatric Research, Education, and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (3)Cleveland VA Medical Center, Cleveland, OH YeongSeo Ahn, RN1, Hye-Ran Choi, RN, MPH1, Jae Sim Jeong, RN, MPH, PhD2 and Jeong Hye Kim, RN, PhD1, (1)University of Ulsan, Seoul, Korea, The Republic of, (2)Department of Nursing, University of Ulsan, Seoul, South Korea SCIENCE GUIDING PREVENTION 47 POSTER PRESENTATIONS: FRIDAY, MAY 20 SCIENTIFIC POSTER PRESENTATIONS: FRIDAY, MAY 20 SCIENTIFIC PROGRAM 636 Using Human Factors Engineering to Improve Guideline Compliance: The Case of Ebola Ayse P Gurses, PhD, MPH1, Nancy Edwards-Molello, MBA2, Jen Di Mattina, MS3, Polly Trexler, MS, CIC4, Peter Pronovost, MD, PhD, FCCM5, Lee Jenkins6, Susan Peterson6, Mike Rosen7, Anping Xie, PhD1, Aaron Dietz8, Lauren Benishek8, Myles Leslie8, Trish M Perl, MD, MSc9,10,11, Pete Doyle12, Christina S Halligan8, Sallie Weaver8, Meredith Black, MPH13, JoEllen Harris14, Paula Justice6, Paula Neira12, Tina Tolson12, Kerri Huber12, Glenn Platt15, Pamela Falk, MPH16,17, Jonathan Teter, MS11, Rita Tonner18, Lisa Tomlinson16, Tina Hoang, MHE19, Chelsea Lynch20, Malorie Givan, MPH21, Simone Almeida22 and Lisa L K Maragakis, MD, MPH12, (1)Armstrong Institute for Patient Safety and Quality, Johns Hopkins University, Baltimore, MD, (2)Johns Hopkins Amnstrong Institute, Baltimore, MD, (3)Johns Hopkins Armstrong Institute, Baltimore, MD, (4)The Johns Hopkins Hospital, Baltimore, MD, (5)Johns Hopkins University, Baltimore, MD, (6)JHU, Baltimore, MD, (7)Johns Hopkins Armstrong Institute, Baltimore, MD, (8)Johns Hopkins Armstrong Institute, Baltimore, MD, (9)The Johns Hopkins University, Baltimore, MD, (10) Johns Hopkins Medical Institutions and University, Baltimore, MD, (11) Johns Hopkins University School of Medicine, Baltimore, MD, (12) Johns Hopkins Hospital, Baltimore, MD, (13)John Hopkins Hospital, Baltimore, MD, (14)Johns Hopkins Medicine, SAINT PETERSBURG, FL, (15)Miami University, Oxford, OH, (16)APIC, Washington, DC, (17) Baylor Univerisity Medical Center, Dallas, TX, (18)Suburban Hospital, Bethesda, MD, (19)Johns Hopkins University, baltimore, MD, (20) Veterans Affairs Maryland Health Care System, Baltimore, MD, (21) Sibley Memorial Hospital, Washington, DC, (22)Johns Hopkins Sibley Memorial, Washington, DC 637 Paramyxovirus Outbreak in a Long-Term Care Facility S Shaefer Spires, MD1, H Keipp Talbot, MD, MPH2, Carol Pope, RN3 and Thomas Talbot III, MD, MPH2, (1)VANDERBILT UNIVERSITY SCHOOL OF MEDICINE, Franklin, TN, (2)Vanderbilt University School of Medicine, Nashville, TN, (3)Tennessee Valley Healthcare System, Nashville, TN 638 VIM-Producing Carbapenem-Resistant Enterobacteriaceae in a Neonatal and Adult Intensive Care Unit Anna Quay Yaffee1,2, Lynn Roser1, Kimberly Daniels1, Tom de Man2, Kraig Humbaugh1, Robert Brawley1, Douglas Thoroughman1,2 and Andrea Flinchum1, (1)Kentucky Department for Public Health, Frankfort, KY, (2)Centers for Disease Control and Prevention, Atlanta, GA 639 Carbapenem-Resistant Klebsiella Pneumoniae Outbreak: A Resource Limited Nation’s Response Corey A Forde, MBBS, DM, Queen Elizabeth Hospital, Bridgetown, Barbados SCHEDULE 642 Water Sample Cultures Are More Sensitive Than Swabs in the Detection of Environmental Legionella Spe Brooke K. Decker, M.D., Patricia L. Harris, M.S.N., R.N., Diana L. Toy, B.S.N., R.N., Robert R. Muder, M.D., Ali F. Sonel, M.D. and Cornelius J. Clancy, M.D., VA Pittsburgh Healthcare System, Pittsburgh, PA 643 Ebola Virus Disease Preparation Costs for Acute Care Hospitals in the United States Michael A Smit, MD, MSPH1,2, Leonard A Mermel, DO, ScM, AM (Hon)1,2, Kenneth A Rasinski, PhD3, Barbara I Braun, PhD3, Linda L Kusek, MPH, RN, CIC3, Aaron M Milstone, MD MHS4 and Daniel J Morgan, MD, MS5,6, (1)Brown University, Providence, RI, (2)Rhode Island Hospital, Providence, RI, (3)The Joint Commission, Oakbrook Terrace, IL, (4)Johns Hopkins Hospital, Baltimore, MD, (5)VA Maryland Healthcare System, Baltimore, MD, (6)University of Maryland, Baltimore, MD 644 Evolving Use of Patient Notifications for Communicating Risks Following Infection Control Breaches Kiran Perkins, MD, MPH, Kathy Seiber, MS and Joseph Perz, DrPH, Centers for Disease Control and Prevention, Atlanta, GA 645 Healthcare-Associated Legionella Outbreak : A Collaborative Response Siru Prasai, MD, MPH1, Eugene Livar, MD2, Ronald Klein, RN, BSN1, Jigna Narang, MPH1, Ken Komatsu, MPH2 and Tammy Sylvester, RN, MSN1, (1)Maricopa County Department of Public Health, Phoenix, AZ, (2)Arizona Department of Health Services, Phoenix, AZ 646 Identifying Potential Outbreaks of Clostridium difficile Infections Chelsea Foo, MPH1,2, Kelsey OYong1, L’Tanya D. English, RN, PHN, MPH1, Patricia Marquez, MPH1, Dawn Terashita, MD, MPH1 and Laurene Mascola, MD, MPH1, (1)Los Angeles County Department of Public Health, Los Angeles, CA, (2)CDC/CSTE Applied Epidemiology Fellowship Program, Atlanta, GA 647 Perceived Benefits of EVD Preparation Compared to Cost: A US Nationwide Sample Barbara I Braun, PhD1, Linda L Kusek, MPH, RN, CIC1, Kenneth A Rasinski, PhD1, Leonard A Mermel, DO, ScM, AM (Hon)2,3, Michael A Smit, MD, MSPH2,3, Aaron M Milstone, MD MHS4 and Daniel J Morgan, MD, MS5, (1)The Joint Commission, Oakbrook Terrace, IL, (2)Brown University, Providence, RI, (3)Rhode Island Hospital, Providence, RI, (4)Johns Hopkins Hospital, Baltimore, MD, (5) University of Maryland School of Medicine, Baltimore, MD 640 Costs Associated with Ebola Preparedness at a Pediatric Assessment Center Kari Simonsen, MD1, Amber R. Phipps, MBA2, Mel Hall2, Brenda Heybrock, RN, CIC2, Lindsay Hegemann, BSN, RN, CPN2 and Debra Arnow, DNP, RN, NE-BC2, (1)University of Nebraska Medical Center, Omaha, NE, (2)Children’s Hospital and Medical Center, Omaha, NE 641 Legionnaires’ Disease Outbreak in Outpatients Using a Healthcare Facility Swimming Pool for Aquatic Curtis Donskey, MD1 and Trina F. Zabarsky, RN. MSN, CIC2, (1) Geriatric Research, Education, and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (2)Louis Stokes Cleveland VA Medical Center, Cleveland, OH Top Poster Abstract 48 SHEA Spring 2016 Conference PROGRAM SCHEDULE PLENARY: TELLING STORIES: USING NARRATIVE TO EXPAND AWARENESS OF INFECTION PREVENTION ROLE OF THE MICROBIOME IN RESISTANCE AGAINST HEALTHCARE ASSOCIATED INFECTIONS 1:00 – 2:30 p.m. 2:45 – 3:45 p.m. Peachtree Ballroom CD Moderators: Arjun Srinivasan, MD and Daniel Diekema, MD Speakers: When Antibiotics Fail: A Science Journalist’s Perspective Maryn McKenna, MSJ Patient Advocate Prospective - Victoria Nahum and Armando Nahum Learning Objectives: • Identify methods for improving communication around antibiotic resistance • Describe the patient perspective of HAI FULL CONFERENCE DEVICE-ASSOCIATED INFECTIONS: CAN SCIENCE BRING US TO ZERO? 2:45 – 4:00 p.m. Savannah Ballroom Moderators: Heather Gilmartin, PhD and Shruti Gohil, MD Speakers: CLABSI: The Post-Bundle Frontier - Leonard Mermel, DO VAC: Does Preventing VAC Demand Different Strategies than the VAP Bundle? - Grace Lee, MD CAUTI: Does the CAUTI Bundle Target Patients at Highest Risk for CAUTI Sepsis? - Laurie Conway, PhD Learning Objectives: • Describe the current epidemiology of device-associated infections in light of recent progress toward national targets for HAI reduction • Identify the strengths and limitations of existing bundle elements for addressing “irreducible minimum” device-associated infections • Select strategies beyond the bundle for preventing device-associated infections Chastain Room Moderators: Silvia Munoz-Price, MD and Clifford McDonald, MD Speaker: Eric Pamer, MD Learning Objectives: • Review the human microbiota and microbiome • Discuss the impact of antibiotics and cancer treatment on the human microbiome • Identify the ability of a diverse microbiota to confer resistance against antibiotic-resistant bacterial pathogens and Clostridium difficile A HUMAN FACTORS AND SYSTEMS ENGINEERING APPROACH TO INFECTION PREVENTION 4:15 – 5:45 p.m. Savannah Ballroom Moderators: Michael Rubin, MD and Sarah Krein, PhD Speakers: Basic Concepts in Human Factors Design for Infection Prevention - Sarah Krein, PhD Application of Adherence Engineering to Improve Central Line Maintenance Procedures- Frank Drews, PhD Preventing Clostridium difficile Infection: A Human Factors and Systems Engineering Approach - Nasia Safdar, MD Learning Objectives: • Identify key concepts in human factors engineering • Describe the application of human factors and systems engineering to improve the use of infection prevention practices • Recognize how human factors and systems engineering approaches can be used to improve patient care and healthcare worker safety SCIENCE GUIDING PREVENTION 49 FRIDAY, MAY 20 SCIENTIFIC SCIENTIFIC PROGRAM ORAL ABSTRACT SESSION: TOP ABSTRACT 4:15 – 5:45 p.m. Chastain Room Moderators: Susan Huang, MD and Thomas Talbot, MD 7677Comparing Hospital Compare Ranking With HospitalAcquired Condition Reduction Program Penalty Status Kathleen Gase, MPH, CIC1, Kathleen McMullen, MPH, CIC2 and Hilary Babcock, MD, MPH3, (1)BJC HealthCare, Saint Louis, MO, (2) Christian Hospital, Saint Louis, MO, (3)Washington University School of Medicine, Saint Louis, MO 8039Evaluation of Diagnosis Codes Used to Identify Candidate SSI Events During CMS Validation Michael S. Calderwood, MD, MPH1, Ken Kleinman, ScD2, Christina B. Bruce, BA3, Lauren Shimelman, BA3, Rebecca E. Kaganov, BA3, Richard Platt, MD, MSc3 and Susan S. Huang, MD, MPH4, (1)Brigham and Women’s Hospital, Boston, MA, (2)University of Massachusetts Amherst School of Public Health and Health Sciences, Amherst, MA, (3)Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, (4)Division of Infectious Diseases and Health Policy Research Institute, University of California, Irvine School of Medicine, Irvine, CA 8064Elimination of MRSA and VRE Contact Precautions is Associated with a Reduction in Antimicrobial Use Brandy Bryant, MPH1, Elise M Martin, MD2 and Daniel Uslan, MD2, (1) UCLA, Los Angeles, CA, (2)David Geffen School of Medicine at UCLA, Los Angeles, CA FRIDAY, MAY 20 7716Measuring Antibiotic Appropriateness for Urinary Tract Infections in Nursing Home Residents Taniece Eure, MPH1,2, Nicola Thompson, PhD1,2, Nimalie Stone, MD1,2, Lisa L LaPlace, MPH1,2, Richard Melchreit, MD3, Meghan Maloney, MPH3, Ruth Lynfield, MD4, Tory Whitten4, Linn Warnke4, Ghinwa Dumyati, MD5, Gail Quinlan, RN, MS, CIC5, Cathleen Concannon, MPH5 and Deborah Thompson, MD6,7, (1)Centers for Disease Control and Prevention, Atlanta, GA, (2)Division of Healthcare Quality Promotion, Atlanta, GA, (3)Connecticut Department of Public Health, Hartford, CT, (4)Minnesota Department of Health, Saint Paul, MN, (5)University of Rochester, Department of Health, Rochester, NY, (6)New Mexico Department of Health, Santa Fe, NM, (7)Presbyterian Healthcare Services, Albuquerque, NM 8126Two-State Collaborative Cohort Study of an Intervention to Decrease Ventilator-Associated Events Nishi Rawat, MD, Ting Yang, PhD, MHS, Kisha Jezel Ali, MS, Kathleen Speck, MPH and Sean Berenholtz, MD, MHS, FCCM, Johns Hopkins Medicine Armstrong Institute for Patient Safety and Quality, Baltimore, MD 8159Distribution of Carbapenem-Resistant Gram-Negative Rods — National Healthcare Safety Network, 2014 Maroya Walters, PhD ScM1, Jonathan R Edwards, MStat2, Scott Fridkin, MD2 and Alexander J. Kallen, MD, MPH3, (1)Centers for Disease Control and Prevention, Atlanta, GA, (2)Centers for Disease Control and Prevention, Division of Healthcare Quality Promotion, Atlanta, GA, (3)Division of Healthcare Quality Promotion, CDC, Atlanta, GA 50 SHEA Spring 2016 Conference SCHEDULE S H E A / C D C T R A I N I N G C E R T I F I C AT E C O U R S E I N H O S P I TA L E P I D E M I O L O G Y HOW TO READ A STUDY AND PERFORM RESEARCH 2:45 – 3:30 p.m. Chastain F Speaker: Anthony Harris, MD Learning Objectives: • Examine concepts of study design, implementation of a study infrastructure, analytic methods, data needs and interpretation of data for observational and intervention studies • Distinguish approaches to evaluate the impact of an intervention, including: −− Decreases in rates of HAIs −− Changes in prevalence or incidence of resistant organisms −− Reductions in inappropriate device use −− Reductions in antimicrobial use −− Reductions in length of hospitalization −− Decreases in cost • Assess when to use various study designs such as beforeafter and cluster randomized trials, and when to use various analyses such as time-series analysis • Calculate p values, confidence intervals and effect estimates/ odds ratios to evaluate data for identification of epidemiologic trends, analysis of outbreaks and in the conduct of formal epidemiologic studies • Assess the process for presentation of analytic study data in varying formats, including summary presentations BUSINESS OF INFECTION PREVENTION: PROMOTING GROWTH OF A PROGRAM 3:30 – 4:10 p.m. Chastain F Speaker: Sarah Haessler, MD Learning Objectives: • Explain the importance of physician and administrative leader buy in for an infection prevention Program • Indicate how to write and present to institutional leadership a strategic plan and business case for instituting, maintaining, and expanding of an infection control program • Learn how to successfully recruit physician and administrative champions for planned programs • Discuss how to develop and present a report detailing the rationale and proposed benefits of a Program or intervention, including financial analysis, improvement in patient safety, and justification for funding of proposed team members • Demonstrate how to develop and present annual reports detailing interventions, cost-savings/maintenance, improved patient safety SCIENTIFIC PROGRAM S H E A / C D C T R A I N I N G C E R T I F I C AT E C O U R S E I N H O S P I TA L E P I D E M I O L O G Y SCHEDULE SHEA ANTIBIOTIC STEWARDSHIP TRAINING COURSE THE ROLE OF THE LABORATORY IN HEALTHCARE EPIDEMIOLOGY INFORMATICS AND STEWARDSHIP 4:15 – 5:00 p.m. Speaker: Jerod Nagel, PharmD Chastain F Speaker: Daniel Diekema, MD Chastain E Learning Objectives: • Discuss the major roles of the clinical laboratory in infection prevention, outbreak response, and antibiotic stewardship • Identify promising developments in rapid and/or molecular diagnostic testing in the microbiology lab, including when and how such testing should be incorporated into infection prevention efforts • Assess test characteristics (e.g. sensitivity, specificity, positive and negative predictive value) and that a change in testing methodology may result in an apparent change in incidence or prevalence of an infection or pathogen • Develop and interpret an antibioGram that is consistent with Clinical and Laboratory Standards Institute (CLSI) recommendations • Know when to utilize molecular typing methods for infection prevention and outbreak response, and describe the strengths and limitations of existing typing methods PUTTING IT ALL TOGETHER: LEADING YOUR HEALTHCARE FACILITY THROUGH A MASSIVE EXPOSURE SITUATION Chastain F Speaker: Sarah Haessler, MD Learning Objectives: • Review an interactive case which leads course participants through the work up of a massive exposure in their healthcare facility • Identify skills learned to identify which pathogen is responsible, and the mode of transmission • Identify which healthcare workers and patients were exposed and who needs prophylaxis and/or isolation. • Apply communication skills to effectively convey information within the healthcare organization and to the media • List leadership skills to help respond, organize, and manage the massive exposure. • Identify how information technology infrastructure may assist stewardship programs • Describe how to assess IT resources and external proprietary software programs • List examples of how information technology has assisted successful stewardship programs in various settings CPE Number: 0221-9999-16-092-L04-P MANAGEMENT OF RESISTANT GRAM POSITIVE INFECTIONS 3:30 – 4:00 p.m. Chastain E Speaker: Deverick Anderson, MD Learning Objectives: • Identify common mechanisms of resistance for different bug/ drug combinations including Gram-positive organisms • Discuss therapeutic options for highly resistant organisms • Discuss MICs and breakpoints and their role in determining appropriate therapy CPE Number: 0221-9999-16-093-L01-P MANAGEMENT OF RESISTANT GRAM NEGATIVE INFECTIONS 4:15 – 4:45 p.m. Chastain E Speaker: Christopher Pfeiffer, MD Learning Objectives: • Identify common mechanisms of resistance for different bug/ drug combinations including Gram-negative organisms • Discuss therapeutic options for highly resistant organisms • Discuss MICs and breakpoints and their role in determining appropriate therapy CPE Number: 0221–9999–16–094–L01–P SCIENCE GUIDING PREVENTION 51 FRIDAY, MAY 20 Learning Objectives: 5:00 – 5:45 p.m. 2:45 – 3:30 p.m. SCIENTIFIC PROGRAM SHEA ANTIBIOTIC STEWARDSHIP TRAINING COURSE CASE STUDY #3: STEWARDSHIP AND C. DIFFICILE INFECTION 4:45 – 5:45 p.m. Chastain E Speaker: Belinda Ostrowsky, MD Learning Objectives: • Define laboratory approaches to testing for C. difficile testing and interpret results • Review the association between use of antimicrobials and the development of C. difficile infections • Identify strategies to decrease C. difficile infection rates that include improving antibiotic use and understand how to implement them in a collaborative group including infection prevention FRIDAY, MAY 20 CPE Number: 0221-9999-16-095-L05-P 52 SHEA Spring 2016 Conference SCHEDULE PROGRAM CONTINENTAL BREAKFAST 7:00 – 7:50 a.m. 7th Floor: Augusta Ballroom SCHEDULE ORAL ABSTRACT SESSION: ANTIBIOTIC AND TEST STEWARDSHIP 8:00 – 9:30 a.m. FULL CONFERENCE Moderators: Trevor Van Schooneveld, MD and Matthew Linam, MD PRO/CON: UNIVERSAL PPE 8:00 – 9:30 a.m. Savannah Ballroom Moderators: Ann-Christine Nyquist, MD and Leonard Mermel, DO Speakers: Pro - Anthony Harris, MD Con - Gonzalo Bearman, MD Enduring Competency in PPE - Kari Simonsen, MD Learning Objectives: • Discuss the evidence supporting universal approaches to PPE in healthcare settings • Describe the potential advantages to universal PPE approaches and highlight disadvantages to pathogen-specific approaches to PPE • Discuss the evidence supporting individualized and pathogen-specific approaches to PPE use in healthcare settings • Discuss potential advantages to pathogen-specific/individualized approaches and disadvantages to universal approaches to PPE • Describe the role of planning, preparedness, and competency with a chosen PPE approach • Discuss the evidence supporting the need for demonstrating competency in PPE utilization CROSSING THE STEWARDSHIP CONTINUUM 8:00 – 9:30 a.m. Chastain Room Chastain F Moderators: Neil Fishman, MD and Waleed Javaid, MD Speakers: Not the Usual Suspects - Prescribing in Community Lauri Hicks, DO Breaking the Cycle: Collaborative Antibiotic Use Across the Continuum - Robin Jump, MD Academic and Community Hospital Partnerships in ASP Elizabeth Dodds-Ashley, PharmD Learning Objectives: • Discuss antibiotic stewardship priorities, interventions, implementation and successes across the spectrum of healthcare facilities • Discuss prescribing and antibiotic stewardship initiatives in non-acute care settings, e.g., outpatient offices, pediatrics, urgent care centers • Discuss prescribing challenges and antibiotic stewardship initiatives in long-term care, long-term acute care and chronic facilities, including continuity of prescribing between facilities • Discuss delivery of antibiotic stewardship in different acute care settings including smaller hospital, community settings, large networks. 7883A New Measure of Antimicrobial Use: the NHSN Standardized Antimicrobial Administration Ratio Katharina L. van Santen, MSPH, Jonathan R Edwards, MStat, Arjun Srinivasan, MD, Scott Fridkin, MD and Daniel A. Pollock, MD, Centers for Disease Control and Prevention, Division of Healthcare Quality Promotion, Atlanta, GA 7894Effective Antibiotic Conservation by Emergency Antimicrobial Stewardship During a Drug Shortage Michael Durkin, MD, MPH1,2,3, Maria Reyes, MD1, Tamara Krekel, PharmD2, Ed Casabar, PharmD2, David Ritchie, PharmD2,4, Amanda Hays, PharmD, MHA5, Michael A. Lane, MD, MPH, MSc1,5 and Kevin Hsueh, MD1,2, (1)Washington University School of Medicine, St. Louis, MO, (2)Barnes-Jewish Hospital, St. Louis, MO, (3)Washington University Institute of Public Health, St. Louis, MO, (4)St. Louis College of Pharmacy, St. Louis, MO, (5)BJC HealthCare, St. Louis, MO 7924Impact of Clinical Decision Support Tool on Antimicrobial Stewardship in a Large Health System Roy Guharoy, Pharm.D., MBA1,2, Mylinda Dill, PharmD1, Karen Smethers, Pharm.D.1, Florian Daragjati, Pharm.D.1 and Mohamad Fakih, MD, MPH3, (1)Ascension Health, St. Louis, MO, (2)University of Massachusetts Medical School, Worcester, MA, (3)Care Excellence, Ascension Health, St. Louis, MO 8274IRobot vs. ID: Personalizing Initial Antibiotic Therapy for Patients Hospitalized with Infections Becky Smith, MD1,2, Jessica P Ridgway, MD, MS2, Nirav Shah, MD1,2, Jeffery Semel, MD1,2, Ari Robicsek, MD1,2 and Lance Peterson, MD1,2, (1)NorthShore University HealthSystem, Evanston, IL, (2)University of Chicago, Chicago, IL 7555Evaluating an Antibiotic Stewardship Intervention in Rural China Yanhong Hu, 1B, winter drive1,2, Xiaolin Wei, PhD3,4, Martin Wong, M.D PHD5, Joseph D Tucker, M.D PHD6, Zhitong Zhang, MPH7, Yuanyuan Huang, MPH8 and Simin Deng, MPH9, (1)University of North Carolina, Chapel Hill, NC, (2)The chinese university of HongKong, HongKong, Hong Kong, (3)The chinese university of HongKong, HongKong, China, (4)University of Toronto, Toronto, ON, Canada, (5) Family Medicine and Primary Healthcare, JC School of Public Health and Primary Care, HongKong, China, (6)UNC Chapel Hill Institute for Global Health & Infectious Diseases, Chapel Hill, NC, (7)Nuffield Centre for International Health and Development, University of Leeds, UK (Based in China), Shenzhen, China, (8)Shenzhen CDC, Shenzhen, China, (9)Nuffield Centre for International Health and Development, University of Leeds, UK (Based in China),, Shenzhen, China 7811National Prevalence and Appropriateness of Urine Culture Testing Molly Horstman, MD1, Andrew Spiegelman, PhD2, Aanand Naik, MD1 and Barbara Trautner, MD, PhD3,4, (1)Center for Innovations in Quality, Effectiveness, and Safety, Houston, TX, (2)The Advisory Board Company, Washington, DC, (3)Baylor College of Medicine, Houston, TX, (4)Center for Innovations in Quality, Effectiveness and Safety, Houston, TX SCIENCE GUIDING PREVENTION 53 SATURDAY, MAY 21 SCIENTIFIC SCIENTIFIC PROGRAM NETWORKING BREAK 9:30 – 10:00 a.m. 7th Floor: Augusta Ballroom CLOSING PLENARY: CREATING A CULTURE OF ACCOUNTABILITY AND PROFESSIONALISM TO DRIVE IMPROVEMENT 10:00 – 12:00 p.m. Peachtree Ballroom CD Moderators: Silvia Munoz-Price, MD and Robert Duncan, MD Speakers: Professional Accountability in Pursuit of a Culture of Safety Gerald Hickson, MD Utilizing Shared Accountability in Infection Prevention: The Vanderbilt Hand Hygiene Adventure - Thomas Talbot, MD Peer to Peer Stewardship and SSI Prevention Daniel Raymond, MD Learning Objectives: SATURDAY, MAY 21 • Discuss the importance of a standardized accountability process to address variability in performance • Describe the use of such a process to improve clinician behaviors in terms of hand hygiene compliance, antibiotic stewardship, and adherence to Hai prevention bundles 54 SHEA Spring 2016 Conference SCHEDULE NOTES SCIENCE GUIDING PREVENTION 55 NOTES 56 SHEA Spring 2016 Conference SEE YOU NEXT YEAR! SHEA Spring 2017 Conference March 29-31, 2017, St. Louis, MO Break Root Cause Analysis Practical Session 3:45 - 4:15 PM Change Management and the Science of Safety 2:45 - 3:45 PM The Compendium Strategies for Preventing HAIs 1:45 - 2:30 PM Practical Strategies for Surveillance 1:00 - 1:45 PM Strategies to Prevent Infections & MDROs 4:15 - 5:30 PM Overview of Antibiotic Stewardship 4:30 - 5:30 PM Changing Approaches in Surveillance 2:30 - 4:00 PM Managing Outbreaks 1:00 - 2:15 PM Transmission of Infectious Agents in Healthcare Settings 11:15 - 12:00 AM Introduction to Healthcare Epidemiology 10:15 - 11:15 AM Course Overview 10:00 - 10:15 AM The Possibilities of Innovative Automated Tools in Hand Hygiene Compliance Measurement 11:00 - 12:00 PM Breakout: Advanced AS 1:00 - 2:30 PM What Every Steward Should Know About Pharmacokinetics Pharmacodynamics 2:45 - 3:15 PM Breakout: Beginning AS 1:00 - 2:30 PM AS in Skilled Nursing Facilities & Long Term Care 11:00 - 12:00 PM Challenging Situations 10:00 - 11:00 AM CDI Management 8:45 - 9:30 AM Occupational Health & Safety 8:00 - 8:45 AM Choosing Wisely Co-Organized by The Society of Infectious Diseases Pharmacists (SIDP) 4:15 - 5:45 PM 4:15 - 5:45 PM Oral Abstract Session: Innovation In Infection Prevention Break Case Study #1: Using Benchmarking to Enhance Antibiotic Stewardship 5:00 - 5:45 PM Antibiotic Stewardship: Navigating the Liability Risks 4:30 - 5:00 PM Break An Update on Duration of Therapy and Therapeutic Monitoring: Our Role as Stewards 3:45 - 4:15 PM Pediatric Infection Oral Abstract Session: Prevention: Focus on Outbreaks Allergies, Interactions and Adverse Guideline Implementation 2:45 - 3:30 PM Events 2:45 - 4:00 PM 3:15 - 3:45 PM Implementation Academy: Oral Abstract Session: Turning Science into MDROs Improved Practice 1:00 - 2:30 PM 1:00 - 2:30 PM Creating a Level Playing Field with PublicallyReported HAI Data 10:00 - 12:00 PM Are there Global Standards for Endoscope Reprocessing Methods? 10:00 - 11:00 AM Opening Plenary: CDC and Healthcare Associated Infections: Prevention in the Past, the Present, and the Future 8:00 - 9:30 AM Wednesday, May 18 Surgical Site Infection Prevention: Where Do we SCIP and HOP from Here? 10:00 - 12:00 PM Special Populations: Immunocompromised, ICU, Dialysis & Burn Patients 4:30 - 5:30 PM Environment, Sterilization & Disinfection 3:30 - 4:15 PM PAC<C: Changing the National Landscape and Infection Prevention 2:45 - 3:30 PM Updates from the CDC Prevention Epicenters Program: A Public Health/Academic Research Partnership 4:15 - 5:45 PM Is There Quality in Quality Metrics? 4:15 - 5:45 PM Pro/Con: To Wash or Rub Off C. Difficile and Making the Most of C. Difficile PCR 2:45 - 4:00 PM Break Oral Abstract Session: HAI Surveillance 2:45 - 4:00 PM Movement Break Plenary: Reaching out to New Partners 1:00 - 2:30 PM Practical Considerations in HAI Research 10:00 - 12:00 PM Networking Break (9:30 - 10:00 AM) Selling Your Reults: To Suits, Scientists and Society 8:00 - 9:30 PM Breakfast (7:00 - 7:50 AM) Environmental Disinfection 8:00 - 9:30 PM Lunch (12:00 - 1:00 PM) Problem Session: Outbreak in the OR 11:30 - 12:00 PM Approach to Epidemic/Outbreak Investigation 10:45 - 11:30 AM Unique Aspects of Pediatric Infection Control 10:00 - 10:45 AM CDC Problem Sessions 8:00 - 9:30 AM Thursday, May 19 Art of Antibiotic Stewardship 11:30 - 12:00 PM How to Find Resources at your Institution or Health System 10:30 - 11:30 AM Update on National Stewardship Activities 10:00 - 10:.30 AM Rapid Diagnostic Tests and How to Implement their Use: Minilecture & Case Study #2 8:45 - 9:30 AM Integration of the Microbiology Lab & Antibiotic Stewardship: Beginning Concepts 8:00 - 8:45 AM Regional Approach to MDRO Prevention 10:00 - 12:00 PM Challenging Cases and Issues in Infection Prevention 10:00 - 12:00 PM Research Methods in Novel Engineering Healthcare Solutions to Epidemiology: Environmental Hygiene Practical 8:00 - 9:30 PM Considerations 8:00 - 9:30 PM Putting it all Together 5:00 - 5:45 PM The Role of the Laboratory in Healthcare Epidemiology 4:15 - 5:00 PM Break Business of Infection Prevention: Promoting Growth of a Program 3:30 - 4:10 PM How to Read a Study & Perform Research 2:45 - 3:30 PM Case Study #3: Stewardship and C. Difficile Infection 4:45- 5:45 PM Management of Resistant Gram Negative Infections 4:15 - 4:45 PM Management of Resistant Gram Positive Infections 3:30 - 4:00 PM Informatics and Stewardship 2:45 - 3:30 PM A Human Factors and Systems Engineering Approach to Infection Prevention 4:15 - 5:45 PM Break Device-Associated Infections: Can Science Bring us to Zero? 2:45 - 4:00 PM Top Oral Abstract Session 4:15 - 5:45 PM Role of the Microbiome in Resistance Against Healthcare Associated Infections 2:45 - 3:45 PM Plenary: Telling Stories: Using Narrative to Expand Awareness of Infection Prevention 1:00 - 2:30 PM Regulatory & Emergency Preparedness 11:00 - 12:00 PM Occupational Health Issues 10:00 - 11:00 AM The Hospital Epidemiologist as a Clinician Educator 8:45 - 9:30 AM Leadership and Communication Skills 8:00 - 8:45 AM Friday, May 20 CONFERENCE AGENDA — View inside Schedule at a Glance Crossing the Stewardship Continuum 8:00 - 9:30 PM Oral Abstract Session: Antibiotic and Test Stewardship 8:00 - 9:30 AM Closing Plenary: Creating a Culture of Accountability and Professionalism to Drive Improvement 10:00 - 12:00 PM Pro/Con: Universal PPE 8:00 - 9:30 PM Saturday, May 21